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“Science, my lad, is built upon many mistakes; but they are errors which it is good to fall 
into, for they lead little by little to the truth.” 
- Jules Verne 
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 vii 
Abstract and Layout of Thesis 
Nature abounds with ingenious nanoscopic machines employed to carry out all of the 
requisite tasks that collectively contribute to the molecular basis of life.  This thesis 
focuses primarily on a sub-set known as "molecular walkers" which can perambulate 
along intracellular molecular motorways carrying out such essential tasks as vesicle 
transport and muscle contraction.  A summary of these incredible natural motors is 
presented in Chapter I along with a review of the artificial small-molecule mimics 
reported to date.  When elucidating a set of design principles for synthetic analogues, 
inspiration is taken from the mechanism of the biological bipedal motor protein kinesin 
with a focus on potential strategies to enable directional walking. 
Transition metal-ligand chemistry is utilised as one such strategy in Chapter II through 
the governance of walker-track interactions in the design, synthesis and operation of a 
bimetallic molecular biped.  A palladium(II) moiety is selectively and intramolecularly 
stepped between pyridine-derivative binding sites in the track using a thermal stimulus 
in the presence of a coordinating solvent.  Acid-base manipulations facilitate directional 
stepping by means of an energy ratchet mechanism allowing the track to do work on 
the biped unit and ultimately drive it away from equilibrium. 
The potential of malleable transition metal binding-event energetics is explored further 
in Chapter III with the design and synthesis of a platinum(II)-complexed [2]rotaxane.  
Thermodynamic and kinetic stimuli are investigated as means to mediate selective 
shuttling of a Pt-complexed macrocycle between two ligand binding sites in the thread.  
The substitution pattern of the ligands and the kinetic stability of the metal-ligand 
bonds afford exceptional metastability to the co-conformers of the molecule in the 
absence of an external stimulus providing the possibility for long-term information 
storage. 
In Chapter IV, a novel macrocycle is used to demonstrate the chemical orthogonality of 
acid-mediated hydrazone exchange with respect to the palladium(II) stepping 
mechanism described in Chapter II and show that two such motifs can be 
independently addressed within a single molecule.  These linkages are then utilised as 
mutually exclusive chemo-selective switches to individually operate opposing feet in an 
unprecedented first-generation small-molecule walker-track system. 
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"Any intelligent fool can make things bigger and more complex.  It takes a touch of genius 
- and a lot of courage - to move in the opposite direction." 





At the dawn of the twenty first century, man stands in awe of Nature's phenomenal 
achievements in moulding the world around us.  Its intangible complexities have provided 
myth and mystery to our forebears with each successive generation of philosophers 
offering their own theories and solutions in the gradual evolution of our knowledge and 
understanding.  As awareness of the molecular basis of life has grown over the last fifty 
years, the exquisite intricacies of Nature's methods have become evermore apparent and 
one conclusion has been prevalent throughout: the control of molecular-level motion is 
fundamentally essential to life. 
Nature employs a host of hugely varied and sophisticated molecular machines and motors 
to instigate controlled movement at the molecular level; each individually suited to its 
environment and specifically designed to carry out essential tasks such as vesicle 
transport, sensory transduction and muscle contraction.  Kinesins are a particularly 
impressive superfamily of linear motor protein that act as "molecular walkers" capable of 
transporting cargoes along cellular motorways to predefined locations.  The primary 
obstacle to designing artificial analogues of these systems is the incorporation of 
appropriate interactions between the "feet" of the walker unit and the track upon which it 
walks.  DNA base-pair interactions and dynamic covalent chemistry have both been used 
successfully in the past but the advancement of the field depends upon developing 
improved levels of control over stepping mechanisms and the potential to customise 
systems for specific environments.  In this thesis, transition metal-ligand motifs are 
developed as the molecular sub-components for one such mechanism and the first 





The science of substances in the seventeenth century was dominated, as it had been for 
many years prior, by those with an aim of transmuting lead into gold and the quest for 
the ever-illusive Philosopher’s Stone.  As the century drew to a close, however, the 
threads of Aristotle’s four element theory were beginning to come loose and, with the 
publication of The Sceptical Chymist1 in 1661, Robert Boyle effectively sounded the 
death knell on alchemy and implored its ambassadors to lay down their quills in favour 
of the test tube and rigorous calculated experiment; for, to his mind, only with the 
accompaniment of concurrent results from such experiments could their theories ever 
be unequivocally proven fact.  This radical idea shook the very foundations of science 
and set in motion a revolution that would eventually herald him as one of the founding 
fathers of modern chemistry. 
A veritable explosion of scientific research and discovery soon followed fuelling an 
exponential growth in mankind’s understanding of the fundamentals of life on Earth, 
matched only by his will to control them.  However, with this increasing wealth of 
knowledge came an awakening sense of awe at the disparity between Nature and 
humankind’s respective capacities to constructively wield the forces of the world, most 
notably at the molecular level.  This realisation was famously laid out by Richard 
Feynman in a speech to the California Institute of Technology2 in 1959 when he 
proposed that scientists would one day be able to manufacture active molecular species 
that function and carry out useful tasks on a nanoscopic scale, in much the same way 
that Nature manipulates molecular-level movement to perform the vast majority of its 
key operations. The rise of the field of synthetic molecular machines has been 
instrumental in meeting some of the challenges thrown down by Feynman and 
examples now exist of fully functional synthetic molecular motors3 that consume fuel 
and do mechanical work at the molecular level.  Most of these systems are designed to 
achieve rotary motion4 whilst linear molecular motors have received far less attention. 
This chapter will address a particular set of linear motors known as "molecular 
walkers", which are motor units that can walk down molecular tracks.  A general set of 
principles for the design of such systems is outlined and the progression of the field to 




1.3 Molecular Machines 
Molecular motors and machines are ubiquitous throughout biology as the shepherds of 
chemical systems at the molecular level.  They are capable of controlling nano- and 
micrometre scale movements on account of their inherent ability to drive said systems 
away from equilibrium, thereby enabling specific tasks to be performed and work to be 
done.3,5 Thus far however, scientists have struggled to synthetically replicate anything 
close to such control, primarily due to the fact that the macroscopic mechanical 
engineering that has been developed and mastered over the years is governed by 
fundamental physics inapplicable at the molecular level.6 
Molecules and their constituent parts do not subscribe to the Newtonian laws of 
momentum.  Instead they are incredibly susceptible to temperature variation and exist 
in a constant state of flux, moving incessantly and in a random, chaotic manner known 
as Brownian motion.  The effect of gravity on these systems is negligible and, when in 
solution, movement is dominated by the frictional forces of their extremely viscous 
surroundings.7 Consequently, any attempt at controlled, inertia-induced displacement 
is rendered ineffectual by the overpowering effects of the environment’s background 
motion.  R. D. Astumian deemed Brownian machines’ remarkable proficiency to 
overcome these ordeals equivalent to man being able to “swim in molasses and walk in a 
hurricane”.8 They accomplish this feat, not by attempting to counteract and overpower 
the adverse forces, but rather by harnessing them in order to meet their own ends.  
This is often achieved through the use of mechanical bonds that can incur restrictions 
upon the degrees of freedom available to a machine’s component parts with respect to 
one another, whilst still retaining the potential for large amplitude displacement along 
certain desired vectors.  By using a stimulus that can affect the nature of these 
mechanical bonds, it is possible to drive the systems away from their equilibrated 
states, which can subsequently result in overall controlled, directional molecular 
motion.  It should be noted, however, that this capacity alone does not warrant a 
system to be termed a "molecular machine", as the other prerequisite for such an 
accolade is the ability to carry out constructive work. 
It is pertinent at this juncture to more rigorously define the term and hereafter 




stimulus triggers the controlled, large amplitude mechanical motion of one component 
relative to another which results in a net task being performed”.3 
One area in which Nature truly displays a tour de force in terms of manipulating 
molecular motion is in biology’s wide array of motor proteins.  These fall into the two 
broad classes of rotary and linear motors. 
1.4 Motor Proteins 
Nature employs an army of incredibly diverse motor proteins throughout biology with 
a huge range of different molecular architectures and cellular roles, but all of them 
commonly operate by converting an energy input into mechanical or chemical work.  
This is how DNA and RNA polymerases9 are able to convert monomeric nucleotides 
into incredibly sequence-specific polymers; how translocation pores10 are able to 
selectively transport proteins through membranes against concentration gradients; 
how the remarkable rotary motor of bacterial flagellar11 propels bacteria at speeds of 
hundreds of micrometres per second; how the rotating motor F0F1-ATPase12 uses a 
proton gradient to produce the ubiquitous cellular fuel adenosine triphosphate (ATP); 
and how the hoards of different molecular walkers walk along molecular cytoskeletal 
polymer highways within the cell performing such tasks as mitosis, sensory 
transduction and muscle contraction as well as the imperative act of intracellular cargo 
transportation.  These natural molecular walkers are known as cytoskeletal motor 
proteins13 and are of particular importance here as they provide the inspiration for the 
work carried out in this thesis. 
Linear Motor Proteins 
As previously mentioned, the crowded cytoplasmic environment within cells is not 
conducive to efficient cargo conveyance by means of one-off spot forces because 
inertial terms are heavily outweighed by motion dampening frictional forces in the 
highly viscous surroundings.  Nor can diffusion alone be counted upon to accommodate 
the many important intracellular reactions at a suitable rate.  Nature, therefore, often 
employs linear motor proteins as cargo carrying molecular walkers to manage these 
highly specific tasks.  These proteins fall into three superfamilies; myosins, dyneins, 
and kinesins (Figure 1.1) and all function by converting chemical energy into 





Figure 1.1 - Comparison of examples from the three superfamilies of Nature’s linear proteins: (a) 
myosin-V; (b) cytoplasmic dynein; (c) kinesin-I.  Colour coding: dark blue: motor domains; light 
blue: mechanical amplifiers; purple: cargo attachment site; green: motor units.  Modified with 
permission (Cell Press).13c 
Differential to their rotary analogues, linear motor proteins achieve controlled 
translational motion with the aid of well-defined tracks to which they adhere and along 
which they can "walk".  Myosins,14 responsible for muscle-contraction in the body and 
intracellular vesicle transport, bind actin filaments15 as a track whereas dyneins16 and 
kinesins17 traverse along tightly wound biopolymers known as microtubules.18  Many 
of the members of these three superfamilies exhibit different modes of action and are 
employed simultaneously within the same organism to carry out specific tasks.  
Although kinesins were the last of the three superfamilies to be discovered,19 they have 
since proven susceptible to simple manipulation using the various tools of molecular 
biology, and a prolific wealth of literature is now devoted to them.17,20  To date, it has 
been established that the human body plays host to at least 45 discernable kinesins 




the motor domains throughout the set.21  The majority of research has predominantly 
revolved around conventional kinesin (also known as kinesin-1 and hereafter referred 
to simply as kinesin) due to the ease of its purification from brain homogenates20d and 




Figure 1.2 - Conventional Kinesin: illustration based upon the crystal structure of the catalytic 
core and neck linker and the electron-microscopy images of the chain and tail domains. Modified 
with permission (Nature Publishing Group).24 
Kinesin is a homodimeric species made up of two chains of 120 and 130 kDa each and 
comprising three distinct domains: motor; chain; and tail as shown in Figure 1.2.  The 
motor domain consists of two identical motor heads or "feet", each containing a 
catalytic core that binds to tubulin subunits in the microtubule track22 and controls ATP 
hydrolysis in the molecule. The feet are connected to the central stalk chain domain via 
adjacent flexible neck linkers, which control their respective orientation and ensure 
that they are held at the optimum separation of 8 nm;23 in keeping with the spacing 
between α/β-tubulin dimers in microtubules and hence kinesin’s individual stepping 
distance.  The coiled-coil stalk of the chain domain is in turn bound to the tail domain, 






Figure 1.3 - Kinesin’s mode of action: (a) “resting state” with one head strongly bound to the track, 
the other free to explore binding sites. (i) ATP (T) binds kinetically locked foot; (b) stepping foot 
forms weekly-bound state with next binding site. (ii) dissociation of phosphate (Pi) and ADP (D); 
(a’) analogous to initial resting state but one tubulin dimer along the track. α and β represent the 
different tubulin dimers that impose overall polarity on the track. 
The walking action of kinesin is fuelled by the hydrolysis of ATP to adenosine 
diphosphate (ADP) and an inorganic phosphate (Pi).  In a resting state (Figure 1.3a), 
kinesin is tightly attached to the microtubule track via a kinetically locked, nucleotide-
free foot.  The tethered foot, meanwhile, is not bound to the track but its motor domain 
is bound to ADP (D), the microtubule-activated release of which is stably inhibited.20c,25 
ATP can selectively bind the locked foot with its vacant motor domain, partially 
relieving this inhibition whilst simultaneously releasing a significant amount of energy.  
This release gives rise to docking of the neck linker to the motor domain, which 
manifests itself in a conformational change that slings the tethered foot towards the 
plus-end of the microtubule in the so-called power-stroke.  The unbound foot is then 
free to explore the available binding sites, both in front and behind its opposing foot; 
however, the neck-linker docking enforces a temporary asymmetric energy potential 
favouring the forward step (Figure 1.3b) and is therefore responsible for the overall 
directionality of kinesin's movement by means of a Brownian ratchet mechanism3 (vide 
infra).  There is still some debate as to the order in which the following events proceed, 
but in Block's "consensus model",17a ADP is released from the anterior foot leading to 
tightened binding with the microtubule and increased ring strain which supresses 




respective ATP expelling inorganic phosphate.20c,d,26 This process culminates in an 
analogous state to the original resting state, only two tubulin units along23b (Figure 
1.3a') and is tantamount to a single catalytic stepping cycle, the repetition of which 
constitutes kinesin’s complete walking mode of action.  This locomotive method is 
commonly referred to as a "passing-leg" or "hand-over-hand" mechanism and, after 
years of debate, was independently confirmed for kinesin by both Kaseda et al.27 and 
Yildiz et al.26b Optical trapping studies have shown kinesin to be capable of up to 100 
ATP turnovers before complete dissociation from its track equating to a walk of ~1 mm 
in a single direction.20a,28 
Whereas in day-to-day life the walker decides which route to take, in the case of 
kinesin, it is in fact the track that ultimately dictates directionality.  This comes as a 
result of anisotropy in the polymeric microtubule where the chains of self-assembled 
α/β-tubulin dimers create an inherent overall polarity in the track.29 As previously 
mentioned, kinesins walk unidirectionally with 42 of the 45 human kinesins known to 
perambulate from negative to positive, which, in most cells, amounts to anterograde 
motion where cargo is transported away from the centre to the periphery of the cell.21 
The primary aim of this project is to use the fundamental principles of molecular 
walking exhibited by kinesin to investigate potential chemical motifs for use as 
components in the design of simplified synthetic small molecular analogues. 
1.6 Design Principles For Synthetic Walking Molecules 
The term "molecular walker" has so far been applied to a class of natural linear motors 
because they move in a manner reminiscent of man's own mode of perambulation.  
However, considering the staggering differences between life at the macro- and 
molecular levels in terms of environments and the laws by which they are governed, it 
seems prudent to outline a precise set of definitions for use when establishing 
principles for the design of minimalist artificial analogues.  The Oxford English 
Dictionary defines stepping as, “An act of bodily motion consisting in raising the foot 
from the ground and bringing it down again in a fresh position” and walking as, “The 
action of moving or travelling . . . by lifting and setting down each foot in turn so that one 
of the feet is always touching the ground”.  From this it can be said that a walker must 
have at least two well-defined feet that, as a pair or set, act as the only necessary points 




prerequisite exists such that one foot must be in contact with the surface or track at all 
times regardless of the other foot/feet.  Such a system will cease to be termed a walker 
if it begins to translocate its centre of mass without the use of discrete steps (e.g. rolling 
or tumbling) or at such a time that no feet remain attached to the track (e.g. running or 
jumping).  By adopting these provisos the basic principles of walking can be transferred 
to a synthetic design.  However, whereas Nature has had millions of years to evolve, try 
and test-drive the molecular walkers described in the previous sections, synthetic 
analogues must be designed, tuned and built for instant effective operation.  In a recent 
critical review of walking molecules, von Delius and Leigh30 outlined five fundamental 
characteristics of the dynamic behaviour with respect to the interactions between the 
walker units and their tracks, which are discussed in detail below.   
1.7 Keep Your Feet On The Ground - Processivity 
Processivity is the ability of a molecular walker to remain attached to its track during 
operation.  Whereas their macroscopic counterparts enjoy the benefit of gravity to keep 
their feet securely on the ground, molecular walkers must incorporate additional 
safeguards to ensure this linkage at all times.  Whilst not all of Nature's linear motors 
operate processively (e.g. conventional myosin), non-processive motors can only do 
work in large ensembles where multiple walker units are simultaneously attached to 
the same track.  This is a very difficult and complicated feat to achieve synthetically and 
so this project will focus primarily upon walker units that do not fully detach from their 
tracks.  One factor that can significantly affect a system's processivity is the act of inter-
track stepping, but this can be quite easily avoided in artificial systems by operating 
under dilute reaction conditions or appending the molecular track to a suitable surface. 
In a perfectly processive molecular walker, the walker unit is attached to its track by 
some means at all times.  The easiest way to achieve this synthetically is to incorporate 
two chemically different feet that can be labilised under mutually exclusive conditions 
so that when one foot is undergoing a stepping process, the other is kinetically locked 
to the track and acts as an inert pivot.  The simplest possible hypothetical walker unit 
of this kind is outlined in Figure 1.4 and has two feet (1 and 2) linked together by an 
inelastic, non-rigid linker motif that separates them by a fixed distance (x).  Consider 
setting this walker unit upon a track with two alternating footholds (A and B), each 





Figure 1.4 - Generic two-footed walker unit upon an ABABAB track in state [1A, 2B].31 
If it is specified that, dependent upon two mutually exclusive external stimuli, 1 and 2 
can have binding preferences for either A or B, then locked generic linkages 1A, 1B, 2A, 
and 2B can all be readily formed.  The walker’s initial position can be described as  
[1A, 2B], with foot 1 shown in yellow, foot 2 in red and A and B are green and blue 
respectively.  Applying a stimulus that labilises foot 1 from foothold A whilst leaving 
linkage 2B unperturbed generates the intermediate [2B]1*, where foot 2 is still strongly 
bound to foothold B but foot 1 is free to explore other binding sites (here indicated  
by *) via free rotation around the non-rigid linker (Figure 1.5).  Upon removal of the 
stimulus, foot 1 will regain its affinity for foothold A and re-form a locked generic 1A 
linkage with the closest suitable foothold giving rise to a statistical 1:1 ratio of spatial 
isomers [1A, 2B] and [2B, 1A’], where 1A’ indicates that this linkage is one AB unit away 
from the origin. 
 
Figure 1.5 - Mid-step co-conformation of [2B]1* (top) gives rise to equal populations of the two 
states [1A, 2B] (left) and [2B, 1A’] (right) when the stimulus is applied favouring the formation of 
generic linkage 1A. 
By applying a second, orthogonal stimulus that labilises foot 2 from foothold B whilst 
leaving linkages 1A and 1A’ unperturbed, generic states of the type [1A]2* are formed.  
Free rotation about the non-rigid linker, followed by subsequent removal of the second 
stimulus, regenerates generic 2B linkages resulting in three statistically populated 
translational isomers; [1A, 2B], [2B, 1A’], and [1A’, 2B’] in the ratio 2:1:1 (Figure 1.6).  
This distribution is the result of the walker units starting from state [1A, 2B] (half of the 




down the track due to constraints imposed by the inelastic link to locked foot 1 on 
foothold A, whilst the walker units initially in state [2B, 1A’] can either recover this 
state, or advance to [1A’, 2B’] upon removal of the stimulus, each outcome having a 
probability of 0.5. 
 
Figure 1.6 - Three co-conformers possible after the second step of an ABABAB walker. 
Reapplying the first stimulus labilises all generic 1A linkages generating various 
different states of [2B]1*, which then give rise to four inequivalent spatial isomers upon 
removal of the stimulus to the ratio of 3:3:1:1.  The second law of thermodynamics 
states that unidirectional motion can only be achieved in conjunction with energy 
expenditure.32 In a system such as this, devoid of chemical fuel and where there is no 
in-built directional bias, there can be no controlled directed motion and the overall 
populations of each state are governed purely by statistics.  In this sense, Figure 1.6 is 
slightly misleading because, as drawn, it implies a general migration of walker units 
from left to right.  However, this is only because [1A, 2B] was arbitrarily elected as the 
starting state.  In fact, if the sequence of alternating stimuli were repeated for a suitably 
long time, the system would reach equilibrium with the populations of each state 
abiding by a normal distribution about a modal population class in the centre of the 
track.  A molecule such as this, that uses two simple switches as feet and migrates in 
either direction along a track with equal probability cannot be deemed a motor because 





1.8 Ratchet Mechanisms - Directionality 
For a molecular walker to be directional it must migrate either preferentially, or 
exclusively to a single end of a molecular track in the same manner as all of Nature's 
translational molecular motors.  The study of non-equilibrium statistical mechanics and 
thermodynamics has proven to be a very useful tool in elucidating key aspects of 
achieving directional bias in molecular-level motion.  The Principle of Detailed 
Balance33 states that, within a system at equilibrium, transitions between any two 
states take place in either direction at an equal rate. 
Eqn 1.1 -    NiPij=NjPji 
For a system that contains species i and j in dynamic exchange at equilibrium, the 
number of transitions from state i to state j is equal to the number of transitions in the 
opposite direction as described by Equation 1.1, where Ni is the number of particles in 
state i and Pij is the probability of transition from state i to j for a given particle.34 
These terms can help define the key differences between simple molecular switches 
and genuine molecular motors.  A switch can be described as a system that progresses 
from state i to j along a reaction pathway and can only be returned to its original state 
by returning along that same pathway, thereby undoing the task performed in the 
initial transition.  Alternatively, a motor can return to state i from j via a different, non-
reciprocal route to the one already travelled meaning that the completion of a cycle of 
operation can reset the motor without undoing the mechanical work done on the 
system.  In this way switches are said to influence a system as a function of state, 
whereas motors influence a system as a function of the trajectory of their components 
or substrates.3 Regardless of the molecular device in question, be it a switch or a motor, 
directionality can only be achieved by disturbing the equilibrium with an energy input 
(a fuel or external stimulus) that facilitates the breaking of detailed balance.  A dynamic 
switch will re-equilibrate to its thermodynamic minimum upon suspension of the 
stimulus or fuel input, whereas a molecular motor can harness the work done by 
invoking impassable kinetic barriers to dynamic exchange between states thus 
compartmentalising the system.3 This method is exploited in both biological and 
synthetic molecular motors8,35 and can be described according to Brownian ratchet 
theory,36 which explains how the thermally driven positional displacement of a 




displacement once the thermodynamic driving force is removed.  Although many 
different theoretical variations exist, they all rely upon three key facets of the theory: 
the presence of a randomising element (Brownian motion in molecular scale motors); 
an energy input; and an asymmetric potential of energy or information in the direction 
of the motion.  In this way, a Brownian particle can be transported directionally along a 
compartmentalised potential energy surface.  The instillation of directionality is 
governed by the nature of the third of these tenets which can be divided into the two 
general classes of energy ratchets and information ratchets. 
Energy Ratchets 
In an energy ratchet mechanism, the transport of a particle along a potential energy 
surface is achieved by periodic perturbation of the thermodynamic minima and kinetic 
barriers.  Cyclic fluctuation of energy maxima and minima can facilitate directional 
movement irrespective of the position of the particle on the surface. 
 
Figure 1.7 - Brownian energy ratchet mechanism.  Sequential fluctuation of the energy maxima 
and minima induce directional movement of a Brownian particle (green). 
Figure 1.7 shows a Brownian particle (green) at equilibrium upon an asymmetric 
potential energy surface that incorporates a periodic series of two unique energy 
maxima and two unique energy minima.  The particle can be transferred from left to 
right by simultaneously or sequentially inverting the relative energies of the 
thermodynamic minima and the kinetic barriers.  Although some transport of the 
particle from right to left will still occur, the majority of the particles will translocate 
rightwards because, as drawn, the orange and blue thermodynamic minima always 
have the greater kinetic barrier to their left.  It is clear that the direction of transport 




several catenane- and rotaxane-based molecular motors and devices have been 
reported that operate using energy ratchet mechanisms.4c,d,37 
Information Ratchets 
Alternatively, the thermodynamic minima of the potential energy surfaces of 
information ratchets are fixed and directional motion is achieved by raising and 
lowering kinetic barriers to translation according to the position of the particle.  There 
is therefore a requirement for information of the particle's position to be 
communicated to the kinetic barrier. 
 
Figure 1.8 - Brownian Information ratchet mechanism.  A Brownian particle (green) is 
directionally transported along an asymmetric potential energy surface.  The relative magnitudes 
of the kinetic barriers result from an information transfer between the particle and the barrier 
(dotted arrow). 
In Figure 1.8, a Brownian particle lies at equilibrium upon an asymmetric potential 
energy surface that incorporates a series of identical potential energy wells, each 
separated by a kinetic barrier.  A stipulation exists such that the particle can only 
communicate its presence to the kinetic barrier directly to its right.  In so doing, the 
barrier can be lowered establishing a new equilibrium where a 1:1 distribution will 
form between the first two wells and the barrier is subsequently raised again.  Because 
migration to the left is impossible, the particle can progress directionally despite the 
unbiased reversibility of step ii.  Although reports of rotaxane-based information 
ratchets have been scarce,38 a synthetic small molecule capable of directionally walking 
along a track by means of information ratchet mechanisms has recently been 




1.9 Repetitive, Progressive, Autonomous Operation 
The other stipulation for linear molecular motors is that they can be operated in a 
repetitive and progressive manner.  This means that they must be able to repeatedly 
carry out similar mechanical cycles, and that it is possible to reset the walker-track 
conjugate after operation without undoing the physical task that was originally 
performed.  This can be readily achieved in non-interlocked molecular walker systems 
by detachment of the walker unit from the end of the track along which it has walked, 
and subsequently reattaching it at the original starting position.  In terms of ratchet 
nomenclature, this is known as an "escapement"37a where the ratcheted substrate (the 
walker unit) can be released and the system reset with the overall achievement of net-
mechanical work being done.  The presence of an escapement defines the difference 
between a simple ratchet and a genuine motor. 
Autonomous operation is certainly a long-term goal for synthetic systems as the vast 
majority of cytoskeletal motor proteins operate allosterically and autonomously in the 
constant presence of an ATP fuel.  Their feet are coordinated and the systems employ 
complex structural gates to enforce processivity.  Two synthetic examples have been 
reported recently in which small molecules can walk processively along polyamine 
tracks through reversible imine formation without the aid of external stimuli,40 
however, both systems are non-directional.  It is also difficult to envisage how one 
might instil an appropriate bias with current synthetic techniques, short of simply 
introducing a thermodynamic sink at the end of the track to which the walker units 
would statistically migrate. 
An alternative approach is to devise designs that incorporate sequential stepping of 
feet controlled by external stimuli, which can ultimately allow for greater degrees of 
control over the direction of movement as well as the rate and distances travelled.  The 
following discussion will therefore exclusively cover sequenced stepping mechanisms, 
specifically in bipedal systems.  These designs rely upon the operator’s ability to 
address each foot-foothold interaction independently of the other.  In the design of 
random walkers based on the simplistic models described in Section 1.7, this 
requirement is practically realisable through the incorporation of two orthogonal, 
chemo-selective molecular switches that individually govern the foot-track 




attain the coveted prize of directionality, an asymmetric potential must be sequentially 
introduced during the stepping process of each foot, in other words, one must 
substitute simple switches for ratchet motifs. 
1.10 Molecular Motion: Switches, Shuttles and Ratchets 
Nature's methods of manipulating molecular movement through the control of 
Brownian motion have been an inspiration to scientists for decades, but it was not until 
the late twentieth century that synthetic skills reached a suitable level for mimics to be 
designed and made in the laboratory.  In 1994, Stoddart et al. reported one of the first 
examples of a synthetic molecular device capable of harnessing Brownian motion to 
produce well-defined movement of its constituent parts.41 The system made use of 
template-directed rotaxane synthesis to achieve a [2]rotaxane with a tetra-cationic 
cyclophane macrocycle threaded onto a stoppered two-station track as shown in Figure 
1.9.  A biphenol and a benzidine unit provide the two π-electron donor stations. 
 
Figure 1.9 - Switchable molecular shuttle: (top) neutral conditions, the macrocycle preferentially 
occupies the benzidine station (left); (bottom) protonation of the benzidine moiety results in 




At room temperature, the macrocycle shuttles between stations at a rate comparable to 
the NMR timescale, however, when the system was cooled, 1H NMR and 
ultraviolet/visible spectroscopy confirmed that the majority of the macrocycles resided 
on the benzidine station.  It was then shown that the average distribution of 
macrocycles could be shifted to have a majority on the biphenol station by two separate 
means: either by adding two equivalents of acid and hence protonating the basic 
nitrogen atoms on the benzidine residue, or alternatively, by the electrochemical 
oxidation of this station.  Both of these methods make use of repulsive electrostatic 
interactions between the positively charged macrocycle and the post-switching cationic 
nature of the benzidine station, ultimately resulting in a controlled shuttling process.  
This system was one of the first examples of what have come to be known as molecular 
shuttles, a subset of switchable species within the then-emerging field of synthetic 
molecular machines, and provided precedent for a whirlwind of research that followed 
which has been comprehensively reviewed.3,42 An enormous amount of work has since 
focused upon the goal of achieving unidirectional motion by controlling relative inter-
component movement of interlocked molecular devices, both rotational,4a,b,43 and 
translational.44 Catenanes and rotaxanes have proven to be particularly suited to such 
tasks, as they possess mechanical bonds that can incur significant restrictions upon the 
degrees of freedom available to the interlocked components whilst simultaneously 
accommodating large amplitude motion along a desired vector.  Molecular shuttles of 
the type outlined in Figure 1.9 can be described in terms of their individual 
components where the thread fulfils the role of the "machine" entity and can do work 
on the macrocycle, which is regarded as a Brownian particle.  The vast majority of 
examples in the literature represent simple rotaxane switches that can be moved 
between positional states, but each time the position is switched, the work done during 
the previous positional change is consequently undone.  In 2006, Leigh et al. reported 
the first example of a [2]rotaxane that could be locked in an out-of-equilibrium state by 
means of an energy ratchet mechanism37a meaning the thread could be reset after 
operation without automatically instigating the reverse shuttling of the macrocycle.  
Only a few examples of such molecular ratchets exist in the literature,37,38 the most 




Figure 1.10 - Operation conditions and positional bias of switchable palladium(II)-complexed 
molecular shuttle that operates by an energy ratchet mechanism.37c 
The system comprises a palladium(II)-complexed macrocycle threaded on a stoppered 
two-station track.  A 4-dimethylaminopyridine (DMAP) and a pyridine group (Py) in 
the track provide the two ligand-binding sites (stations).  The metal remains complexed 
to the macrocycle at all times and translocation of the ring-complex is dictated by 
simple ligand exchange.  The stimulus for labilising palladium from either of the two 
monodentate ligands in the thread is elevated temperature in the presence of a 
coordinating solvent.  Re-coordination to a particular station in the track is achieved by 
allowing the system to cool to room temperature.  Whilst the labilising stimulus is 
being applied, an equilibrium is established to which an asymmetric bias can be 
induced by addition or removal of protons.  Protonation of the more basic binding site 
determines the position of equilibrium.  Importantly, the stability of the Pd-N bond in 
these complexes ensures that variations in the chemical state of the thread, i.e. degree 
of protonation, have no effect on the position of the macrocycle without application of 
the labilising stimulus because of a kinetic barrier to equilibration, thus rendering the 
system an efficient molecular energy ratchet.  Combining the mechanistic principles 
extrapolated from biology with the expertise and knowledge cultivated through 
development of rotaxanes as molecular switches and ratchets has led to the first steps 




1.11 Synthetic Walking Molecules  
Until relatively recently, the only synthetic structures capable of taking multiple, 
processive steps along a molecular track had been unanimously assembled, at least in 
part, from DNA building blocks.45 These DNA walkers represent genuine linear 
molecular motors where the walker units migrate progressively in a specified direction 
along molecular tracks and can be operated in a repetitive manner.  The systems are 
highly efficient and can be synthesised in an automated fashion, thus providing 
valuable inroads to useful and applicable mimics of Nature's packhorse motor proteins.  
However, whereas high precision analytical techniques such as nuclear magnetic 
resonance spectroscopy (NMR) and high performance liquid chromatography (HPLC) 
are largely incompatible with the large chemical structures involved in DNA walkers, 
they can be readily applied to small-molecule systems facilitating more intricate 
mechanistic analysis and tunability of components.  Although many examples exist of 
small molecules who's mode of motion is purported as "walking",40,46 most lack the 
requisite processivity or directional bias to be deemed verifiable molecular walkers 
and it was not until 2010 that von Delius et al. reported the synthesis and operation of 
the first highly processive two-legged small molecule translational motor capable of 
walking up and down a molecular track.39  Whereas linear motor proteins and synthetic 
DNA walkers utilise non-covalent interactions to bind the walker to the track, this 
system made use of dynamic covalent chemistry so that, during the walking process, 
the different feet form actual covalent bonds with the track that are either labile, or 
kinetically locked under different sets of conditions. 
 
Figure 1.11 - First non-DNA based small-molecule capable of directional motion along a track: 
Local equilibria connect the four positional isomers (1,2), (2,3), (3,4), and (1,4) under various 
conditions.  The upper pathway represents the major passing-leg mechanism from (1,2) to (3,4) 




The design outlined in Figure 1.11 incorporates many of the theoretical concepts 
covered so far.  The walker unit functions using a passing-leg gait and has two 
chemically different feet, one that forms a hydrazone bond with the track, and one that 
forms a disulphide bond.  These feet reversibly bind different footholds of the track 
depending on the applied stimulus.  Under acidic conditions, the disulfide bond 
between one foot and the track is kinetically locked whilst the hydrazone foot is free to 
explore other binding sights.  In contrast, when basic conditions are applied, the 
hydrazone foot is locked in place and the disulfide foot is free to sample forward and 
backward binding sites.  When operated in this form by simply alternating the stimuli, 
this system is directly comparable to the first hypothetical example discussed in 
Section 1.7.  The predicted outcome is confirmed with a steady-state, minimum-energy 
distribution of walkers around a central point achieved after several stimulant 
oscillations (results do not match the theoretical model perfectly due to elasticity in the 
linker).  Directional bias was introduced by replacing the base-promoted disulfide 
exchange reaction with a kinetically controlled redox reaction and hence, leading the 
system to conform to an information ratchet mechanism.  Not only did this provide the 
first example of a non-DNA based synthetic molecular walker, but the two passing-leg 
gait steps taken in this system constitute the full repeat cycle necessary for the 
molecule to walk down a hypothetically infinite polymeric track of alternating 
benzaldehyde and benzylic disulfide stations, presenting potential for the transport of 
molecular cargo over relatively long distances. 
 
Figure 1.12 - Operating mechanism of a directional light-driven walker-track conjugate based on 
adjustable ring strain between the walker (red) and the track in one positional isomer: (i) 
minimises walker-track ring-strain in the 2,3 position; (ii) labilises the disulfide foot; (iii) 
maximises walker-track ring-strain in the 2,3 position; (iv) labilises the hydrazone foot. The 
reaction sequence shown results in transport of the walker from left to right; switching steps (ii) 




The same hydrazone and disulfide foot-foothold linkage chemistry was utilised in a 
more recent, light-driven synthetic walker molecule that could be transported in either 
direction along a molecular track by means of an energy ratchet mechanism.47 The 
design is very similar to the previous example but for the introduction of a stilbene unit 
between the internal aldehyde and the disulfide foothold of the track (Figure 1.12).  
Selective photoisomerisation of the stilbene moiety provides the potential for 
directionality in this system as it can induce significant ring-strain upon the isomer that 
bridges the stilbene linkage.  E→Z isomerisation favours stepping over the central 
stilbene unit, while subsequent Z→E isomerisation provides a driving force to move 
away from the central position and allows the operator to choose the direction of 
motion by electing which foot is labilised next, an element of control not available to 
natural systems.  The variation in ring-strain induced by stilbene isomerisation equates 
to the manipulation of thermodynamic minima whilst the oscillation of acid and base 
addition mediates the alteration of kinetic barriers experienced by the walker unit 
culminating in exceptional control over the directionality of the biped with the 
maintenance of a high degree of processivity. 
1.12 Conclusions and Aims 
Life on Earth is the product of billions of years of biological evolution.  During this time, 
Nature has learnt to harness, control and manipulate incessant Brownian motion at the 
molecular level as a means of regulating intracellular function in all complex living 
organisms by using a plethora of intricate motor proteins.  The incredible results of this 
progression lie all around and act as vivid inspiration for scientists by illuminating the 
vast scale of possibilities attainable through chemical engineering and nanotechnology.  
Whilst the inherent hydrogen-bonding arrays of DNA base pairing have already been 
utilised in the design of artificial translational molecular motors, the toolbox of 
synthetic chemistry holds vast potential for alternative, ingenious molecular walkers 
capable of carrying out tasks on a much smaller scale than that of motor proteins. 
The aim of this thesis is to investigate new motifs for use as potential components in 
synthetic small-molecule walker units capable of processive and directional migration 
along molecular tracks.  Transition metal-ligand interactions were identified as 
promising foot-foothold connections in this quest on account of their variable 




conjunction with Brownian ratchet mechanisms.  Experimental research in the pursuit 
of this goal has led to an effective palladium(II) motif for use in directional stepping 
along poly-pyridyl tracks (Chapter II), comprehensive investigation into similar 
platinum(II) moieties to achieve variable dynamics (Chapter III), and finally the 
orthogonal combination of palladium(II)-ligand interactions with dynamic covalent 
chemistry in the design and synthesis of an unprecedented first-generation molecular 
walker. 
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Building on the generic design principles laid out in Chapter I, novel methods of 
practically instilling directional stepping mechanisms into chemical walker-track systems 
were explored.  In this chapter the design, synthesis, characterisation, and operation of a 
bimetallic molecular biped is described.  It comprises a three-foothold track upon which a 
palladium(II) complex can be selectively stepped between 4-dimethylaminopyridine and 
pyridine ligand sites via reversible protonation whilst remaining attached to the track by 
means of a kinetically inert platinum(II) complex throughout.  The substitution pattern of 
the three ligand binding sites and the kinetic stability of the metal-ligand coordination 
bonds afford the two positional isomers a high degree of metastability and mean that 
altering the chemical state of the track does not automatically instigate stepping in the 
absence of an additional stimulus (heat in the presence of a coordinating solvent).  This 
enables the track to do work on the biped unit and ultimately drive it away from 





Although transition metal coordination motifs have been widely employed as 
molecular switches and devices1 where redox-,2 chemical-,3 or photo-stimulation4 have 
been used effectively to direct molecular structure and function, the application of 
metal-ligand interactions to induce controlled molecular-level motion away from 
equilibrium1,5 has been far less widely reported.  Apart from the interim use of zinc(II) 
ions to instigate conformational change in a single stroke of a rotary motor,3e examples 
of genuine molecular ratchets involving metal-ligand bonds have been limited to 
interlocked stimuli-switchable molecular shuttles6 in which a thread can be 
manipulated to translocate a submolecular component energetically uphill and 
subsequently reset without undoing the task performed.5 Such a facet grants these 
systems a higher degree of sophistication than that of simple dynamic switches.1,7 
However, the interlocked nature of the designs confines the molecular motion to a 
single dimension constraining not only the relative movement of the components, but 
also the achievable ambitions of the machines.  For instance, a moveable macrocycle 
mechanically linked to a thread cannot select between branches or manoeuvre 
junctions within that thread without breaking covalent bonds.  Whilst an interlocked 
approach can still yield systems capable of doing work on a substrate,5 there are only 
limited examples of bona fide molecular motors synthesized in this way8 as such an 
accolade requires the potential for repetitive operation.  The fulfilment of said requisite 
depends upon the presence of an escapement (a means of releasing the ratcheted 
substrate) so that the entire system can be reset and operated again without undoing 
the previously performed task.  Escapement is inherently difficult in interlocked 
architectures and is usually only achieved when the subject of the operation upon 
which the work is being done is either part of a separate entity,9 or in a cyclic system 
such as a catenane.8 
In order to match the growing fervour for building molecular machines with greater 
scope for applications beyond one-dimensional motion, there is a requirement to move 
away from interlocked species towards designs with more degrees of freedom.  Metal-
ligand bonding is set to be a powerful tool in this progression as it provides a potential 
conduit to compartmental control over individual submolecular components.  Facile 
manipulation of binding kinetics may facilitate the transportation pathways of 




established rotary field,3e,8,10 and the relatively new area of linear motors including 
synthetic molecular walkers.11 
This chapter chronicles the assembly and operation of a molecular energy ratchet 
based on a tethered bimetallic transition metal complex where palladium(II) and 
platinum(II) complexes function as opposing feet on a poly-pyridyl track comprising 
three distinct ligand binding sites (footholds).  The palladium(II) complex can be 
selectively stepped between vacant footholds by acid-base manipulations using the 
kinetically inert platinum(II) complex as a pivot.  In so doing, this non-interlocked 
species can be driven energetically uphill and ultimately fixed into a 
thermodynamically unfavourable positional isomer distribution without permanently 
altering the state of the footholds, thus constituting the efficient metal-mediated 
stepping of a molecular biped along a track. 
2.3 Complex Design and Selective Addressability 
The palladium(II) complex is based upon a motif previously used to organise tridentate 
pyridine 2,6-dicarboxamide and derivatised monodentate pyridine ligands about a 
square planar palladium(II) centre in the assembly of catenanes,12 rotaxanes13 and 
molecular shuttles.6 This N,N,N-pincer complex is particularly attractive due to the 
stability afforded by the chelate effect, ensuring the metal ion remains bound at all 
times by the tridentate ligand with only one binding site available for monodentate 
ligand substitution14 and the maintenance of an overall neutral system throughout.  The 
design shown in Figure 2.1 exploits the preference of this class of palladium(II) and 
platinum(II) complexes to selectively bind N-heterocycles as a function of basicity6,15 
enabling their thermodynamic bias towards different ligands to be controlled by acid-
base manipulations.  The palladium(II) complex can therefore be stepped back and 
forth between a 4-dimethylaminopyridine (DMAP) and a pyridine (Py) foothold by 
means of protonation/deprotonation and thermal activation.  Throughout this process 
the palladium(II) foot remains tethered to the track via the opposing platinum(II) 
complex, which has a considerably higher kinetic stability under the stepping 
conditions.  The substitution pattern of the pyridine derivatives and the kinetic stability 
of the metal-ligand bonds mean that altering the chemical state of the track by adding 
or removing protons does not automatically cause a change in the positional isomer 






Figure 2.1 - Two metastable positional isomers of the bimetallic biped: L1Pd-(2,6-DMAP)16 and 
L1Pd-(2,6-Py). 
Operational control over discrete, well-defined stepping mechanisms is a prerequisite 
in the design of extended molecular walker systems based upon alternating stimuli-
induced directional stepping17 and can be achieved through careful consideration of the 
thermodynamics and kinetics of each step.  For the present design, the effect of varying 
the substitution patterns of Py and DMAP ligands on the stabilities of their respective 
metal complexes was investigated. 
In simple exchange experiments analogous to previous studies with macrocyclic 
palladium(II) complexes,6a L2Pd- could be selectively switched between 2,6-dihexylPy 
and 2,6-dihexylDMAP ligands by the addition of acid or base in the presence of a 
coordinating solvent, as shown in Scheme 2.1a and 2.1b.  All L2Pd-2,6-disubstituted 
complexes were shown to be stable at both ambient and elevated temperature (338 K) 
in the non-coordinating solvent CDCl3.  Conversely, some exchange of the monodentate 
ligands was observed in these reactions when carried out in neat CD3CN at room 
temperature (See Experimental Section (ES), Figure 2.7), allowing the solvent mixture 





Scheme 2.1 - Reversible exchange of monodentate ligands18 in L2Pd-complexes and the kinetic 
stability of L2Pt-complexes in CDCl3/CD3CN (7:3) at 338 K: (a) neutral conditions; (b) in the 
presence of CH3SO3H (1 equiv). Times required to reach equilibrium: † 12 h; ‡ 40 h. No exchange of 
2,6-dihexylheterocyclic ligands was observed in CDCl3 under neutral conditions or in the presence 
of CH3SO3H, even at 338 K for 2 days; (c) did not reach equilibrium after 12 h in which time <10% 
exchange of 2,6-dihexylPy for DMAP was observed. Equilibrium was reached after 14 days in DMF-
d7/CD3CN (1:1) at 348 K. 
Switchable kinetic control is imperative to the proposed ratchet mechanism,5 and an 
optimised solvent mixture of CDCl3/CD3CN (7:3) was used where all 2,6-disubstituted 
complexes in Scheme 2.1 were shown to be kinetically inert at ambient temperature 
(stimulus OFF state).  However, upon heating at 338 K (stimulus ON state), 80% of the 
2,6-dihexylPy coordinated to L2Pd was exchanged for 2,6-dihexylDMAP (Scheme 2.1a) 
within 12 h on account of the latter's superior binding ability.19 This process could be 
reversed (Scheme 2.1b) by adding one equivalent of methanesulfonic acid, where the 
inverted selectivity is defined by the relative basicities of the two heterocycles.20 
Although palladium(II) complexes of 3,5-disubstituted pyridines were 
thermodynamically preferred to the 2,6-disubstituted analogues (ES Figure 2.6), their 
lability in the absence of the external stimuli renders them unsuitable for use as feet in 




The analogous platinum(II) complex L2Pt-(3,5-dihexylPy) showed a similar superior 
thermodynamic preference for unsubstituted DMAP over Py (See Chapter III,  
Figure 3.2), although the kinetic stability of the 3,5-disubstituted pyridine complex in 
CDCl3/CD3CN (7:3) was sufficient for it to be considered relatively inert under the 
palladium(II) stepping conditions (<10% exchange after 12 h at 338 K) (Scheme 2.1c).  
Additionally, the steric hindrance of 2,6-dihexylPy was found to prevent any observable 
coordination to platinum(II) centres, enabling L2Pt- complexes to perfectly 
discriminate between 2,6- and 3,5-disubstituted pyridines. 
The results indicated that a tethered palladium(II) complex could be made to step along 
a track whilst maintaining a high degree of processivity17 (that is, a constant 
attachment to the track) through linkage to a fixed opposing foot.  In this first example, 
a platinum(II) complex is employed as an inert foot-foothold pivot motif in a model for 
a bimetallic molecular walker with the potential for future development of orthogonal 
stimuli capable of independently operating a second foot. 
2.4 Synthesis and Characterisation of Tethered Bimetallic Transition 
Metal complex L1Pd-(2,6-DMAP) 
Bimetallic complex L1Pd-(2,6-DMAP) was achieved by a compartmentalised strategy.    
The key reactions of the synthetic route for the feet and foothold sub-components are 
shown in Scheme 2.2 and the final assembly of the complete machine is illustrated in 
Scheme 2.3.  Comprehensive synthetic details are given in Experimental Section 2.8. 
Component 18 was prepared in 42% overall yield via a series of Sonogashira cross-
coupling reactions21 starting from 2,6-diiodo-4-dimethylaminopyridine (1),  
3,5-dibromopyridine (4) and suitable alkyne building blocks (2 & 5), using standard 
conditions as well as TMS deprotection of 6 with tetrabutylammonium fluoride and 
subsequent hydrogenation of the alkyne groups with Pd(OH)2/C.  The final 
 foothold of the track, compound 9, was prepared through Boc protection of  
6-iodopyridin-2-ylmethylamine (7) prior to Sonogashira coupling with alkyne 8, 
hydrogenation, and finally Boc-removal using trifluoroacetic acid.  Hydrolysis of the 
methyl ester group of 18 using LiOH, and subsequent PyBroP mediated amide coupling 





Scheme 2.2 - Synthesis of subcomponents. Reagents and conditions: (a) PdCl2(PPh3)2, CuI, 
Et3N/THF, 56%; (b) (i) 5, PdCl2(PPh3)2, CuI, Et3N/THF, 85%, (ii) methyl-4-pentynoate, 
PdCl2(PPh3)2, CuI, Et3N/THF, 71%; (c) (i) 7, Boc2O, CH2Cl2, 97%, (ii) 8, Pd(PPh3)4, CuI, Et3N/THF, 
88%, (iii) H2, Pd(OH)2/C, K2CO3, THF, 98%, (iv) CF3COOH, CHCl3, 96%; (d) 1,2-dibromoethane, 
K2CO3, acetone, 72%; (e) NaN3, NaI, DMF, 81%; (f) NaH, PtCl2(SMe2)2, THF, 64%; (g) Pd(OAc)2, 
CH3CN, 84%; (h) i) trimethylsilylacetylene, PdCl2(PPh3)2, CuI, THF/Et3N, (ii) KOH, MeOH, 94%; (i) 
(i) 2,6-lutidine, CH2Cl2 (ii) 15, DIPEA, Cu(CH3CN)4·PF6, TBTA, 80% (from 12). 
The metal complexes were prepared from the common pyridine-2,6-dicarboxamide 
unit 12, obtained in two steps by Williamson etherification and subsequent azide SN2 
displacement from 10 (Schemes 2.2d & 2.2e).  The platinum(II) moiety required 
deprotonation of the amide groups of 12 with NaH in THF and subsequent reaction 
with PtCl2(SMe2)2 to yield the dimethylsulfide-platinum(II) complex 13 (Scheme 2.2f).  
Selective coordination of this complex to the preferred central foothold on track 19 was 
achieved by simply stirring an equimolar solution of the two components, exploiting 





Scheme 2.3 - Synthesis of Bimetallic Complex L1Pd-(2,6-DMAP).  Reagents and conditions:  
(a) (i) 6, TBAF, THF/H2O (9:1), 95%; (ii) Pd(PPh3)4, CuI, Et3N/THF, 86%, (iii) H2, Pd(OH)2/C, 
K2CO3, THF, 78%; (b) (i) LiOH, MeOH/H2O/THF, 97%. (ii) 9, PyBroP, DIPEA, DMF, 86%;  (c) 13, 
DMF, 62%;  
(d) 17, DIPEA, Cu(CH3CN)4·PF6, TBTA, 85%; (e) CHCl3/CH3CN (7:3), 76%. 
Palladium(II) complex 16 was prepared through reaction of  pyridine-2,6-
dicarboxamide 12 with palladium(II) acetate in CH3CN for 16 h to give the product as a 
yellow precipitate (Scheme 2.2g), which was converted in one pot to 17 in 80% yield 
(Scheme 2.2i) by complexation to 2,6-lutidine in CH2Cl2 and subsequent copper(I)-
catalyzed azide-alkyne Huisgen cycloaddition22 (CuAAC) using 5 equivalents of 
dialkyne 15 (N,N-diisopropylethylamine (DIPEA), Cu(CH3CN)4·PF6, tris[(1-benzyl-1H-
1,2,3-triazol-4-yl)methyl]amine (TBTA), 12 h).  This key reaction established the 
applicability of versatile CuAAC "click" chemistry in the presence of palladium(II) 




demanding as it required the coupling of palladium(II) and platinum(II) precursors 
(17, and 20 respectively) using the established CuAAC "click" reaction in addition to 
selective intramolecular coordination of the palladium(II) centre to the preferred N-
heterocycle binding site.  To achieve this, an equimolar mixture of 17 and 20 was 
subjected to adjusted Huisgen cycloaddition conditions to afford bimetallic 
intermediate L1Pd-(2,6-lutidine) demonstrating that CuAAC "click" reactions are 
practical synthetic ligation tools in the presence of transition metal complexes and 
multiple metal binding sites (Scheme 2.3d), despite the potential for pyridines to bind 
Cu(I).  Adjusting the reaction concentration to favour intramolecular coordination of 
the 2,6-DMAP foothold, L1Pd-(2,6-lutidine) was subjected to the optimised conditions 
used in the model exchange experiments (CHCl3/CH3CN (7:3), 0.16 mM, 338 K, 14 h, 
Scheme 2.1a) exploiting both the disparate ligand strengths of the free 2,6-lutidine and 
the 2,6-DMAP/Py footholds of the track, as well as the kinetic stability of the Pt-(3,5-Py) 
complex, to form bimetallic complex L1Pd in a remarkable 76% yield after silica 
column chromatography purification (Scheme 2.3e).  Electrospray mass spectrometry 
confirmed the isolated product constitution as L1Pd with mass peaks at m/z = 2225.6 
and 2247.9 corresponding to the [M+H]+ and [M+Na]+ ions respectively with isotopic 
distributions concordant with theoretical predictions. 
In order to further explore the potential of this approach in building multi-foothold 
synthetic molecular walkers, an alternative incremental route was also attempted using 
bimetallic transition metal complex 21 (Figure 2.2) as a core scaffold for extended 
systems.23 Such a convergent strategy would not only allow for compartmental 
extension of the track, but also provide the basis for branched systems through the 
addition of a range of different footholds.  Ultimately, difficulties in hydrolysis of the 
methylester in the presence of the palladium(II) complex, along with the demonstrated 
ease of selective attachment of platinum(II) to the central foothold of track 19 resulted 
in this route being abandoned for the large scale preparation of the complete machine 
L1Pd-(2,6-DMAP).24 The method did, however, provide invaluable information allowing 
for unambiguous 1H NMR assignment that confirmed the bimetallic structure as  





Figure 2.2 - Graphic representations of bimetallic complex 21. Hydrogen and deuterium atoms are 
omitted for clarity: (a) chemical structure; (b) X-ray crystal structure. Solvent molecules are 
omitted for clarity. Nitrogen atoms are shown in blue, oxygen atoms in red, the palladium atom in 
gold, the platinum atom in pink and carbon atoms in grey (DMAP and pyridine carbon atoms are 
shown in green and red respectively). Selected bond lengths (Å) and angles (°): Pd1−N52, 2.027; 
Pd1−N55, 1.939; Pd1−N61, 2.034; Pd1−N101, 2.113; Pt1−N2, 2.021; Pt1−N5, 1.925; Pt1−N11, 
2.027; Pt1−N81, 2.043; N52−Pd1−N61, 160.3; N11−Pt1−N2, 160.6; N55−Pd1−N101, 178.1; 
N5−Pt1−N81, 179.0. 
Slow evaporation of a solution of bimetallic complex 21 in CHCl3/EtOH afforded 
suitable single crystals for X-ray diffraction analysis.25 The solid-state structure 
confirms the coordination of the palladium(II) moiety to the DMAP foothold.  All metal-
ligand bonds lie within the expected ranges and are similar for both the palladium(II) 
and the platinum(II) complexes with a distorted square-planar coordination geometry 
observed for each of the metal centres (Figure 2.2b).  The tolyl rings of the 
dicarboxamide motifs do not participate in π-π-stacking with the DMAP or Py footholds 
of the track, instead adopting a similar conformation to those observed previously in 




coplanar with the three central hydrogen atoms engaged in intermolecular hydrogen-
bond interactions with the oxygen atom of a carbonyl group of an adjacent 
palladium(II)-containing motif ([C−H···O] distances 2.38, 2.39 and 2.39 Å). 
1H NMR spectroscopy of the isolated complex L1Pd (Figure 2.3b) revealed a single 
positional isomer with the palladium(II) complex of the biped coordinated solely to the 
2,6-DMAP-foothold, analogous to compound 21.  A comparison between the spectra of 
free track 19 (Figure 2.3a) and L1Pd-(2,6-DMAP) in CD2Cl2 shows the expected upfield 
shifts of the signals of both the 2,6-DMAP- (ΔδHi = −0.20 ppm and  ΔδHk = −0.18 ppm), 
and the 3,5-Py-groups (ΔδHr = −0.88 ppm, ΔδHs = −0.29 ppm and ΔδHt = −0.45 ppm ), 
while the resonances of the 2,6-Py-foothold (Haa-cc), and those relating to the adjacent 
methylene (Hz) occur at almost identical values in both species. 
 
Figure 2.3 - 1H NMR spectra (500 MHz, CD2Cl2, 298K) of the two positional isomers of the 
bimetallic complex L1Pd and the free track for comparison: (a) track 19; (b) L1Pd-(2,6-DMAP);  




2.5 Protonation-Driven Stepping 
In accordance with model studies, in the absence of acid, the palladium(II) complex of 
L1Pd-(2,6-DMAP) can be classified as thermodynamically stable when heated in 
CDCl3/CD3CN (7:3) at 338 K.26 Furthermore, upon addition of 1 equivalent of 
methanesulfonic acid to a pure sample at room temperature, the 1H NMR spectrum 
showed significant broadening in the 2,6-Py resonances (Haa-cc) but no discernable 
change in either the 2,6-DMAP (Hi-k), nor the 3,5-Py signals (Hr-t), indicating that 
protonation of the 2,6-Py foothold had occurred but no positional isomerisation had 
taken place.  No changes were observed after 30 h at room temperature, indicating that 
the transition metal complexes are kinetically locked in the presence of acid under 
ambient conditions.  In fact, stepping of the palladium(II) complex was only observed at 
338 K in the presence of 1 equivalent of acid (Scheme 2.4).  The operation was 
monitored by 1H NMR spectroscopy and shown to reach equilibrium within 40 h, after 
which no further exchange was observed, indicating that a thermodynamic minimum 
had been reached.  The reaction mixture was diluted with toluene by a factor of two 
and the solvents removed gradually under reduced pressure to ensure a consistently 
low concentration of the machine with respect to the coordinating solvent, CH3CN.27 
The crude residue was deprotonated (K2CO3, CH2Cl2, 30 min) and the sample analysed 
by 1H NMR and high-performance liquid chromatography (HPLC) to reveal an 
equilibrium 15:85 distribution of L1Pd-(2,6-DMAP):(2,6-Py) (ES Figure 2.14). 
 
Scheme 2.4 - Stepping of Pd(II)/Pt(II)-Complexed Molecular Biped. † No exchange after 30 h at 
298 K in CDCl3/CD3CN (7:3) with CH3SO3H (1 equiv), <5% exchange in CDCl3/CD3CN after 30 h at 




The neutral positional isomers obtained were readily separated by preparative thin 
layer chromatography to give pure, kinetically stable samples of both L1Pd-(2,6-Py) 
(major product) and L1Pd-(2,6-DMAP) (minor product).  The 1H NMR spectrum of the 
former is shown in Figure 2.3c, while the latter matches that of L1Pd-(2,6-DMAP) 
precisely.  After operation, the resonances of the 2,6-DMAP-foothold (Hi+k) were found 
to have shifted downfield (ΔδHi = 0.17 ppm and ΔδHk = 0.18 ppm) resembling the non-
complexed 2,6-DMAP-foothold in free track, 19 (Figure 2.3a).  Similarly, the 2,6-Py 
signals (Haa-cc) show shifts (ΔδHaa = 0.31 ppm, ΔδHbb = 0.16 ppm and ΔδHcc = 0.24 ppm) 
in accordance with the equivalent resonances in the model exchange experiment 
(Scheme 2.1b & ES Figure 2.9 for NMR).  Interestingly, upon enclosing the amide bond 
of the track within the macrocycle of L1Pd-(2,6-Py), two separate signals can be seen 
for both the amide proton (Hy/y'), and the adjacent methylene protons (Hz/z') as a result 
of the cis/trans-amide isomers (Hy+z, major isomer, Hy'+z', minor isomer).  Using 
variable temperature 1H NMR (C2D2Cl4, 378 K), these two pairs of resonances were 
shown to coalesce.  Electrospray mass spectrometry of the product showed identical 
peaks  
(m/z = 2226.0 [M+H]+ and 2248.0 [M+Na]+) with matching isotopic distribution to 
those observed for L1Pd-(2,6-DMAP), supporting the identity of the new product as the 
positional isomer L1Pd-(2,6-Py). 
2.6 Deprotonation-Driven Stepping 
A sample of the of the neutralised 15:85 crude mixture of L1Pd-(2,6-DMAP:2,6-Py) 
from the protonation-driven stepping experiment was subjected to exchange 
conditions (338 K in CDCl3/CD3CN (7:3)).  After 24 h at elevated temperature, the ratio 
had changed to >95:5 in favour of L1Pd-(2,6-DMAP), whilst in an identical sample left 
at room temperature for the same period, no change was observed.  The ratio observed 
at equilibration at 338 K is in accordance with the previous neutral stepping 
experiment demonstrating an equilibrium distribution almost completely in favour of 
L1Pd-(2,6-DMAP) in the absence of acid, and the absolute reversibility of the switching 
mechanism.  These experiments illustrate that the reaction conditions identified in this 
study allow the system to be locked in a thermodynamically unfavourable positional 
isomer distribution between the two footholds enabling ratcheting of the biped unit 




2.7  Conclusion 
Nature boasts a veritable plethora of molecular-level systems in which the 
thermodynamics and kinetics of binding events can be rapidly and systematically 
controlled via ingenious manipulation of hydrogen bonding and electrostatic 
interactions to achieve phenomenal control over molecular-level motion.  Routes to 
synthetic mimics of these systems have thus far proven elusive as the mastery of such 
weak and ephemeral binding events lies at the boundary of modern-day synthetic 
chemistry.  Metal coordination motifs have shown exciting signs as one potential 
method and have indeed provided examples of controlled molecular-level motion by 
exploiting the kinetics and thermodynamics of ligand binding events.6 This chapter has 
described an acid-base operable ratchet based upon a non-interlocked 
palladium(II)/platinum(II) bimetallic system in which one of two transition metal 
complexes can be selectively labilised and stepped either way along an energy gradient 
between two different binding sites by means of an energy ratchet mechanism, and 
kinetically relocked with a high degree of positional discrimination.  In so doing, a 
strategy has been developed for synthesising sophisticated tracks with multiple metal 
ion binding sites using Sonogashira methodology and a means of attaching transition 
metal units through an orthogonal combination of metal coordination and CuAAC 
"click" chemistry.  Such expertise, coupled with further investigation into the 
thermodynamics and kinetics of a potential opposing foot moiety should prove useful 
in the development of switchable, metastable components for advanced molecular 
machinery, most notably linear molecular motors in the form of synthetic small 
molecule molecular walkers. 
2.8 Experimental Section 
General Information 
Unless stated otherwise, all reagents and solvents were purchased from Aldrich 
Chemicals and used without further purification.  Compounds 1,6a 4,28 PtCl2(SMe2)229 
and tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine (TBTA)11a,30 were prepared 




Synthesis of Model Ligands 
Scheme 2.5 - Reagents and conditions: (a) (i) CuI, PdCl2(PPh3)2, THF/Et3N, (ii) H2, Pd(OH)2/C, 
K2CO3, THF, 54%; (b) (i) CuI, PdCl2(PPh3)2, THF/Et3N, (ii) H2, Pd(OH)2/C, K2CO3, THF, 77%;  
(c) (i) CuI, PdCl2(PPh3)2, THF/Et3N, (ii) H2, Pd(OH)2/C, K2CO3, THF, 54%. 
Synthesis of S1 
 
A solution of 2,6-dibromopyridine (540 mg, 2.31 mmol, 1.00 equiv) in THF/Et3N (1:1, 8 
mL) was purged with nitrogen for 20 min.  1-Hexyne (750 mg, 9.07 mmol, 4.00 equiv) 
was added via syringe and the mixture purged for a further 10 min.  PdCl2(PPh3)2 (95.0 
mg, 0.14 mmol, 0.06 equiv) and CuI (12.9 mg, 0.07 mmol, 0.03 equiv) were added and 
the reaction stirred at 50 °C for 12 h.  A precipitate formed, was filtered off and the 
filtrate was concentrated under reduced pressure.  The residue was dissolved in CH2Cl2 
(20 mL) washed with sat. NH4Cl (2 × 20 mL) and dried over MgSO4.  The crude product 
was purified by column chromatography (SiO2, petroleum ether/EtOAc 95:5) to give a 
pale yellow oil which was immediately dissolved in THF (10 mL).  Pd(OH)2/C (20 wt.% 
Pd, 100 mg, 30 wt. %) and K2CO3 (5.00 equiv) were added and the reaction was stirred 
under a hydrogen atmosphere at room temperature for 16h.  The solution was filtered 
through a pad of Celite® and the solvent removed under reduced pressure to give S1 
(334 mg, 58%) as a clear, brown oil.  1H NMR (CDCl3, 400 MHz): δ = 7.48 (t, J = 7.7 Hz, 
1H, Ha), 6.94 (d, J = 7.7 Hz, 2H, Hb), 2.79–2.70 (m, 4H, Hc), 1.75–1.58 (m, 4H, Hg), 1.44–
1.04 (m, 12H, Hd+e+f), 0.87 (t, J = 7.0 Hz, 7H, Hh).  13C NMR (125 MHz, CDCl3): δ = 162.1, 
136.5, 119.7, 38.8, 31.9, 30.3, 29.3, 22.7, 14.2. HRMS (NSI+): m/z = 248.2368 [M+H]+ 





Synthesis of S2 
 
A solution of 2,6-diiodo-4-(N,N-dimethylamino)-pyridine (300 mg, 0.80 mmol, 1.00 
equiv) in THF/Et3N (1:1, 15 mL) was purged with nitrogen for 20 min.  PdCl2(PPh3)2 
(56.0 mg, 0.08 mmol, 0.10 equiv) and CuI (7.70 mg, 0.04 mmol, 0.05 equiv) were added 
and the mixture purged for a further 10 min.  1-Hexyne (750 mg, 9.07 mmol, 4.00 
equiv) was added via syringe and the reaction stirred at 50 °C for 18 h in the absence of 
light.  The solvent was removed under reduced pressure.  The residue was dissolved in 
EtOAc (50 mL) washed with sat. NH4Cl (60 mL) and dried over MgSO4.  The crude 
product was purified by column chromatography (SiO2, petroleum ether/EtOAc 4:1) to 
give a pale, yellow oil which was immediately dissolved in THF (30 mL).  Pd(OH)2/C 
(20 wt.% Pd, 150 mg, 30 wt. %) and K2CO3 (500 mg, 3.41 mmol, 5.00 equiv) were 
added and the reaction was stirred under H2 at room temperature for 16 h.  The 
solution was filtered through a pad of Celite® and the solvent removed under reduced 
pressure to give S2 (190 mg, 77%) as a pale yellow oil.  1H NMR (500 MHz, CDCl3): δ = 
6.20 (s, 2H, Hb), 2.95 (s, 6H, Ha), 2.63 (m, 4H, Hc), 1.66 (m, 4H, Hd), 1.41–1.23 (m, 12H, 
He+f+g), 0.86 (t, J = 7.1 Hz, 6H, Hh).  13C NMR (125 MHz, CDCl3): δ = 162.1, 155.4, 102.8, 
39.3, 39.2, 31.9, 30.5, 29.4, 22.7, 14.2.  HRMS (NSI+): m/z = 291.2792 [M+H]+ (calcd. 
291. 2795 for C19H35N2+). 
Synthesis of S3 
 
A solution of 3,5-dibromopyridine (540 mg, 2.31 mmol, 1.00 equiv) in THF/Et3N (1:1, 8 
mL) was purged with nitrogen for 20 min.  1-Hexyne (750 mg, 9.07 mmol, 4.00 equiv) 
was added via syringe and the mixture purged for a further 10 min.  PdCl2(PPh3)2 (95.0 
mg, 0.14 mmol, 0.06 equiv) and CuI (13.0 mg, 0.07 mmol, 0.03 equiv) were added and 
the reaction stirred at 50 °C for 12 h.  A precipitate formed, was filtered off and the 
filtrate concentrated under reduced pressure.  The crude residue was dissolved in 
CH2Cl2, washed with sat. NH4Cl (2 × 20 mL) and dried over MgSO4. The crude product 




pale, yellow oil which was immediately dissolved in THF (10 mL) and purged with 
nitrogen for 10 min.  Pd(OH)2/C (20 wt.% Pd, 100 mg, 30 wt. %) and K2CO3 (5.00 
equiv) were added and the solution purged with hydrogen for 10 min.  The reaction 
was left to stir under hydrogen at room temperature for 16 h.  The solution was filtered 
through a pad of Celite® and the solvent removed under reduced pressure to give S3 
(330 mg, 58%) as an orange oil.  1H NMR (CDCl3, 400 MHz): δ = 8.25 (s, 2H, Hb), 7.28 (s, 
1H, Ha), 2.57 (t, J = 7.7 Hz, 4H, Hc), 1.68–1.51 (m, 4H, Hd), 1.43–1.19 (m, 12H, He+f+g), 
0.88 (t, J = 6.9 Hz, 6H, Hh).  13C NMR (125 MHz, CDCl3): δ = 147.5, 137.6, 135.9, 33.1, 
31.8, 31.3, 29.0, 22.7, 14.2. HRMS (NSI+): m/z = 248.2368 [M+H]+ (calcd. 248.2373 for 
C17H30N+). 
Synthesis of Model Complexes 
Scheme 2.6 - Reagents and conditions: (a) MeI, K2CO3, DMF, quant.; (b) Pd(OAc)2, CH3CN, 79%;  
(c) S1, CH2Cl2, 79%; (d) S2, CHCl3, 80%; (e) NaH, PtCl2(SMe2)2, THF, 74%; (f) 4-




Synthesis of 10 
 
A 250 mL oven dried flask was charged with chelidamic acid monohydrate (2.98 g, 16.2 
mmol, 1.00 equiv) and pentafluorophenol (6.13 g, 33.3 mmol, 2.00 equiv).  To the solids 
was added THF (70 mL) and the suspension cooled to 0 °C. Dicyclohexylcarbodiimide 
(7.70 g, 35.4 mmol, 2.20 equiv) was added and, once dissolved, DMAP (100 mg, 0.05 
equiv) was added and the reaction mixture stirred at room temperature for 18 h.  A 
precipitate formed and was filtered off.  The filtrate was concentrated under reduced 
pressure and the residue purified by column chromatography (SiO2, petroleum 
ether/EtOAc 3:2) affording a yellow oil which was immediately dissolved in CHCl3 (200 
mL) and cooled to 0 °C.  4-methylbenzylamine (5.90 g, 49.0 mmol, 3.00 equiv) and Et3N 
(8.22 g, 81.2 mmol, 5.00 equiv) were added dropwise via syringe and the reaction 
mixture stirred at room temperature for 1 h.  A precipitate evolved and was filtered off.  
The solvent was removed under reduced pressure, the residue re-dissolved in CH2Cl2 
and washed successively with saturated NH4Cl (2 × 100 mL) and water (2 × 100 mL) 
and dried over MgSO4. The crude yellow solid was purified by flash column 
chromatography (SiO2, CH2Cl2/MeOH 95:5) to give 10 (2.20 g, 35%) as an off-white 
solid. m.p. 162−165 °C.  1H NMR (400 MHz, CDCl3): δ = 8.08 (s, 4H, He+g), 7.23 (d, J = 7.8 
Hz, 4H, Hb), 7.15 (d, J = 7.8 Hz, 4H, Hc), 4.63 (d, J = 6.0 Hz, 4H, Hd), 2.35 (s, 6H, Ha).  13C 
NMR (125 MHz, CDCl3): δ = 166.0, 163.2, 150.2, 136.1, 135.3, 128.5, 126.9, 111.6, 42.1, 




Synthesis of S4 
 
To a solution of 10 (430 mg, 1.10 mmol, 1.00 equiv) in DMF (10 mL) was added CH3I 
(190 mg, 1.20 mmol, 1.20 equiv) and K2CO3 (750 mg, 5.50 mmol, 5.00 equiv) and the 
solution stirred at room temperature for 15 h.  The solvent was removed under 
reduced pressure and the residue dissolved in CH2Cl2 and washed with H2O.  The 
organic phase was dried over MgSO4 and the solvent removed under reduced pressure 
to yield S4 (440 g, quant.) as an off-white solid.  m.p. 130-132 °C.  1H NMR (500 MHz, 
CDCl3): δ = 7.98 (t, J = 5.8 Hz, 2H, Hg), 7.88 (s, 2H, Hb), 7.21 (d, J = 8.0 Hz, 4H, He), 7.12 
(d, J = 7.8 Hz, 4H, Hd), 4.61 (d, J = 6.0 Hz, 4H, Hc), 3.96 (s, 3H, Ha), 2.33 (s, 6H, Hf).  13C 
NMR (125 MHz, CDCl3): δ = 168.6, 163.5, 150.9, 137.4, 135.2, 129.5, 127.9, 111.3, 56.2, 
43.4, 21.3. HRMS (ESI+): m/z = 404.1966 [M+H]+ (calcd. 404.1969 for C24H26N3O3+). 
Synthesis of S5 
 
To a solution of S4 (220 mg, 0.55 mmol, 1.00 equiv) in CH3CN (15 mL) was added 
Pd(OAc)2 (150 mg, 0.66 mmol, 1.20 equiv) and the solution stirred at room 
temperature for 12 h.  A precipitate was filtered off, washed with ice-cold CH3CN and 
dried under reduced pressure to give S5 (240 mg, 79%) as an amorphous green/grey 
solid.  1H NMR (500 MHz, CDCl3): δ = 7.23 (s, 2H, Hb), 7.19 (d, J = 7.9 Hz, 4H, He), 7.08 
(d, J = 7.9 Hz, 4H, Hd), 4.49 (s, 4H, Hc), 3.97 (s, 3H, Ha), 2.30 (s, 6H, Hf), 2.00 (s, 3H, Hg).  
13C NMR (125 MHz, CDCl3): δ = 170.7, 170.2, 154.7, 138.7, 135.9, 129.0, 127.3, 116.5, 
110.8, 56.9, 50.1, 21.2, 2.0.  HRMS (NSI+): m/z = 508.0844 [M−CH3CN+H]+ (calcd. 




Synthesis of S6 
 
A solution of S4 (300 mg, 0.74 mmol, 1.00 equiv) in THF (25 mL) was purged with N2 
for 1 h.  NaH (50.0 mg, 2.10 mmol, 2.80 equiv) was added in THF via syringe and the 
mixture stirred at room temperature for 5 h.  The clear yellow solution formed was 
wrapped in foil and cooled to 0 °C.  PtCl2(SMe2)2 (340 mg, 0.89 mmol, 1.20 equiv) was 
added and the solution allowed to warm to room temperature while stirring for 16 h.  
The solvent was removed under reduced pressure and the crude residue purified by 
flash column chromatography (SiO2, CH2Cl2/MeOH 99:1) to yield S6 (360 mg, 74%) as 
an orange solid.  m.p. 200 °C (dec.).  1H NMR (500 MHz, CDCl3): δ = 7.38 (s, 2H, Hb), 7.16 
(d, J = 7.9 Hz, 4H, He), 7.06 (d, J = 7.9 Hz, 4H, Hd), 4.77 (s, 4H, Hc), 4.01 (s, 3H, Ha), 2.27 
(s, 6H, Hf), 1.82 (s, 6H, Hg).  13C NMR (125 MHz, CDCl3): δ = 172.4, 170.5, 152.0, 137.0, 
136.1, 129.2, 126.6, 110.9, 57.0, 50.2, 22.1, 21.2.  HRMS (NSI+): m/z = 659.1650 [M+H]+ 
(calcd. 659.1652 for C26H30N3O3PtS+). 
Synthesis of L2Pd-(2,6-dihexylPy) 
 
A solution of S5 (30.0 mg, 0.06 mmol, 1.00 equiv) and S1 (17.0 mg, 0.06 mmol, 1.00 
equiv) in CH2Cl2 (1.5 mL) was stirred at room temperature for 12 h.  The solvent was 
removed under reduced pressure and the crude product purified by flash column 
chromatography (SiO2, CH2Cl2/MeOH 98:2) to give L2Pd-(2,6-dihexylPy) (35.0 mg, 
79%) as an orange crystalline solid.  m.p. 240 °C (dec.).  1H NMR (500 MHz, CDCl3): δ = 
7.74 (t, J = 7.8 Hz, 1H, Hh), 7.37 (s, 2H, Hb), 6.99 (d, J = 7.8 Hz, 2H, Hg), 6.81 (d, J = 7.8 Hz, 




Hi), 2.22 (s, 6H, Hf), 1.40 – 1.12 (m, 16H, Hj+k+l+m), 0.87 (t, J = 7.1 Hz, 6H, Hn).  13C NMR 
(125 MHz, CDCl3): δ = 171.3, 169.9, 164.1, 154.5, 138.7, 138.3, 135.8, 128.8, 127.5, 
120.8, 110.7, 56.8, 49.6, 38.8, 31.9, 29.3, 27.7, 22.7, 21.1, 14.2.  HRMS (NSI+): m/z = 
755.3142 [M+H]+ (calcd. 755.3152 for C41H53N4O3Pd+); 777.2959 [M+Na]+ (777.2972 
for C41H52N4NaO3Pd+). 
Synthesis of L2Pd-(2,6-dihexylDMAP) 
 
A solution of S5 (60.0 mg, 0.11 mmol, 1.00 equiv) and S2 (31.8 mg, 0.11 mmol, 1.00 
equiv) in CHCl3 (10 mL) was stirred at room temperature for 18 h.  The solvent was 
removed under reduced pressure and the crude was purified by column 
chromatography (SiO2, CH2Cl2/MeOH 95:5) to afford L2Pd-(2,6-dihexylDMAP) (70.3 
mg, 80%) as a yellow solid.  m.p. 210 °C (dec.).  1H NMR (500 MHz, CDCl3): δ = 7.34 (s, 
2H, Hb), 6.85 (d, J = 7.8 Hz, 4H, He), 6.65 (d, J = 7.9 Hz, 4H, Hd), 6.14 (s, 2H, Hg), 3.99 (s, 
7H, Ha+c), 3.12 (s, 6H, Hh), 2.76 (m, 4H, Hi), 2.24 (s, 6H, Hf), 1.39–1.10 (m, 16H, Hj+k+l+m), 
0.86 (t, J = 7.2 Hz, 6H, Hn).  13C NMR (125 MHz, CDCl3): δ = 171.3, 169.6, 162.4, 155.7, 
154.6, 138.6, 135.5, 128.6, 127.7, 110.4, 103.5, 56.7, 49.7, 39.6, 38.8, 32.0, 29.4, 27.9, 
22.8, 21.1, 14.2. HRMS (NSI+): m/z = 798.3586 [M+H]+ (calcd. 798.3585 for 
C43H58N5O3Pd+). 
Synthesis of L2Pt-(3,5-dihexylPy) 
 
S6 (30.0 mg, 0.05 mmol, 1.00 equiv) and S3 (11.0 mg, 0.05 mmol, 1.00 equiv) were 
dissolved in CH2Cl2 and the resulting mixture was stirred at room temperature for 12h.  




chromatography (SiO2, CH2Cl2/MeOH 98:2) to give L2Pt-(3,5-dihexylPy) (36.0 mg, 
95%) as a yellow solid.  m.p. 230 °C (dec.).  1H NMR (400 MHz, CDCl3): δ = 7.70 (d, J = 
1.7 Hz, 2H, Hg), 7.35 (s, 2H, Hb), 7.16 (s, 1H, Hh), 6.84 (d, J = 7.8 Hz, 4H, He), 6.68 (d, J = 
7.8 Hz, 4H, Hd), 4.35 (s, 4H, Hc), 4.00 (s, 3H, Ha), 2.28–2.23 (m, 4H, Hi), 2.22 (s, 6H, Hf), 
1.47–1.36 (m, 4H, Hj), 1.35–1.22 (m, 12H, Hk+l+m), 0.90 (t, J = 6.8 Hz, 6H, Hn).  13C NMR 
(100 MHz, CDCl3): δ = 171.8, 169.8, 153.6, 149.9, 140.1, 137.6, 137.2, 135.4, 128.7, 
126.7, 110.7, 56.8, 49.6, 32.5, 31.6, 30.4, 29.1, 22.7, 21.1, 14.2.  HRMS (NSI+): m/z = 
844.3766 [M+H]+ (calcd. 844.3763 for C41H53N4O3Pt+). 
Synthesis of L2Pt-DMAP 
 
A dry 50 mL round bottom flask was charged with S6 (29.0 mg, 0.05 mmol, 1.00 equiv) 
and 4-dimethylaminopyridine (6.0 mg, 0.05 mmol, 1.00 equiv) in CH2Cl2 (1.5 mL) and 
the solution stirred at room temperature for 16 h.  The solvent was removed under 
reduced pressure and the crude product was purified by flash column chromatography 
(SiO2, CH2Cl2/MeOH 98:2) to yield L2Pt-DMAP (26.0 mg, 83%) as an orange crystalline 
solid.  m.p. 250 °C (dec.).  1H NMR (400 MHz, CDCl3): δ = 7.61 (d, J = 7.2 Hz, 2H, Hg), 7.31 
(s, 2H, Hb), 6.88 (d, J = 8.0 Hz, 4H, He), 6.81 (d, J = 8.0 Hz, 4H, Hd), 6.10 (d, J = 7.2 Hz, 2H, 
Hh), 4.35 (s, 4H, Hc), 3.98 (s, 3H, Ha), 3.05 (s, 6H, Hi), 2.24 (s, 6H, Hf).  13C NMR (125 
MHz, CDCl3): δ = 171.8, 169.5, 153.7, 150.9, 137.8, 135.3, 128.5, 127.1, 110.4, 107.4, 





General Procedures for Model Ligand Exchange Experiments 
Ligand exchange experiments in CD3CN  
Stock solutions of complexes L2Pd-(2,6-dihexylPy) and L2Pd-(3,5-dihexylPy), and 
ligands S1 and S3 (0.4 mM in CD3CN) were independently prepared.  0.6 mL aliquots of 
the relevant complex solution and 0.6 mL of the corresponding ligand solution were 
mixed to get 1:1 solutions (0.2 mM) of the Pd(II) complexes with respect to the 
exchange ligand.  The reaction mixtures were then either left at room temperature or 
heated at 65 °C and monitored by 1H NMR spectroscopy. 
 
 
Figure 2.4 - Elevated temperature (338 K) exchange of 2,6-dihexylPy for CD3CN by Pd(II) complex 
L2Pd-(2,6-dihexylPy) in CD3CN. Partial 1H NMR (500 MHz, CD3CN) of: (a) L2Pd-(2,6-dihexylPy) 






Figure 2.5 - Elevated temperature (338 K) exchange of 3,5-dihexylPy for CD3CN by Pd(II) complex 
L2Pd-(3,5-dihexylPy) in CD3CN. Partial 1H NMR (500 MHz, CD3CN) of: (a) L2Pd-(3,5-dihexylPy) 






Figure 2.6 - Elevated temperature (338 K) exchange of 3,5-dihexylPy for 2,6-dihexylPy or CD3CN 
by Pd(II) complex L2Pd-(3,5-dihexylPy) and L2Pd-(2,6-dihexyl-Py) in CD3CN. Partial 1H NMR (500 
MHz, CD3CN) of: (a) 0.2 mM 1:1 mixture of L2Pd-(3,5-dihexylPy) (0.2 mM) and 2,6-dihexylPy; (b) 
solution (a) heated at 338 K for 12 h; (c) solution (d) heated at 338 K for 12 h;  (d) 1:1 mixture of 





Figure 2.7 - Room temperature exchange of 3,5-dihexylPy for 2,6-dihexylPy or CD3CN by Pd(II) 
complex L2Pd-(3,5-dihexylPy) in CD3CN. Partial 1H NMR (500 MHz, CD3CN) of a 1:1 solution of 
L2Pd-(2,6-dihexylPy) (0.2 mM) and 3,5-dihexylPy maintained at room temperature for: (a) 0 h; (b) 
5 h; (c) 15 h. 
Ligand exchange experiments in CDCl3  
Stock solutions of complexes L2Pd-(2,6-dihexylPy), L2Pd-(2,6-dihexylDMAP) and L2Pt-
(3,5-dihexylPy), ligands S1, S2 and S3 and CH3SO2H were prepared (45.0 mM in 
CDCl3).  Aliquots of the relevant metal complex (0.33 mL), the corresponding exchange 
ligand (0.33 mL) and methanesulfonic acid solution (0.33 mL, for acid-driven ligand 
exchange experiments) or CDCl3 (0.33 mL, for ligand exchange experiments in neutral 
conditions) were combined in order to obtain equimolar solutions of the Pd(II) or Pt(II) 
complex and the exchange ligand (and acid where appropriate).  Aliquots of CDCl3 
(0.42 mL) were added to these mixtures and the resulting solution (10 mM of each of 
the components) were divided into two samples (0.60 mL): one heated at 65 °C and the 
other one maintained at room temperature. The samples were monitored by 1H NMR 
spectroscopy. 
Ligand exchange experiments in CDCl3/CD3CN (7:3) 
Stock solutions of complexes L2Pd-(2,6-dihexylPy), L2Pd-(2,6-dihexylDMAP) and L2Pt-




in CDCl3).  Aliquots of the relevant metal complex (0.33 mL), the corresponding 
exchange ligand (0.33 mL) and the methanesulfonic acid solution (0.33 mL for acid-
driven ligand exchange experiments) or CDCl3 (0.33 mL for ligand exchange 
experiments in neutral conditions) were combined in order to obtain equimolar 
solutions of the Pd(II) or Pt(II) complex and the exchange ligand (and acid where 
appropriate).  Aliquots of CD3CN (0.42 mL) were added to these mixtures and the 
resulting solution (10 mM of each of the components) were each divided into two 
samples (0.60 mL): one heated at 65 °C and the other one maintained at room 
temperature. The samples were monitored by 1H NMR spectroscopy. 
 
 
Figure 2.8 - Elevated temperature (338 K) exchange of 2,6-dihexylPy for 2,6-dihexylDMAP by 
Pd(II) complex L2Pd-(2,6-dihexylPy) in CDCl3/CD3CN. Partial 1H NMR (400 MHz, CDCl3/CD3CN 
7:3) of: (a) reference spectrum of L2Pd-(2,6-dihexylPy); (b) 1:1 mixture of L2Pd-(2,6-dihexylPy) 
(10 mM) and 2,6-dihexylDMAP; (c) mixture (a) heated at 338 K for 12 h showing 80% exchange; 






Figure 2.9 - Elevated temperature (338 K) acid-driven exchange of 2,6-dihexylDMAP for 2,6-
dihexylPy by Pd(II) complex L2Pd-(2,6-dihexylDMAP) in CDCl3/CD3CN. Partial 1H NMR (400 MHz, 
CDCl3/CD3CN 7:3) of: (a) reference spectrum of L2Pd-(2,6-dihexylDMAP); (b) 1:1:1 mixture of 
L2Pd-(2,6-dihexylDMAP) (10 mM), 2,6-dihexylPy and CH3SO2H; (c) mixture (a) heated at 338 K for 






Synthesis of Track 19 
 
Scheme 2.7 - Synthesis of molecular track.  Reagents and conditions: (a) 4-pentyn-1-ol, PPh3, 
DIAD, THF, 92%; (b) PdCl2(PPh3)2, CuI, THF/Et3N, 56%; (c) PdCl2(PPh3)2, CuI, Et3N/THF, 85%; 
(d) methyl-4-pentynoate, PdCl2(PPh3)2, CuI, Et3N/THF, 71%; (e) (i) TBAF, THF/H2O (9:1), 95%, 
(ii) PdCl2(PPh3)2, CuI, Et3N/THF, 74%; (f) H2, Pd(OH)2/C, K2CO3, THF, 78%; (g) LiOH, 
MeOH/H2O/THF 6:3:1, 97%; (h) phthalimide, PPh3, DIAD, THF, 92%; (i) NaI, CuI, N,N’-
dimethylethylenediamine, 90%; (j) hydrazine monohydrate, EtOH, 92%; (k) Boc2O, CH2Cl2, 97%; 
(l) propargyl bromide, K2CO3, 2-butanone, 91%; (m) CuI, Pd(PPh3)4, THF/Et3N, 88%; (n) H2, 





Synthesis of 2 
 
To a solution of triphenylphosphine (15.5 g, 59.5 mmol, 1.00 equiv) in THF (100 mL) 
was added DIAD (12.0 g, 59.5 mmol, 1.00 equiv) at 0 °C under an atmosphere of 
nitrogen and the mixture stirred for 30 min.  4-Pentyn-1-ol (5.00 g, 59.5 mmol, 1.00 
equiv) was added dropwise and the mixture stirred for 20 min.  4-Cresol (6.10 g, 56.5 
mmol, 0.95 equiv) was added slowly over 30 min and the solution was allowed to warm 
to room temperature. The solvent was removed under reduced pressure and the 
residue purified by column chromatography (SiO2, petroleum ether/EtOAc 95:5) to 
yield 2 (9.00 g, 92%) as a colourless oil.  1H NMR (500 MHz, CDCl3): δ = 7.07 (d, J = 8.5 
Hz, 2H, Hb), 6.80 (d, J = 8.5 Hz, 2H, Hc), 4.04 (t, J = 6.1 Hz, 2H, Hd), 2.40 (td, J = 7.0, 2.6 
Hz, 2H, Hf), 2.28 (s, 3H, Ha), 1.99 (p, 2H, He), 1.96 (t, J = 2.6 Hz, 1H, Hg).  13C NMR (125 
MHz, CDCl3): δ = 156.9, 130.1, 130.0, 114.5, 83.7, 68.9, 66.4, 53.6, 28.4, 20.6.  HRMS 
(EI+): m/z = 174.1038 [M]+ (calcd. 174.1039 for C12H14O+). 
Synthesis of 3 
 
To a solution of 2 (2.79 g, 16.0 mmol, 1.00 equiv) and 2,6-diiodo-4-(N,N-
dimethylamino)-pyridine (1) (6.00 g, 16.0 mmol, 1.00 equiv) in degassed THF/NEt3 
(5:3, 80 mL) was added PdCl2(PPh3)2 (1.12 g, 1.60 mmol, 0.10 equiv) and CuI (610 mg, 
3.20 mmol, 0.20 equiv) and the solution stirred at 55 °C for 15 h.  The reaction mixture 
was cooled to room temperature, poured into ammonia solution (10%, 300 mL), and 
extracted with CH2Cl2 (3 × 75 mL).  The organic layer was washed with brine (2 × 150 
mL), dried over MgSO4, filtered, and concentrated under reduced pressure.  The 
residue was purified by column chromatography (SiO2, petroleum ether/EtOAc 9:1) to 
yield 3 (4.10 g, 61%) as a colourless solid.  m.p. 68-70 °C.  1H NMR (400 MHz, CDCl3): δ 
= 7.07 (d, J = 8.5 Hz, 2H, Hb), 6.81 (m, 3H, Hc+i), 6.55 (d, J = 2.3 Hz, 1H, Hg), 4.05 (t, J = 6.1 




2H, He).  13C NMR (100 MHz, CDCl3): δ = 156.8, 154.6, 143.3, 130.0, 118.4, 115.9, 114.5, 
109.8, 89.5, 80.6, 66.5, 39.4, 28.2, 20.6, 16.3.  HRMS (ESI+): m/z = 421.0777 [M+H]+ 
(calcd. 421.0771 for C19H22IN2O+). 
Synthesis of S8 
 
To a solution of 2,6-dibromopyridine (1.99 g, 7.03 mmol, 1.00 equiv) in THF (50 mL) 
and Et3N (25 mL) was added CuI (260 mg, 1.40 mmol, 0.20 equiv) and PdCl2(PPh3)2 
(490 mg, 0.70 mmol, 0.10 equiv).  Trimethyl-(3-prop-2-ynyloxyprop-1-ynyl)-silane 
(1.16 g, 7.03 mmol, 1.00 equiv) was added to the reaction mixture via syringe and the 
solution stirred at 65 °C for 16 h.  The solvents were removed under reduced pressure, 
the resulting residue re-dissolved in EtOAc and washed with aqueous NH4Cl (2 × 50 
mL) and brine (50 mL).  The organic extracts were collected and dried over Na2SO4.  
After concentration under reduced pressure, the crude residue was purified by flash 
column chromatography (SiO2, hexane/Et2O 9:1) to yield S8 (1.93 g, 85%) as a white 
solid.  m.p. 64-66 °C.  1H NMR (500 MHz, CDCl3): δ = 8.61 (br, 2H, Hd+f), 7.88 (s, 1H, He), 
4.48 (s, 2H, Hc), 4.30 (s, 2H, Hb), 0.19 (s, 9H, Ha).  13C NMR (CDCl3, 100 MHz): δ = 150.5, 
150.3, 141.1, 121.3, 120.3, 100.3, 92.7, 89.5, 82.0, 57.9, 57.2, 0.0.  HRMS (ESI+): m/z = 
322.0258 [M+H]+ (calcd. 322.0257 for C14H17BrNOSi+). 
Synthesis of 6 
 
S8 (5.07 g, 16.0 mmol, 1.00 equiv) was dissolved in THF/Et3N (1:1, 100 mL) and 
purged with nitrogen for 20 min.  Methyl-4-pentynoate (5.90 g, 35.0 mmol, 1.10 equiv) 
was added and the solution purged for an additional 5 min.  PdCl2(PPh3)2 (2.20 g, 3.30 
mmol, 0.10 equiv) and CuI (310 mg, 1.7 mmol, 0.05 equiv) were added and the reaction 
stirred at 50 °C for 15 h.  The reaction mixture was cooled to room temperature, 
filtered and the filtrate concentrated under reduced pressure. The residue was 
dissolved in CH2Cl2 (150 mL) and washed with sat. NH4Cl (2 × 100 mL). The organic 




residue was purified by column chromatography (SiO2, petroleum ether/EtOAc 9:1) to 
yield 6 (3.96 g, 71%) as an orange oil.  1H NMR (400 MHz, CDCl3): δ = 8.56 (br, 2H, 
Hd+f), 7.71 (s, 1H, He), 4.47 (s, 2H, Hc), 4.30 (s, 2H, Hb), 3.73 (s, 3H, Hi), 2.75 (m, 2H, Hg), 
2.64 (m, 2H, Hh), 0.19 (s, 9H, Ha).  13C NMR (125 MHz, CDCl3): δ = 172.1, 151.4, 150.7, 
141.0, 135.9, 124.8, 120.2, 119.1, 100.3, 92.5, 88.3, 82.7, 57.7, 57.1, 52.0, 33.1, 15.4, 0.0.  
HRMS (ESI+): m/z = 354.1522 [M+H]+ (calcd. 354.1520 for C20H24NO3Si+). 
Synthesis of S9 
 
Compound 6 (5.86 g, 16.7 mmol, 1.00 eq.) was dissolved in THF/H2O (9:1, 60 mL), and 
tetrabutylammonium fluoride solution in THF (20 mL, 1.20 equiv) was added dropwise 
to the reaction mixture.  The reaction was monitored by TLC and after 2 h, the reaction 
mixture was directly adsorbed onto silica and purified by column chromatography 
(SiO2, petroleum ether/EtOAc 8:2) to yield an oil (4.39 g, 94%) which was immediately 
added to a solution of 3 (5.66 g, 13.5 mmol, 1.00 equiv) in degassed THF/Et3N (5:2, 
70 mL).  Pd(PPh3)4 (780 mg, 0.68 mmol, 0.05 equiv) and CuI (0.19 g, 1.01 mmol, 
0.08 equiv) were added and the solution was stirred at 50 °C for 18 h.  The reaction 
mixture was cooled to room temperature, poured into ammonia solution (10%, 
500 mL), and extracted with CH2Cl2 (3 × 100 mL).  The organic layer was washed with 
brine (2 × 200 mL), dried over MgSO4, filtered, and concentrated under reduced 
pressure.  The residue was purified by column chromatography (SiO2, CH2Cl2/MeOH 
97:3) to yield S9 (6.61 g, 86%) as a colourless oil.  1H NMR (500 MHz, CDCl3): δ = 8.54 
(d, J = 2.0 Hz, 1H, Hl), 8.52 (d, J = 2.0 Hz, 1H, Hn), 7.70 (t, J = 2.0 Hz, 1H, Hm), 7.06 (d, J = 
8.3 Hz, 2H, Hb), 6.80 (d, J = 8.5 Hz, 2H, Hc), 6.61 (d, J = 2.5 Hz, 1H, Hi), 6.56 (d, J = 2.5 Hz, 
1H, Hg), 4.54 (s, 2H, Hk), 4.51 (s, 2H, Hj), 4.06 (t, J = 6.1 Hz, 2H, Hd), 3.73 (s, 3H, Hs), 2.98 
(s, 6H, Hh), 2.75 (t, J = 7.2 Hz, 2H, Ho), 2.64 (t, J = 7.2 Hz, 2H, Hp), 2.61 (t, J = 7.1 Hz, 2H, 
Hf), 2.26 (s, 3H, Ha), 2.09–2.04 (m, 2H, He).  13C NMR (125 MHz, CDCl3): δ = 172.3, 
156.9, 154.5, 151.5, 150.9, 143.9, 142.5, 141.2, 130.0, 120.4, 119.3, 114.6, 109.4, 109.4, 
92.6, 88.6, 88.5, 87.2, 82.9, 82.4, 81.3, 77.3, 66.6, 57.6, 57.5, 52.1, 39.3, 33.2, 28.3, 20.6, 




Synthesis of 18 
 
S9 (1.20 g, 2.10 mmol, 1.00 equiv) was dissolved in THF/ethanol (4:1, 50 mL) and 
degassed with N2, followed by H2.  K2CO3 (14.0 mg, 0.10 mmol, 0.05 equiv) and 
Pd(OH)2/C (20 % Pd, 120 mg, 10 wt. %) were added and the reaction continued to be 
purged with H2 for an additional 10 min before being allowed to stir for 16 h under an 
H2 atmosphere.  The crude residue was filtered through Celite® and purified by column 
chromatography (SiO2, CH2Cl2/MeOH 9:1) to yield 18 (0.993 g, 78%) as a brown oil.  
1H NMR (500 MHz, CDCl3): δ = 8.27 (d, J = 1.9 Hz, 1H, Hr), 8.25 (d, J = 1.9 Hz, 1H, Ht), 
7.30 (s, 1H, Hs), 7.05 (d, J = 8.3 Hz, 2H, Hb), 6.77 (d, J = 8.5 Hz, 2H, Hc), 6.25 (d, J = 2.2 Hz, 
1H¸ Hk), 6.22 (d, J = 2.2 Hz, 1H, Hi), 3.91 (t, J = 6.6 Hz, 2H, Hd), 3.66 (s, 3H, Hy), 3.47 (t, J 
= 6.5 Hz, 2H, Hn), 3.42 (t, J = 6.3 Hz, 2H, Ho), 2.98 (s, 6H, Hj), 2.75 (m, 2H, Hl), 2.71–2.65 
(m, 4H, Hh+q), 2.59 (t, J = 7.2 Hz, 2H, Hu), 2.33 (t, J = 7.0 Hz, 2H, Hx), 2.26 (s, 3H, Ha), 1.99 
(m, 2H, Hm), 1.87 (m, 2H, Hp), 1.83–1.73 (m, 4H, He+g), 1.67–1.63 (m, 4H, Hv+w), 1.53 (m, 
2H, Hf).  13C NMR (125 MHz, CDCl3): δ = 174.0, 157.1, 155.6, 147.7, 147.6, 137.0, 136.9, 
135.9, 129.9, 129.7, 114.5, 103.2, 103.1, 70.6, 69.8, 68.1, 51.7, 39.4, 38.7, 35.2, 33.9, 
32.7, 31.3, 30.7, 30.4, 30.2, 29.6, 29.4, 26.1, 24.6, 20.6.  HRMS (ESI+): m/z = 590.3942 
[M+H]+ (calcd. 590.3952 for C36H52N3O4+). 
Synthesis of S10 
 
To a solution of 18 (700 mg, 1.20 mmol, 1.00 equiv) in MeOH/H2O/THF (6:3:1, 
22.5 mL) was added LiOH (145 mg, 6.00 mmol, 6.00 equiv) and the reaction mixture 
stirred at room temperature for 16 h.  The mixture was poured into sat. NH4Cl 
(150 mL) and extracted with CHCl3/iPrOH (3:1, 10 × 30 mL).  The organic layer was 
washed with brine (2 × 50 mL), dried over MgSO4, filtered, and concentrated under 
reduced pressure to yield S10 (685 mg, 97%) as a yellow oil.  1H NMR (500 MHz, 




6.75 (d, J = 8.4 Hz, 2H, Hc), 6.31 (d, J = 2.5 Hz, 1H, Hi), 6.26 (d, J = 2.5 Hz, 1H, Hk), 3.90 (t, 
J = 6.4 Hz, 2H, Hd), 3.43 (t, J = 6.2 Hz, 2H, Hn), 3.30 (t, J = 6.1 Hz, 2H, Ho), 3.10 (s, 6H), 
3.00 (m, 2H, Hl), 2.94  (m, 2H, Hh), 2.67 (t, J = 7.0 Hz, 2H, Hq), 2.61 (m, 2H, Hu), 2.32 (m, 
2H, Hx), 2.25 (s, 3H, Ha), 2.02 (m, 2H, Hm), 1.89–1.75 (m, 6H, He+g+p), 1.68 (m, 4H, Hv+w), 
1.54 (m, 2H, Hf).  13C NMR (125 MHz, CDCl3): δ = 177.9, 157.2, 157.0, 156.8, 156.5, 
147.1, 147.0, 137.6, 137.0, 136.6, 129.9, 129.8, 114.5, 103.7, 103.6, 70.2, 68.7, 67.8, 
39.9, 35.8, 33.8, 32.6, 30.9, 30.8, 30.6, 30.3, 29.8, 29.5, 29.4, 29.0, 29.0, 25.8, 25.4, 20.6. 
Synthesis of S11a 
 
To a solution of PPh3 (950 mg, 3.62 mmol, 1.20 equiv) in dry THF (30 mL) was added 
DIAD (0.65 mL, 3.30 mmol, 1.10 equiv) dropwise at 0 ˚C.  The mixture was stirred for 
15 min at this temperature during which time a suspension formed.  2-Bromo-6-
(hydroxymethyl)-pyridine (567 mg, 3.02 mmol, 1.00 equiv) in THF (2 mL) was added 
dropwise at 0 ˚C and the mixture stirred for another 20 min at 0 ˚C.  Phthalimide 
(485 mg, 3.30 mmol, 1.10 equiv) was added as a solid in one portion.  The resulting 
orange solution was stirred for 16 h without further cooling.  The solution was 
concentrated under vacuum and the residue purified by column chromatography (SiO2, 
CH2Cl2) to give S11a (813 mg, 85%) as an off-white solid.  m.p. 124-126 ˚C.  1H NMR 
(400 MHz, CDCl3): δ = 7.88–7.92 (m, 2H, He), 7.74−7.78 (m, 2H, Hf), 7.48 (t, J = 7.6, 1H, 
Hb), 7.37 (d, J = 7.6,  1H, Ha), 7.16 (d, J = 7.6, 1H, Hc), 4.99 (s, 2H, Hd),).  13C NMR (100 
MHz, CDCl3): δ = 167.9, 156.9, 141.9, 139.0, 134.2, 132.1, 127.0, 123.6, 119.9, 42.5.  
HRMS (ESI+): m/z = 316.9923 [M+H]+ (calcd. 316.9920 for C14H10BrN2O2+). 
Synthesis of S11b 
 
A solution of N,N'-dimethylethylenediamine (41.0 mg, 50.0 μL, 0.47 mmol, 0.10 equiv) 
in dry dioxane (35 mL) was degassed with nitrogen for 30 minutes.  CuI (45.0 mg, 
0.24 mmol, 0.05 equiv), NaI (8.90 g, 59.0 mmol, 12.5 equiv), and S11a (1.50 g, 
4.73 mmol, 1.00 equiv) were added and the mixture stirred vigorously at 105 ˚C for 




aqueous ammonia (20 % w, 25 mL) was added and the mixture extracted into EtOAc (3 
× 50 mL).  The combined organic layers were washed with brine and water, and dried 
over MgSO4.  The crude product was purified by column chromatography (Al2O3 basic, 
activity II, CH2Cl2), to give S11b (1.55 g, 90%) as a colourless solid.  m.p. 138-140 ˚C.  
1H NMR (400 MHz, CDCl3): δ = 7.88−7.92 (m, 2H, He), 7.74−7.78 (m, 2H, Hf), 7.60 (t, J = 
7.8, 1H, Ha), 7.25 (t, J = 7.8, 1H, Hb), 7.15 (d, J = 7.8, 1H, Hc), 4.98 (s, 2H, Hd).  13C NMR 
(100 MHz, CDCl3): δ = 167.9, 157.3, 138.0, 134.2, 133.8, 132.1, 123.6, 120.1, 117.8, 42.5.  
HRMS (ESI+): m/z = 364.9784 [M+H]+ (calcd. 364.9782 for C14H10IN2O2+). 
Synthesis of 7 
 
S11b (2.18 g, 6.00 mmol, 1.00 equiv) and hydrazine monohydrate (0.35 mL, 6.00 mmol, 
1.00 equiv) were suspended in EtOH (50 mL) and the mixture heated to reflux for 2 h.  
Additional hydrazine monohydrate (50.0 µL, 0.86 mmol, 0.15 equiv) was added and the 
solution stirred at reflux for a further 2 h.  The reaction mixture was allowed to cool to 
room temperature, diluted with Et2O (300 mL) and the solids removed via filtration.  
The filtrate was concentrated under reduced pressure and the resulting crude residue 
purified by column chromatography (SiO2, CH2Cl2/MeOH/Et3N 79:20:1) to give 7 (1.29 
g, 92%) as a yellow solid.  m.p. 30-32 ˚C.  1H NMR (CDCl3, 400 MHz): δ = 7.58 (dd, J1 = 
6.5, J2 = 2.1, 1H, Hc), 7.24−7.30 (m, 2H, Ha,b), 3.92 (s, 2H, Hd).  13C NMR (CDCl3, 100 
MHz): δ = 164.2, 137.9, 132.8, 120.2, 117.8, 47.2. HRMS (ESI+): m/z = 234.9726 [M+H]+ 
(calcd. 234.9727 for C6H8IN2+). 
Synthesis of S12 
 
Boc2O (3.60 g, 16.5 mmol, 1.10 equiv) was dissolved in CH2Cl2 (35 mL) and the 
solution cooled to 0 ˚C.  To this solution was added 7 (3.51 g, 15.0 mmol, 1.00 equiv) as 
a solid in one portion and the reaction mixture stirred at room temperature for 14 h. 
Removal of the solvents under reduced pressure, followed by column chromatography 
(SiO2, CH2Cl2/EtOAc 8:2) yielded S12 (4.86 g, 97%) as a white solid.  m.p 84-86 ˚C.  




(br, 1H, He), 4.38 (d, J = 5.8, 2H, Hd), 1.46 (s, 9H, Hf).  13C NMR (CDCl3, 100 MHz): δ = 
159.9, 155.9, 138.1, 133.4, 120.8, 117.4, 79.7, 45.4, 28.4.  HRMS (ESI+): m/z = 335.0250 
[M+H]+ (calcd. 335.0251 for C11H16IN2O2+). 
Synthesis of 8 
 
To a solution of 4-tert-butylphenol (300 mg, 1.99 mmol, 1.00 equiv) in 2-butanone (35 
mL), was added K2CO3 (1.38 g, 9.95 mmol, 5.00 equiv) and propargyl bromide (80 
wt.% in toluene, 0.70 mL, 5.99 mmol, 3.00 equiv) and the mixture was stirred at 70 °C 
for 15 h.  H2O (40 mL) was added and the phases separated.  The aqueous layer was 
extracted with ether (2 × 30 mL).  The combined organic extracts were dried over 
MgSO4 and the solvent removed under reduced pressure.  The crude was purified by 
column chromatography (SiO2, petroleum ether/CH2Cl2 2:1) to yield 8 (341 mg, 91%) 
as a yellow oil.  1H NMR (400 MHz, CDCl3): δ = 7.39 (d, J = 8.9 Hz, 2H, Hb), 6.99 (d, J = 8.9 
Hz, 2H, Hc), 4.72 (d, J = 2.4 Hz, 2H, Hd), 2.56 (t, J = 2.4 Hz, 1H, He), 1.38 (s, 9H, Ha).  13C 
NMR (100 MHz, CDCl3): δ = 155.4, 144.3, 126.4, 114.4, 79.0, 75.5, 55.8, 34.2, 31.6. HRMS 
(APCI+): m/z = 189.1272 [M+H]+ (calcd. 189.1274 for C13H17O+). 
Synthesis of S13 
 
To a solution of S12 (2.50 g, 7.50 mmol, 1.00 equiv) and 8 (1.66 g, 9.35 mmol, 
1.25 equiv) in degassed THF/Et3N (3:1 40 mL), was added Pd(PPh3)4 (433 mg, 
0.38 mmol, 0.05 equiv) and CuI (107 mg, 0.56 mmol, 0.08 equiv) and the solution 
stirred at 45 °C for 22 h.  The reaction mixture was cooled to room temperature, 
poured into ammonia solution (10%, 200 mL), and extracted with CH2Cl2 (3 × 50 mL).  
The organic layer was washed with brine (2 × 50 mL), dried over MgSO4, filtered, and 
concentrated under reduced pressure.  The residue was purified by column 
chromatography (SiO2, CH2Cl2/MeOH 99.5:0.5) to yield S13 (2.60 g, 88%) as a brown 
solid.  1H NMR (500 MHz, CDCl3): δ = 7.60 (t, J = 7.8 Hz, 1H, Hf), 7.35–7.28 (m, 3H, Hb+e), 




4.41 (d, J = 5.4 Hz, 2H, Hh), 1.45 (s, 9H, Hj), 1.29 (s, 9H, Ha).  13C NMR (125 MHz, CDCl3): 
δ = 158.4, 156.1, 155.7, 144.5, 141.9, 137.1, 126.5, 126.1, 121.6, 114.5, 86.1, 84.7, 79.8, 
56.7, 45.9, 34.3, 31.6, 28.5.  HRMS (ESI+): m/z = 395.2332 [M+H]+ (calcd. 395.2329 for 
C24H31O3N2+). 
Synthesis of S14 
 
A mixture of S13 (200 mg, 0.51 mmol, 1.00 equiv), K2CO3 (0.35 g, 2.53 mmol, 5.00 
equiv) and Pd(OH)2/C (20.0 mg, 10%w) in THF (20 mL) was stirred under a H2 
atmosphere at room temperature for 5h.  The resulting mixture was filtered through a 
pad of Celite and the filtrate concentrated under reduced pressure to afford S14 (200 
mg, 98%) as a brown oil.  1H NMR (400 MHz, CDCl3): δ = 7.60 (t, J = 7.7 Hz, 1H, Hh), 7.32 
(d, J = 8.8 Hz, 2H, Hb), 7.11 (m, 2H, Hg+i), 6.85 (d, J = 8.8 Hz, 2H, Hc), 5.63 (br, 1H, Hk), 
4.45 (d, J = 4.7 Hz, 2H, Hj), 4.01 (t, J = 6.2 Hz, 2H, Hd), 3.00 (t, J = 7.5 Hz, 2H, Hf), 2.34–
2.17 (m, 2H, He), 1.49 (s, 9H, Hl), 1.32 (s, 9H, Ha).  13C NMR (125 MHz, CDCl3): δ = 160.8, 
156.8, 156.8, 156.1, 143.3, 137.0, 126.2, 121.4, 119.0, 114.0, 79.4, 67.1, 45.8, 34.5, 34.1, 
31.6, 29.2, 28.5.  HRMS (ESI+): m/z = 399.2640 [M+H]+ (calcd. 399.2642 for 
C24H35O3N2+). 
Synthesis of 9 
 
A solution of S14 (200 mg, 0.50 mmol, 1.00 equiv) in CHCl3/CF3COOH (1:1, 8 mL) was 
stirred at room temperature for 4 h.  The resulting mixture was basified with K2CO3 
until pH>10 and the extracted with CH2Cl2 (3 × 25 mL).  The combined organic extracts 
were dried with MgSO4 and the solvent was reduced under reduced pressure to yield 9 
(140 mg, 96%) as a brown oil.  1H NMR (500 MHz, CDCl3): δ = 7.54 (t, J = 7.6 Hz, 1H, 
Hh), 7.28 (d, J = 8.8 Hz, 2H, Hb), 7.09 (d, J = 7.8 Hz, 1H, Hi), 7.05 (d, J = 7.7 Hz, 1H, Hg), 
6.82 (d, J = 8.8 Hz, 2H, Hc), 3.99 (m, 4H, Hd+j), 3.58 (br, 2H, Hk), 2.95 (t, J = 7.6 Hz, 2H, 




156.8, 143.3, 137.1, 126.3, 121.4, 118.8, 114.0, 67.1, 46.8, 34.7, 34.1, 31.6, 29.3.  HRMS 
(ESI+): m/z = 299.2122 [M+H]+ (calcd. 299.2118 for C19H27ON2+). 
Synthesis of 19 
 
To a solution of S10 (200 mg, 0.34 mmol, 1.00 equiv), 9 (120 mg, 0.40 mmol, 1.20 
equiv) and PyBroP (190 mg, 0.40 mmol, 1.20 equiv) in DMF (15 mL) under N2 at 0 °C, 
was added DIPEA (0.18 mL, 1.02 mmol, 3.00 equiv).  The resulting mixture was allowed 
to reach room temperature while stirring for 4 h.  The reaction was quenched by 
addition of aqueous KHSO4 1 M (10 mL).  The mixture was diluted with brine (40 mL) 
and extracted with CH2Cl2 (3 × 75 mL).  The combined organic extracts were washed 
with brine (75 mL) and aqueous LiCl 5% (2 × 75 mL) and dried over MgSO4.  The 
solvent was removed under reduced pressure and the crude mixture purified by 
column chromatography (SiO2, CH2Cl2/MeOH/Et3N 94.5:5:0.5) to afford 19 (250 mg, 
86%) as a colourless oil.  1H NMR (400 MHz, CDCl3): δ = 8.23 (m, 2H, Hr+t), 7.52 (t, J = 
7.7 Hz, 1H, Hbb), 7.30 (s, 1H, Hs), 7.26 (d, J = 8.7 Hz, 2H, Hgg), 7.05 (d, J = 8.4 Hz, 2H, Hb), 
7.09–6.98 (m, 2H, Haa+cc), 6.79 (d, J = 8.7 Hz, 2H, Hhh), 6.74 (d, J = 8.4 Hz, 2H, Hc), 6.32 (d, 
J = 2.4 Hz, 1H, Hi), 6.26 (d, J = 2.4 Hz, 1H, Hk), 4.49 (d, J = 4.9 Hz, 2H, Hz), 3.95 (t, J = 6.2 
Hz, 2H, Hff), 3.89 (t, J = 6.3 Hz, 2H, Hd), 3.47 (t, J = 6.0 Hz, 2H, Hn), 3.39 (t, J = 6.2 Hz, 2H, 
Ho), 3.11 (s, 6H, Hj), 3.05 (t, J = 7.5 Hz, 2H, Hl), 2.98 (t, J = 7.7 Hz, 2H, Hq), 2.92 (t, J = 7.6 
Hz, 2H, Hdd), 2.65–6.54 (m, 4H, Hh+u), 2.30 (t, J = 7.1 Hz, 2H, Hx), 2.24 (s, 3H, Ha), 2.21–
2.13 (m, 2H, Hee), 2.12–2.00 (m, 2H, Hm), 1.88–1.74 (m, 6H, He+g+p), 1.72–1.59 (m, 4H, 
Hv+w), 1.60–1.48 (m, 2H, Hf), 1.26 (s, 9H, Hii).  13C NMR (100 MHz, CDCl3): δ = 172.9, 
160.8, 157.0, 156.8, 156.0, 147.6, 143.4, 137.2, 136.0, 129.9, 129.8, 126.3, 121.5, 119.4, 
114.4, 114.0, 103.9, 103.6, 69.9, 69.7, 67.8, 67.1, 44.5, 40.0, 36.4, 34.6, 34.1, 32.8, 31.6, 
31.1, 30.9, 30.0, 29.5, 29.5, 29.3, 29.0, 25.7, 25.4, 20.5.  HRMS (ESI+): m/z = 856.5727 




Synthesis of L1Pd-(2,6-DMAP) 
Synthesis of 11 
 
To a solution of 10 (1.50 g, 3.85 mmol, 1.00 equiv) and 1,2-dibromoethane (3.62 g, 19.2 
mmol, 5.00 equiv) in acetone (30 mL), was added K2CO3 (2.65 g, 19.2 mmol, 5.00 
equiv) and the suspension was refluxed for 18 h.  The solvent was removed under 
reduced pressure and the residue washed with water, extracted with butanone, and 
dried over MgSO4.  The crude product was purified by column chromatography (SiO2, 
CH2Cl2/MeOH 95:5) to give 11 (1.38 g, 72%) as a brown solid.  m.p. 121-123 °C.  1H 
NMR (400 MHz, CDCl3): δ = 7.92 (t, 2H, Hd), 7.90 (s, 2H, Hc), 7.22 (d, J = 8.0 Hz, 4H, Hf), 
7.14 (d, J = 8.0 Hz, 4H, Hg), 4.62 (d, J = 6.1 Hz, 4H, He), 4.47 (t, J = 6.1 Hz, 2H, Hb), 3.68 (t, 
J = 6.1 Hz, 2H, Ha), 2.34 (s, 6H, Hh).  13C NMR (100 MHz, CDCl3): δ = 166.9, 163.5, 151.0, 
137.3, 135.1, 129.5, 127.8, 111.4, 68.3, 43.3, 28.0, 21.2.  HRMS (ESI+): m/z = 496.1225 
[M+H]+ (calcd. 496.1230 for C25H27BrN3O3+). 
Synthesis of 12 
 
A solution of 11 (1.08 g, 2.17 mmol, 1.00 equiv), NaN3 (1.43 g, 22.0 mmol, 10.0 equiv) 
and NaI (50.0 mg, 0.33 mmol, 0.15 equiv) in DMF (10 mL) was stirred at 90 °C for 18 h.  
The solvent was removed under reduced pressure.  The residue was dissolved in 
CH2Cl2, washed with H2O, and dried over MgSO4.  The crude product was purified by 
flash column chromatography (SiO2, petroleum ether/EtOAc 3:1) to yield 12 (810 mg, 




7.90 (s, 2H, Hc), 7.21 (d, J = 8.0 Hz, 4H, Hf), 7.12 (d, J = 8.0 Hz, 4H, Hg), 4.61 (d, J = 6.1 Hz, 
4H, He), 4.30 (t, J = 6.1 Hz, 2H, Ha), 3.67 (t, J = 6.1 Hz, 2H, Hb), 2.33 (s, 6H, Hh).  13C NMR 
(125 MHz, CDCl3): δ = 167.2, 163.3, 151.2, 137.5, 135.1, 129.6, 127.9, 111.6, 67.8, 49.8, 
43.5, 21.3.  HRMS (ESI+): m/z = 459.2137 [M+H]+ (calcd. 459.2139 for C25H27N6O3+). 
Synthesis of 13  
 
Azide 12 (1.51 g, 3.30 mmol, 1.00 equiv) was dissolved in THF (20 mL) and purged 
with nitrogen for 20 min.  NaH (290 mg, 7.26 mmol, 2.20 equiv) was added and the 
mixture stirred at room temperature for 2 h.  The reaction mixture was then cooled to 0 
°C and protected from light.  PtCl2(SMe2)2 (2.32 g, 5.93 mmol, 1.80 equiv) was added 
and the reaction stirred for 18 h.  The solvent was removed under reduced pressure 
and the residue purified by flash column chromatography (SiO2, CH2Cl2/MeOH 99:1) to 
give 13 (1.50 g, 64%) as an orange solid.  m.p. 260 °C (dec.).  1H NMR (500 MHz, CDCl3): 
δ = 7.40 (s, 2H, Hc), 7.16 (d, J = 7.9 Hz, 4H, Hf), 7.06 (d, J = 7.9 Hz, 4H, Hg), 4.77 (s, 6H, 
He), 4.33 (t, J = 4.8 Hz, 2H, Hb), 3.71 (t, J = 4.8 Hz, 2H, Ha), 2.27 (s, 6H, Hh), 1.81 (s, 6H, 
Hd).  13C NMR (125 MHz, CDCl3): δ = 172.2, 169.1, 152.3, 137.0, 136.1, 129.2, 126.6, 
111.2, 68.6, 50.2, 49.7, 22.1, 21.2. HRMS (ESI+): m/z = 714.1823 [M+H]+ (calcd. 
714.1821 for C27H31N6O3PtS+). 
Synthesis of 15 
 
To a solution of 3,5-dibromoanisole (2.66 g, 10.0 mmol, 1.00 equiv) and 
trimethylsilylacetylene (4.30 mL, 30.0 mmol, 3.00 equiv) in degassed THF/Et3N (2:1, 
30 mL) was added PdCl2(PPh3)2 (705 mg, 1.00 mmol, 0.10 equiv) and CuI (285 mg, 
1.50 mmol, 0.15 equiv) and the solution was stirred at 65 °C for 16 h.  The reaction 




50 mL) was added.  The reaction mixture was stirred for 1 h at room temperature, 
poured into brine (150 mL), and extracted with CH2Cl2 (3 × 50 mL).  The organic layer 
was dried over MgSO4, filtered, and concentrated under reduced pressure.  The residue 
was purified by column chromatography (SiO2, petroleum ether/EtOAc 98:2) to yield 
15 (1.47 g, 94%) as colourless crystals.  m.p. 63-65 °C.  1H NMR (400 MHz, CDCl3): δ = 
7.22 (t, J = 1.3 Hz, 1H, Hc), 7.01 (d, J = 1.3 Hz, 2H, Hb), 3.80 (s, 3H, Hd), 3.07 (s, 2H, Ha).  
13C NMR (100 MHz, CDCl3): δ = 159.2, 128.41, 123.5, 118.4, 82.7, 77.8, 55.6.  HRMS 
(EI+): m/z = 156.0572 [M]+ (calcd. 156.0570 for C11H8O+). 
Synthesis of 16 
 
To a solution of 12 (780 mg, 1.72 mmol, 1.00 equiv) in MeCN (25 mL) was added 
Pd(OAc)2 (460 mg, 2.06 mmol, 1.15 equiv) and the resulting mixture was stirred at 
room temperature for 16 h.  A yellow precipitate was formed, filtered off and rinsed 
with ice-cold CH3CN to give 16 as a yellow/green solid (870 mg, 84%).  1H NMR (400 
MHz, CDCl3/CD3CN): δ = 7.22 (s, 2H, Hc), 7.17 (d, J = 7.9 Hz, 4H, Hg), 7.06 (d, J = 7.9 Hz, 
4H, Hf), 4.46 (s, 4H, He), 4.25 (t, J = 4.8 Hz, 2H, Hb), 3.64 (m, 2H, Ha), 2.28 (s, 6H, Hh), 
1.98 (s, 3H, Hd).  13C NMR (125 MHz, CDCl3): δ = 170.5, 168.7, 154.9, 138.7, 135.8, 
129.0, 127.4, 111.5, 111.0, 68.5, 50.1, 43.3, 21.2, 2.1.  HRMS m/z = 602.1094 [M−2H+H]+ 




Synthesis of 17 
 
To a solution of compound 16 (300 mg, 0.50 mmol, 1.00 equiv) in CH2Cl2 (6.0 mL) was 
added 2,6-lutidine (60 µL, 0.50 mmol, 1.00 equiv) and the reaction stirred at room 
temperature for 3 h.  The solution was purged with N2 for 20 min. and DIPEA (130 µl, 
1.50 equiv) and 15 (320 mg, 5.00 equiv) were added.  The reaction was stirred at room 
temperature for 5 min.  Cu(CH3CN)4·PF6 (37.0 mg, 20% mol) and a catalytic amount of 
TBTA were added to the reaction which was stirred at room temperature for 12 h.  The 
solvent was removed under reduced pressure and the residue purified by column 
chromatography (SiO2, CH2Cl2/MeOH 98:2) to yield 17 (330 mg, 80%) as a pale, yellow 
solid.  1H NMR (500 MHz, CDCl3): δ = 7.95 (s, 1H, Hk), 7.62 (t, J = 7.7 Hz, 1H, Hj), 7.52 (t, 
J = 1.3 Hz, 1H, Hm), 7.49 (dd, J = 2.4, 1.3 Hz, 1H, Hl/n), 7.36 (s, 2Hc), 7.01 (dd, J = 2.4, 1.3 
Hz, 1H, Hl/n), 6.94 (d, J = 7.7 Hz, 2H, Hi), 6.80 (d, J = 7.8 Hz, 4H, Hg), 6.44 (d, J = 7.8 Hz, 
4H, Hf), 4.91 (t, J = 4.8 Hz, 2H, Ha), 4.63 (t, J = 4.8 Hz, 2H, Hb), 4.00 (s, 4H, He), 3.88 (s, 
3H, Hp), 3.09 (s, 1H, Ho), 2.41 (s, 6H, Hd), 2.24 (s, 6H, Hh).  13C NMR (125 MHz, CDCl3): δ 
= 170.8, 167.9, 160.5, 160.0, 154.9, 147.4, 138.7, 138.0, 136.1, 131.9, 128.8, 127.4, 
123.8, 122.8, 122.2, 121.2, 117.7, 112.2, 110.8, 83.3, 77.6, 67.7, 55.7, 55.5, 53.8, 49.4, 
25.6, 21.2.  HRMS (ESI+): m/z = 826.2346 [M+H]+ (calcd. 826.2333 for C43H42N7O4Pd+); 




Synthesis of 20 
 
To a solution of 19 (150 mg, 0.18 mmol, 1.00 equiv) under N2 in DMF (10 mL), was 
added a solution of 13 (150 mg, 0.21 mmol, 1.20 equiv) in CH2Cl2 (3 mL).  The solution 
was stirred vigorously at room temperature for 16 h.  The resulting mixture was 
concentrated under reduced pressure and the residue purified by column 
chromatography (SiO2, CH2Cl2/MeOH/Et3N 96.5:3:0.5) to yield 20 (173 mg, 62 %) as 
an orange solid.  1H NMR (500 MHz, CDCl3): δ = 7.78 (s, 1H, Ht), 7.62 (s, J = 1.2 Hz, 1H, 
Hr), 7.53 (t, J = 7.7 Hz, 1H, Hbb), 7.31 (s, 2H, H5), 7.30 (br, 1H, Hs), 7.27 (d, J = 8.9 Hz, 2H, 
Hgg), 7.06 (d, J = 7.7 Hz, 2H, Hb), 7.03 (m, 2H, Haa+cc), 6.96 (t, J = 5.0 Hz, 1H, Hy), 6.83 (d, J 
= 7.9 Hz, 4H, H2), 6.81 (d, J = 8.8 Hz, 2H, Hhh), 6.73 (d, J = 8.6 Hz, 2H, Hc), 6.67 (d, J = 7.9 
Hz, 4H, H3), 6.41 (d, J = 2.5 Hz, 1H, Hk/i), 6.33 (d, J = 2.5 Hz, 1H, Hk/i), 4.50 (d, J = 5.0 Hz, 
2H, Hz), 4.39 (d, J = 14.9 Hz, 2H, H4/4’), 4.32 (m, 2H, H6), 4.23 (d, J = 15.1 Hz, 2H, H4/4’), 
3.97 (t, J = 6.2 Hz, 2H, Hff), 3.86 (t, J = 6.3 Hz, 2H, Hd), 3.67 (m, 2H, H7), 3.43 (t, J = 6.0 Hz, 
2H, Hn), 3.33 (t, J = 6.1 Hz, 2H, Ho), 3.13 (s, 6H, Hj), 2.93 (d, J = 7.9 Hz, 2H, Hdd), 2.83 (m, 
2H, Hl), 2.72 (m, 2H, Hh), 2.36 (m, 2H, Hu), 2.30 (t, J = 7.4 Hz, 2H, Hx), 2.25 (m, 5H, Ha+q), 
2.19 (m, 8H, H1+ee), 1.98–1.88 (m, 2H, Hm), , 1.78–1.67 (m, 4H, He+p), 1.67–1.57 (m, 4H, 
Hv+w), 1.52–1.38 (m, 4H, Hf+g), 1.28 (s, 9H, Hii).  HRMS (ESI+): m/z = 1507.7276 [M+H]+ 




Synthesis of L1Pd-(2,6-lutidine) 
 
To a solution of 20 (150 mg, 0.10 mmol, 1.00 equiv) and 17 (90.0 g, 0.11 mmol, 1.10 
equiv) in CH2Cl2 was added DIPEA (20.0 mg, 0.17 mmol, 1.50 equiv) via syringe.  
Cu(CH3CN)4PF6 (15.0 mg, 0.04 mmol, 0.40 equiv) and a catalytic amount of TBTA were 
added forming an orange solution which was stirred under a nitrogen environment at 
room temperature for 12 h.  The solvent was removed under reduced pressure and the 
crude residue purified by flash column chromatography (SiO2, CH2Cl2/MeOH/Et3N 
95.5:4:0.5) to yield L1Pd-(2,6-lutidine) (220 mg, 85%) as a yellow solid.  1H NMR (500 
MHz, CDCl3): δ =  8.35 (s, 1H, H12), 8.29 (s, 1H, H8), 7.69 (s, 1H, Ht), 7.66 (s, 1H, Hr), 7.61 
(s, 1H, H11), 7.60 (t, J = 6.4 Hz, 1H, H22), 7.55 (s, 2H, H10), 7.54 (t, 1H, Hbb), 7.42 (s, 2H, 
H15), 7.40 (s, 2H, H5), 7.28 (d, J = 8.9 Hz, 2H, Hgg), 7.19 (s, 1H, Hs), 7.02–7.09 (m, 2H, 
Haa+cc), 7.05 (d, J = 8.3 Hz, 2H, Hb), 6.92 (d, J = 7.6 Hz, 2H, H21), 6.83–6.75 (m, 12H, 
Hc+hh+2+18), 6.65 (d, J = 7.9 Hz, 4H, H3), 6.43 (d, J = 7.9 Hz, 4H, H17), 6.24 (d, J = 2.3 Hz, 1H, 
Hk), 6.22 (d, J = 2.3 Hz, 1H, Hi), 4.85–4.79 (m, 4H, H7+13), 4.62 (br s, 4H, H6+14), 4.52 (d, J 
= 4.7 Hz, 2H, Hz), 4.39–4.21 (m, 4H, H4), 3.98 (s, 4H, H16), 3.97 (t, J = 6.3 Hz, 2H, Hff), 
3.95 (s, 3H, H9), 3.91 (t, J = 6.5 Hz, 2H, Hd), 3.46 (t, J = 6.5 Hz, 2H, Hn), 3.33 (t, J = 6.1 Hz, 
2H, Ho), 2.97 (s, 6H, Hj), 2.96–2.92 (m, 2H, Hdd), 2.74 (t, J = 7.1 Hz, 2H, Hl), 2.68 (t, J = 7.2 
Hz, 2H, Hh), 2.39 (s, 6H, H20), 2.33–2.30 (m, 2H, Hq), 2.30–2.27 (m, 4Hu+x), 2.26 (s, 3H, 
Ha), 2.22 (s, 6H, H19), 2.19 (s, 6H, H1), 2.19–2.15 (m, 2H, Hee), 2.02–1.95 (m, 2H, Hm), 
1.82–1.77 (m, 2H, He), 1.77–1.73 (m, 2H, Hg), 1.69–1.63 (m, 2H, Hv), 1.62–1.54 (m, 2H, 
Hp), 1.48–1.52 (m, 2H, Hf), 1.48–1.43 (m, 2H, Hw), 1.28 (s, 9H, Hii).  13C NMR (125 MHz, 
CDCl3): δ = 172.4, 171.6, 170.9, 168.3, 168.2, 160.9, 160.9, 160.5, 157.1, 156.8, 155.7, 
154.8, 153.9, 150.0, 149.8, 147.9, 147.9, 143.5, 139.7, 138.7, 138.0, 137.5, 137.4, 137.3, 
136.1, 135.4, 132.4, 130.1, 129.8, 128.8, 127.3, 126.5, 126.4, 122.8, 122.0, 121.9, 121.7, 




55.8, 49.6, 49.4, 49.3, 46.4, 44.5, 39.4, 36.0, 34.7, 34.2, 32.3, 31.7, 30.4, 30.2, 30.1, 30.0, 
29.8, 29.4, 29.3, 29.2, 26.1, 25.6, 25.3, 21.2, 20.6.  HRMS (ESI+): m/z = 2332.9570 
[M+H]+ (calcd. 2332.9548 for C122H139N18O11PdPt+). 
Synthesis of L1Pd-(2,6-DMAP) 
 
A solution of L1Pd-(2,6-lutidine) (96.0 mg, 0.04 mmol, 1.00 equiv) in CH3Cl/CH3CN 
(7:3, 250 mL, 0.16 mM) was stirred at 65 °C for 14 h.  The solvent was removed under 
reduced pressure and the crude mixture purified by column chromatography (SiO2, 
CH2Cl2/MeOH/Et3N 95.5:4:0.5) to yield L1Pd-(2,6-DMAP) (69.0 mg, 76%) as a yellow 
solid.  1H NMR (500 MHz, CDCl3): δ = 8.55 (s, 1H, H12), 8.17 (s, 1H, H8), 7.78 (s, 1H, Ht), 
7.70 (dd, J = 2.4, 1.4 Hz, 1H, H10/10’), 7.60 (dd, J = 2.4, 1.4 Hz, 1H, H10/10’), 7.53 (t, J = 7.7 
Hz, 1H, Hbb), 7.42 (s, 2H, H15), 7.42 (s, 1H, H11), 7.38 (s, 1H, Hr), 7.28 (d, J = 8.9 Hz, 2H, 
Hgg), 7.19 (s, 1H, Hs), 7.19–7.17 (m, 1H, Hy), 7.06–7.03 (m, 4H, Haa+cc+b), 6.98 (s, 2H, H5), 
6.81 (d, J = 8.7 Hz, 2H, Hhh), 6.81 (d, J = 7.7 Hz, 4H, H18), 6.75 (d, J = 8.6 Hz, 2H, Hc), 6.70 
(d, J = 7.6 Hz, 4H, H2), 6.58 (d, J = 7.7 Hz, 4H, H17), 6.56 (d, J = 7.6 Hz, 4H, H3), 6.15 (d, J = 
2.4 Hz, 1H, Hk), 6.10 (d, J = 2.4 Hz, 1H, Hi), 4.96 (t, J = 6.5 Hz, 2H, H7), 4.92 (t, J = 4.6 Hz, 
2H, H13), 4.59 (t, J = 4.6 Hz, 2H, H14), 4.52 (d, J = 4.9 Hz, 2H, Hz), 4.49 (d, J = 15.5 Hz, 2H, 
H4/4’), 4.26 (t, J = 6.5 Hz, 2H, H6), 4.10 (d, J = 15.5 Hz, 2H, H4/4’), 4.03 (d, J = 14.0 Hz, 2H, 
H16/16’), 3.97 (t, J = 6.1 Hz, 2H, Hff), 3.96 (s, 3H, H9), 3.89 (d, J = 14.0 Hz, 2H, H16/16’), 3.85 
(t, J = 6.4 Hz, 2H, Hd), 3.31–3.25 (m, 4H, Hn+o), 3.11 (s, 6H, Hj), 2.95–2.92 (m, 2H, Hdd), 
2.94–2.90 (m, 2H, Hl), 2.73–2.67 (m, 2H, Hh), 2.33 (t, J = 7.8 Hz, 2H, Hx), 2.30 (t, J = 7.3 
Hz, 2H, Hu), 2.27 (s, 3H, Ha), 2.21 (s, 6H, H19), 2.19–2.17 (m, 2H, Hee), 2.18–2.15 (m, 2H, 
Hq), 2.14 (s, 6H, H1), 1.73–1.61 (m, 6H, He+m+v), 1.60–1.47 (m, 6H, Hf+p+w), 1.28 (s, 9H, 
Hii), 1.28–1.24 (m, 2H, Hg).  13C NMR (125 MHz, CDCl3): δ = 172.6, 171.5, 171.0, 167.9, 




148.3, 147.2, 143.5, 139.9, 139.3, 138.5, 137.3, 137.3, 137.1, 135.6, 135.6, 132.6, 132.2, 
131.3, 130.0, 129.9, 128.8, 128.6, 127.8, 126.4, 126.4, 122.5, 122.2, 121.6, 119.3, 116.5, 
114.5, 114.4, 114.4, 113.9, 111.4, 111.3, 111.2, 110.6, 103.8, 103.5, 103.3, 70.4, 70.0, 
68.2, 67.8, 67.2, 67.1, 55.8, 53.6, 49.7, 49.6, 49.0, 48.3, 46.2, 44.6, 40.1, 39.6, 38.7, 36.0, 
35.5, 34.7, 34.2, 32.5, 31.7, 30.2, 29.8, 29.7, 29.4, 29.3, 29.0, 28.7, 27.9, 27.5, 26.2, 25.3, 
21.2, 20.6, 14.3, 9.2. LRMS (ESI+): m/z = 2225.6 [M+H]+; 2247.9 [M+Na]+.   HRMS (ESI+): 
m/z = 1113.4441 [M+2H]2+ (calcd. 1113.4448 for C115H131N17O11PdPt2+). 
 
Figure 2.10 - Isotopic mass distribution for L1Pd-(2,6-DMAP). LRESI+: m/z = 2247.98 [M+Na]+ 
(calcd. 2247.86 for C115H129N17O11PdPtNa+): a) experimental; b) theoretical. 
Synthesis of L1Pd-(2,6-Py) 
 
L1Pd-(2,6-DMAP) (17.0 mg, 7.60 µmol, 1.00 equiv) and CH3SO3H (1.00 equiv) were 
dissolved in a CHCl3/CH3CN mixture (7:3, 76 mL, 0.1 mM) and heated at 65 ºC for 40 h.  
Toluene (50 mL) was added and the solvent slowly removed under reduced pressure. 
The residue was purified by preparative thin layer chromatography (SiO2, 
CH2Cl2/MeOH 95:5) to yield L1Pd-(2,6-Py) (4.5 mg, 26%) as a yellow solid.  1H NMR 




7.82 (s, 2H, H5), 7.81 (s, 1H, Hr), 7.74 (t, J = 6.1 Hz, 1H, Hy’), 7.72 (s, 1H, Ht), 7.70 (t, J = 
6.4 Hz, 1H, Hbb), 7.60 (t, J = 1.4 Hz, 1H, H11), 7.54 (dd, J = 2.4, 1.4 Hz, 1H, H10’), 7.46 (dd, J 
= 2.4, 1.4 Hz, 1H, H10), 7.36 (dd, J = 7.6, 1.0 Hz, 1H, Haa), 7.32 (s, 1H, Hs), 7.30–7.27 (m, 
1H, Hcc), 7.29 (d, J = 8.8 Hz, 2H, Hgg), 7.19 (s, 2H, H15), 7.09 (d, J = 8.0 Hz, 4H, H17), 7.04 
(d, J = 8.2 Hz, 2H, Hb), 6.97 (d, J = 8.0 Hz, 4H, H18), 6.90 (d, J = 7.9 Hz, 4H, H2), 6.86 (d, J = 
8.8 Hz, 2H, Hhh), 6.76 (d, J = 8.2 Hz, 2H, Hc), 6.74 (d, J = 7.9 Hz, 4H, H3), 6.34 (d, J = 2.8 
Hz, 1H, Hi), 6.32 (d, J = 2.8 Hz, 1H, Hk), 5.90 (d, J = 6.0 Hz, 1H, Hz’), 4.89–4.85 (m, 4H, 
H7+13), 4.67 (t, J = 4.8 Hz, 2H, H14), 4.58 (t, J = 4.8 Hz, 2H, H6), 4.49–4.44 (m, 8H, 
Hdd+z+16), 4.29 (d, J = 14.4 Hz, 4H, H4), 4.16–4.12 (m, 2H, Hff), 4.11–4.07 (m, 2H, Hh), 
4.05–4.00 (m, 2H, Hl), 3.93 (s, 3H, H9), 3.90 (t, J = 6.4 Hz, 3H, Hd), 3.56 (t, J = 6.7 Hz, 2h, 
Hn), 3.17 (t, J = 5.8 Hz, 2H, Ho), 3.02 (s, 6H, Hj), 2.60–2.55 (m, 2H, Hee), 2.50–2.47 (m, 
2H, Hq), 2.38–2.27 (m, 6H, Hm+u+x), 2.26 (s, 3H, Ha), 2.23 (s, 12H, H1+19), 2.07–2.02 (m, 
2H, Hg), 1.84–1.77 (m, 2H, He), 1.73–1.66 (m, 2H, Hf), 1.67–1.57 (m, 4H, Hp+w), 1.48 (s, 
2H, Hv), 1.28 (s, 9H, Hii).  13C NMR (125 MHz, CD2Cl2): δ = 174.2, 172.4, 172.3, 171.9, 
168.4, 167.4, 164.3, 163.8, 162.5, 161.4, 161.3, 161.3, 159.9, 157.6, 157.2, 156.0, 154.1, 
152.0, 150.7, 150.6, 148.0, 147.9, 144.1, 140.1, 139.9, 139.6, 139.4, 137.9, 137.3, 136.2, 
136.1, 133.1, 133.0, 130.3, 130.2, 129.6, 129.3, 128.0, 126.8, 126.8, 124.7, 124.4, 122.4, 
121.8, 116.2, 114.8, 114.5, 111.6, 111.5, 111.2, 111.1, 105.8, 105.6, 70.8, 70.5, 68.9, 
68.6, 68.3, 68.0, 67.6, 67.0, 65.7, 65.6, 63.9, 56.2, 50.1, 49.8, 49.7, 46.2, 43.5, 40.2, 39.7, 
36.8, 36.5, 36.4, 34.6, 34.5, 33.6, 32.5, 32.3, 31.8, 30.3, 30.2, 30.2, 30.1, 30.1, 30.1, 30.0, 
29.9, 29.9, 29.8, 29.7, 29.6, 29.4, 28.9, 28.9, 28.7, 26.5, 25.5, 25.4, 25.3, 23.3, 21.4, 21.3, 
20.7, 14.4, 1.3.  LRMS (ESI+): m/z = 2226.0 [M+H]+; 2248.0 [M+Na]+. 
 
Figure 2.11 - Isotopic mass distribution for L1Pd-(2,6-Py). LRESI+: m/z = 2247.96 [M+Na]+ (calcd. 




Synthesis of Bimetallic Complex 21 
 
Scheme 2.8 - Synthesis of bimetallic complex. Reagents and conditions: (a) 13, DMF, 85%; (b) 17, 




Synthesis of S16 
 
Pd(OH)2/C was stirred in D2O for 16 h.  D2O was removed under reduced pressure and 
dried under high vacuum before use.  S9 (1.20 g, 2.10 mmol, 1.00 equiv) was dissolved 
in THF/methanol-d4 (4:1, 50 mL) and degassed with N2, followed by D2.  K2CO3 (14.0 
mg, 0.10 mmol, 0.05 equiv) and Pd(OH)2/C (120 mg, 10 % weight) were added and the 
reaction continued to be purged with D2 for an additional 10 min. before being allowed 
to stir for 16 h under a D2 atmosphere.  The crude residue was filtered through Celite®, 
and purified by column chromatography (SiO2, CH2Cl2/MeOH 9:1) to yield S16 (994 
mg, 78%) as a colourless oil.  1H NMR (500 MHz, CDCl3): δ = 8.27 (d, J = 1.8 Hz, 1H, Hr), 
8.26 (d, J = 1.8 Hz, 1H, Hy), 7.30 (t, J = 2.1 Hz, 1H, Hs), 7.05 (d, J = 8.4 Hz, 2H, Hb), 6.77 (d, 
J = 8.4 Hz, 2H, Hc), 6.25 (d, J = 2.3 Hz, 1H, Hk), 6.22 (d, J = 2.3 Hz, 1H, Hi), 3.91 (t, J = 6.6 
Hz, 2H, Hd), 3.66 (s, 3H, Hy), 3.46 (s, 2H, Hn), 3.41 (s, 2H, Ho), 2.98 (s, 6H, Hj), 2.33 (t, J = 
7.5 Hz, 2H, Hx), 2.27 (s, 3H, Ha), 1.83−1.76 (m, 2H, He), 1.65 (t, J = 7.5 Hz, 2H, Hw), 1.54–
1.49 (m, 2H, Hf). 13C NMR (125 MHz, CDCl3): δ = 174.0, 161.5, 161.5, 157.1, 147.8, 
147.6, 147.6, 136.9, 136.9, 135.9, 130.0, 130.0, 129.7, 114.5, 114.5, 103.2, 103.1, 70.5, 
69.7, 68.1, 67.9, 51.7, 39.4, 33.9, 29.8, 29.3, 25.9, 25.9, 25.8, 24.5, 24.4, 20.6. HRMS 
(ESI+): m/z = 606.4933 [M+H]+ (calcd. 606.4940 for C36H36D16N3O4+). 
Synthesis of S17 
 
S16 (319 mg, 0.53 mmol, 1.00 equiv) was dissolved in DMF (5 mL) and a CH2Cl2 (5 mL) 
solution of 13 (375 mg, 0.53 mmol, 1.00 equiv) was added dropwise.  The reaction was 
stirred vigorously for 16 h.  The solvent was removed under reduced pressure and the 




98.5:2:0.5) to yield S17 (568 mg, 85%) as a yellow solid.  1H NMR (500 MHz, CDCl3): δ = 
7.72 (d, J = 1.9 Hz, 1H, Ht), 7.71 (d, J = 1.9 Hz, 1H, Hr), 7.37 (s, 2H, Hdd), 7.20 (t, J = 1.9 
Hz, 1H, Hs), 7.06 (d, J = 8.4 Hz, 2H, Hc), 6.85 (d, J = 7.9 Hz, 4H, Haa), 6.78 (d, J = 8.4 Hz, 
2H, Hb), 6.69 (d, J = 7.9 Hz, 4H, Hbb), 6.24 (d, J = 2.3 Hz, 1H, Hk), 6.22 (d, J = 2.3 Hz, 1H, 
Hi), 4.36 (s, 4H, Hcc), 4.33 (t, J = 4.3 Hz, 2H, Hee), 3.92 (t, J = 6.6 Hz, 2H, Hd), 3.73–3.69 
(m, 2H, Hff), 3.69 (s, 3H, Hy), 3.47 (s, 2H, Hn), 3.36 (s, 2H, Ho), 2.97 (s, 6H, Hj), 2.33 (t, J = 
7.4 Hz, 2H, Hx), 2.27 (s, 3H, Ha), 2.22 (s, 6H, Hz), 1.84–1.76 (m, 2H, He), 1.60 (t, J = 7.4 
Hz, 2H, Hw), 1.55–1.48 (m, 2H, Hf). 13C NMR (125 MHz, CDCl3): δ = 173.7, 171.7, 168.4, 
162.0, 157.1, 155.5, 153.9, 150.1, 149.9, 137.6, 137.4, 135.4, 130.0, 129.8, 128.8, 126.6, 
114.5, 111.0, 103.2, 103.0, 70.9, 69.4, 68.4, 68.1, 51.8, 49.5, 49.6, 39.4, 33.8, 33.6, 32.1, 
30.3, 29.9, 29.5, 29.4, 26.9, 25.9, 24.4, 22.8, 21.1, 20.6, 14.3.  HRMS (ESI+): m/z = 
1257.6444 [M+H]+ (calcd. 1257.6449 for C61H60D16N9O7Pt+). 
Synthesis of S18 
 
Compounds S17 (480 mg, 0.38 mmol, 1.00 equiv) and 17 (318 g, 0.38 mmol, 1.00 
equiv) were dissolved in CH2Cl2 (25 mL) and the reaction mixture purged with N2 for 
20 min.  DIPEA (100 µL, 1.50 equiv) was added and the mixture stirred for 5 min.  
Cu(CH3CN)4·PF6 (37.0 mg, 0.20 equiv) and a catalytic amount of TBTA were added to 
the reaction which was stirred at room temperature for 14 h.  The solvent was removed 
under reduced pressure and the residue purified by flash column chromatography 
(SiO2, CH2Cl2/MeOH/Et3N 94.5:5:0.5) to yield S18 (706 mg, 88%) as an orange oil.  1H 
NMR (400 MHz, CDCl3): δ = 8.35 (s, 1H, H7/12), 8.28 (s, 1H, H7/12), 7.70 (d, J = 1.5 Hz, 1H, 
Ht), 7.66 (d, J = 1.5 Hz, 1H, Hr), 7.63–7.60 (m, 1H, H9), 7.61–7.57 (m, 1H, H22), 7.56–7.53 
(m, 2H, H8+10), 7.43 (s, 2H, H5), 7.41 (s, 2H, H15), 7.19 (s, 1H, Hs), 7.05 (d, J = 8.2 Hz, 2H, 




6.66 (d, J = 7.9 Hz, 4H, H17), 6.42 (d, J = 7.9 Hz, 4H, H3), 6.24 (d, J = 1.5 Hz, 1H, Hk), 6.23 
(d, J = 1.5 Hz, 1H, Hi), 4.86–4.79 (m, 4H, H6’+13), 4.60–4.65 (m, 4H, H6+14), 4.32 (d, J = 6.2 
Hz, 4H, H16), 3.98 (s, 4H, H4), 3.95 (s, 3H, H11), 3.91 (t, J = 6.5 Hz, 2H, Hd), 3.67 (s, 3H, 
Hy), 3.47 (s, 2H, Hn), 3.35 (s, 2H, Ho), 3.00 (s, 6H, Hj), 2.38 (s, 6H, H20), 2.31 (t, J = 7.4 Hz, 
2H, Hx), 2.26 (s, 3H, Ha), 2.22 (s, 6H, H1), 2.20 (s, 6H, H19), 1.84–1.76 (m, 2H, He), 1.57 
(t, J = 7.4 Hz, 2H, Hf), 1.54–1.48 (m, 2H, H2).  
Synthesis of 21 
 
S18 (1.85 g, 0.89 mmol) was dissolved in DMF/MeCN 1:1 (4.0 L, 0.2 mM) and the 
reaction stirred at 65 °C for 5 h. The solvent was removed at 60 °C under reduced 
pressure. The orange residue was purified by column chromatography (SiO2, 
CH2Cl2/MeOH 95:5) to yield 21 (1.18 g, 67%) as a yellow solid.  1H NMR (500 MHz, 
CDCl3): δ = 8.52 (s, 1H, H12), 8.18 (s, 1H, H7), 7.75 (d, J = 1.3 Hz, 1H, Hr/t), 7.69 (s, 1H, 
H8/10), 7.62 (s, 1H, H8/10), 7.48 (d, J = 1.3 Hz, 1H, Hr/t), 7.44 (s, 2H, H5), 7.41 (s, 1H, H9), 
7.18 (t, J = 1.7 Hz, 1H, Hs), 7.08 (s, 2H, H15), 7.05 (d, J = 8.4 Hz, 2H, Hb), 6.81 (d, J = 7.9 
Hz, 4H, H3), 6.75 (d, J = 8.4 Hz, 4H, Hc), 6.73 (d, J = 8.1 Hz, 4H, H17), 6.62 (d, J = 8.1 Hz, 
4H, H18), 6.58 (d, J = 7.9 Hz, 4H, H2), 6.16 (d, J = 2.6 Hz, 1H, Hi), 6.10 (d, J = 2.6 Hz, 1H, 
Hk), 4.96 (t, J = 6.3 Hz, 2H, H13), 4.92 (t, J = 4.3 Hz, 2H, H6’), 4.60 (t, J = 4.4 Hz, 2H, H6), 
4.42 (d, J = 15.0 Hz, 2H, H16), 4.31 (t, J = 6.3 Hz, 2H, H14), 4.20 (d, J = 15.0 Hz, 2H, H16’), 
4.08 (d, J = 13.9 Hz, 2H, H4), 3.96 (s, 3H, Ha), 3.86 (d, J = 13.9 Hz, 2H, H4’), 3.85 (t, J = 6.3 
Hz, 2H, Hd), 3.68 (s, 3H, Hy), 3.28 (s, 4H, Hn+o), 3.11 (s, 6H, Hj), 2.34 (t, J = 7.3 Hz, 2H, 
Hx), 2.27 (s, 3H, Ha), 2.21 (s, 6H, H1), 2.16 (s, 6H, H19), 1.62–1.58 (m, 2H, Hw), 1.27–1.22 
(m, 2H, Hf).  13C NMR (125 MHz, CDCl3): δ = 173.8, 172.5, 171.5, 171.1, 167.8, 167.7, 
162.4, 162.4, 161.4, 161.0, 161.0, 156.9, 155.6, 154.3, 154.2, 154.1, 150.1, 149.8, 148.3, 




130.0, 129.8, 128.7, 128.6, 127.8, 127.7, 126.5, 126.4, 116.5, 114.3, 111.4, 111.3 111.2, 
110.6, 103.4, 103.3, 70.3, 69.9, 68.1, 67.8, 67.2, 55.8, 51.8, 49.6, 48.9, 48.4, 46.0, 39.7, 
33.6, 29.8, 29.4, 25.9, 24.4, 22.8, 21.2, 20.6. HRMS (ESI+): m/z = 1996.7784 [M–H+Na]+ 
(calcd. 1996.7764 for C97H90D16N15O11PdPtNa+). 
 
Figure 2.12 - Partial 1H NMR (500 MHz, CDCl3) of : a) 21; (b) L1Pd-(2,6-DMAP). 
General Procedure for the Protonation-Driven Switching of L1Pd 
Stock solutions of L1Pd-(2,6-DMAP) (2.0 mM in CDCl3) and CH3SO2H (2.0 mM in CDCl3) 
were prepared.  Aliquots (0.5 mL) of each solution were mixed and CDCl3 (6.0 mL) and 
CD3CN (3.0 mL) were added to obtain a 1:1 solution of L1Pd-(2,6-DMAP) (0.1 mM) and 
CH3SO2H (0.1 mM) in CDCl3/CD3CN (7:3).  Aliquots of this solution (0.5 mL) were 






Figure 2.13 - Partial 1H NMR (500 MHz, CDCl3) of L1Pd-(2,6-DMAP) before (a) and after (b) the 
addition of 1 equivalent of CH3SO2H. 
Figure 2.14 - Partial 1H NMR (500 MHz, CD2Cl2) of: (a) L1Pd-(2,6-DMAP); (b) crude operation 





Figure 2.15 - Partial 1H NMR (400 MHz, C2D2Cl4) of L1Pd-(2,6-Py) at: (a) 298 K; (b) 380 K. 
Figure 2.16 - Partial 1H NMR (500 MHz, CDCl3/CD3CN 7:3) of: (a) 1:1 solution of L1Pd-(2,6-
DMAP) (0.1 mM) and CH3SO2H; (b) mixture (a) heated at 338 K for 40 h; (c) mixture (b) heated at 




2.9 Crystallographic Data 
 
Figure 2.17 - X-ray crystal structures of: (a) L2Pt-(3,5-dihexylPy); (b) L2Pt-DMAP. Hydrogen 
atoms and solvent molecules are omitted for clarity. Nitrogen atoms are shown in blue, oxygen 
atoms red, platinum atoms pink and carbon atoms in grey (DMAP and pyridine carbon atoms are 
shown in green and red respectively). 
 L1Pd-(2,6-DMAP) L2Pt-(3,5-dihexylPy) L2Pt-DMAP 
Chemical formula C101H103D16N15O13PdPt C82H110N8O9Pt2 C62H68N10O7Pt2 
Formula Mass 2068.70 1742.00 1455.46 
Crystal system Triclinic Triclinic Monoclinic 
Space group P-1 P-1 C2/c 
Crystal size/mm 0.03 × 0.20 × 0.20 0.04 × 0.10 × 0.12 0.20  × 0.20 × 0.20 
a/Å 14.238(4) 13.963(5) 24.018(12) 
b/Å 18.939(5) 16.442(5) 20.103(8) 
c/Å 19.681(5) 19.176(5) 16.238(8) 
α/° 104.533(6) 90.185(5) 90 
β/° 96.912(8) 106.795(7) 125.402(8) 
γ/° 94.763(4) 108.246(5) 90 
V/Å3 5064(2) 3981(2) 6391(5) 
Temperature/K 93(2) 93(2) 93(2) 
Z 2 2 4 
Dcalc/Mgm-3 1.357 1.448 1.513 
μ/mm-1 1.624 3.556 4.413 
F(000) 2116 1772 2888 
θ limits 2.16º to 25.33º 2.22º to 25.35º 0º to 25.46º 
hkl limits -17,15/-22,17/-23,23 -16,16/-12,19/-20,23 -24,29/-21,24/-19,19 
No. of reflections 
measured 32421 25292 19911 
No. of independent 
reflections 17832 14087 5872 
Rint 0.0554 0.0345 0.114 
Data/restraints/ 
parameters  17832 / 35 / 1168 14087/20/900 5872/43/366 
R(I> 2σ(I)) R1 = 0.1041  R1 = 0.0521  R1 = 0.092 
R (all data) wR2 = 0.3374 wR2 = 0.1517 wR2 = 0.2694 
Goodness of fit on F2 1.231 1.083 1.052 
Table 1 - X-ray crystallographic experimental and refinement data for L1Pd-(2,6-DMAP), L2Pt-
(3,5-dihexylPy) and L2Pt-DMAP.a In common: Refinement method: full-matrix least-squares on F2. 
Wavelength: 0.71073 Å (Mo/Kα), Temperature: 93(2) K. Absorption correction method: multi-scan 
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Switchable mechanically interlocked molecules have shown promise in the field of 
molecular electronics with potential applications in processors and information storage 
devices.  Further progress in this area demands improvement in molecular switching 
efficiencies during operation and an increase in the lifetimes of resting states.  Herein, the 
design, synthesis, and characterisation of a novel bistable [2]rotaxane is described 
incorporating a platinum(II)-complexed macrocycle interlocked with a two-station 
thread comprising 4-dimethyaminopyridine and pyridine binding sites.  The use of both 
thermodynamic and kinetic stimuli are investigated with the aim of achieving efficient 
and selective translocation of the metal-complexed macrocycle between stations through 
reversible protonation, thus constituting a stimuli-responsive molecular shuttle.  The 
substitution pattern of the ligands and the kinetic stability of the Pt-N bond afford 
exceptional metastability to the co-conformers of the molecule in the resting state; a 
prerequisite in the procurement of long-term information storage. 
In terms of this thesis, the investigation of photoinitiated ligand exchange in platinum(II) 
complexes is also pursued as a potential orthogonal stimulus to the heat/protonation 





The past half-century has witnessed an incredible advancement in the fields of 
technology and electronics; a progression inextricably linked with man's ability to 
miniaturise components in the quest for evermore powerful and efficient devices.  In 
1965, Gordon E. Moore famously laid out a vision for the future of integrated 
electronics and computing in his seminal paper "Cramming more components onto 
integrated circuits"1 where he predicted the number of transistors that could be placed 
into a given area would double every two years.  Although he only foresaw this trend 
holding for a decade or so, innovative engineering and improved manufacturing 
techniques have resulted in the remarkable endurance of so-called Moore's Law up to 
the present day, fuelling the continued progression of electronic device capabilities 
including computer processing-power and data-storage capacity.  After nearly half a 
century and with transistors now registering at an individual length of little over  
20 nm, the end of the law's limits may soon be realised.  Keeping components cool and 
error-free becomes more and more difficult as their dimensions decrease, as do the 
complex and expensive optical lithography and etching techniques required to 
accurately arrange them on integrated circuits from a bulk material.2 In order to match 
the modern-day information society's seemingly insatiable thirst for faster, more 
powerful and portable electronic devices, there is a growing demand for smaller, 
cheaper and more energy efficient alternatives to the silicon chip3 as the predicted 
zenith of its capabilities approaches. 
The field of molecular electronics4 has garnered significant interest as one such avenue 
and involves superlative miniaturisation of parts by incorporating complete electronic 
components within single molecules.  This "bottom-up" approach holds the potential to 
substitute costly factory assembly lines with large-scale laboratory synthesis of 
components, all intricately designed and tuned at the atomic level to meet the ultimate 
goal of molecular electronics, that is: to control macroscopic device properties as a 
function of chemical structure.  This has already been achieved to a certain degree in 
molecular electronic devices where molecules act as solid-state molecular resistors,5 
rectifiers,6 and transistors.7 
Catenanes and rotaxanes that can act as molecular switches and shuttles through 




molecular electronic devices9 because their operation can instigate changes in 
experimentally measureable parameters such as calorimetric transformations,10 shifts 
in electrochemical potentials,11 and temperature-dependent kinetics,10,11a,b,12 thus 
facilitating a tangible correlation between the properties of chemical solution-phase 
switching and the resultant responses of the electronic device.  To date, most examples 
have been based around bistable [2]catenane or [2]rotaxane molecular switches and 
shuttles4b,8c,13 that possess two experimentally differentiable, metastable co-
conformers.  These two states can be translated into a simple binary output where the 
switch is defined as either ON or OFF, very similar to the binary code that has acted as 
the core of computing over the past half-century.  In principle, each single molecule can 
store the 'one' or the 'zero' of a bit of information according to its positional isomeric 
state offering an alternative method of making computer memory14 on an 
unprecedented scale. 
A major challenge facing this approach is the degree of metastability afforded to each 
state.  An effective memory storage system would require fast and facile manipulation 
of the switches when writing information but, equally, each state would need to be 
completely kinetically locked once the data had been stored to ensure long-term 
retention.  This equates to a chemical switch not dissimilar to those already discussed 
for use in the operable feet of molecular walkers and stimuli switchable molecular 
shuttles (Chapter II).  Accordingly, the same beneficial control of binding event kinetics 
and thermodynamics that made metal coordination motifs amenable to these 
aforementioned fields stands them in good stead to play a role in the achievement of 
high integrity information storage through molecular memory. 
Over the past fifteen years or so, J. P. Sauvage et al. have continued to carry out ground-
breaking research in the field of redox-responsive Cu(I)/Cu(II) and Cu(II)/Zn(II) 
mechanically interlocked molecules.15 This work has given rise to an impressive wealth 
of literature and provided the pretext for the palladium(II)-based acid-base switchable 
molecular shuttles16 discussed in Chapter I.   Although these latter Pd(II)-based 
examples do possess an intelligible ON/OFF level and can be fixed in 
thermodynamically unfavourable states by means of an energy ratchet mechanism,17 
the metastability of the co-conformers is not absolute under ambient conditions and 
the systems were reported to gradually return to their equilibrium distributions over 




term memory storage where there is a requirement for complexes to be completely 
kinetically stable unless subjected to switching conditions. 
One approach to improving the retention time of positional integrity in metal-
coordinated molecular shuttles in the absence of their operating stimuli is simply to use 
metal-ligand complexes with greater levels of stability.  The platinum(II)-pyridine 
derivative complexes (L2Pt-) investigated in Chapter II exhibited significantly 
improved stabilities compared to their palladium(II) counterparts (L2Pd-), making 
motifs of this kind attractive for potential use in stimuli switchable molecular shuttles 
aiming to achieve exceptional metastability of co-conformers.  The upshot of this 
increased stability is of course the need for a more rigorous stimulus when operating 
the machine.  Although this would be an issue in the palladium-based shuttles that 
were reported to decompose at very high temperatures used in attempts to accelerate 
shuttling, it was predicted that platinum analogues could withstand far harsher 
conditions whilst still facilitating translocation of the macrocycle on a reasonable 
timescale.  An energetically more efficient alternative would be to employ a different 
stimulus to labilise the macrocycle and the potential for photonically driven 
platinum(II) molecular shuttling is explored in this chapter.  It was postulated that such 
a stimulus may also prove to be effective as an independently operable switch for use 
with an opposing foot to the successful palladium(II) motif laid out in Chapter II and aid 
the design of extended bimetallic molecular walker systems. 
3.3 Basis of Design: Protonation/Deprotonation Driven Ligand Exchange 
The concept outlined in Figure 3.1 is very similar to that of the palladium-based 
molecular shuttles discussed previously16 only with slight structural adjustments to the 
binding sites' (stations') substitution patterns on account of platinum(II) complexes' 
inability to bind 2,6-disubstituted pyridines.  To accommodate these preferences the 
thread was altered to incorporate a 3,5-substituted pyridine, and a DMAP moiety 





Figure 3.1 - Structure and proposed operation method for a pH-switchable Pt(II)-complexed 
molecular shuttle, Py-L3Pt. 
The system's design was based around the hypothesis that, upon application of a 
suitable stimulus, the otherwise kinetically inert Pt-ligand bond will be significantly 
labilised.  Assuming the platinum remains coordinated to the tridentate N,N,N-pincer 
motif of the macrocycle (L3) throughout the application, metal-ligand complex L3Pt 
will act as a brownian particle free to explore both potential ligand binding sites of the 
thread.  Maintenance of the stimulus will drive the system towards a thermodynamic 
minimum at which the relative populations of the Py-L3Pt18 and DMAP-L3Pt states will 
be defined by the energy difference between them.  This ratio could then be fixed upon 
suspension of the stimulus when the macrocycle becomes kinetically locked to the 
thread.  When Py-L3Pt is operated under neutral conditions, labilisation would invoke 
a significant shift in relative populations as the majority of macrocycles in the sample 
translocate to coordinate to the DMAP station on account of its superior ligand 
strength.  The addition of one equivalent of acid and subsequent application of the 
stimulus will bring about a different equilibrium defined by the relative basicities of the 
two heterocycles.  Acidic operation of the system would instigate protonation of the 
more basic DMAP moeity and a net migration of macrocycle units to the Py-station.  
The exceptional kinetic stability of the Pt-N-heterocycle bonds means that shuttling 
should be completely prohibited in the absence of a stimulus for extensive periods of 




automatically induce translocation of the macrocycle.  These operating conditions 
would allow the thread do work on the macrocycle by ultimately ratcheting it 
energetically uphill (from DMAP to Py), an act notoriously difficult to achieve in 
molecular shuttles that operate via non-covalent interactions. Because resetting the 
thread (deprotonation) in the absence of a stimulus was not expected to undo the 
initial translocation task, the macrocycle could be locked in a thermodynamically 
unfavourable distribution.   This method of operation would render the platinum-
complexed [2]rotaxane an acid-base switchable molecular shuttle predicted to possess 
improved levels of metastability from previous examples.16 
3.4 Ligand Exchange Experiments 
The synthesis of a platinum(II)-complexed [2]rotaxane of the kind proposed in  
Figure 3.1 by a threading-and-stoppering strategy19 is inherently more difficult than for 
their palladium counterparts because the metal of the macrocycle is more likely to 
coordinate to the stations on the thread by "perching' (that is, without forming the 
desired interlocked species) because the binding sites are far less sterically hindered 
due to differences in substitution patterns.  This issue can be overcome through 
manipulation of the steric environment of the macrocycle by using a rigid bis-anilide 
ring,16b,20 as opposed to a more flexible benzylic amide macrocycle.16a However, 
although this choice of shuttling component has been shown to improve positional bias 
in previous systems, it has also proven to facilitate superior dynamics in terms of rate 
of equilibration during operation.  Considering the aim of this project is to increase the 
metastability of co-conformers rather than the dynamics between them, some model 
ligand exchange experiments were carried out to investigate the relative stabilities of 
the different kinds of platinum(II)-pyridine complexes and assess their respective 
potentials for use as a components in this new system. 
The tridentate pyridine 2,6-dicarboxamide motif (L2) used to model the palladium(II) 
and platinum(II) complexes in Chapter II also provides a good mimic for a potential 
benzylic amide macrocycle.  A simple exchange experiment (Scheme 3.1) showed  
L2Pt-(3,5-dihexylPy) to be stable in coordinating solvent mixture DMF-d7/MeCN-d3 
(1:1) in the presence of DMAP at room temperature indefinitely and, even at 348 K, it 
took 2 weeks to reach an equilibrium state of 25:75 L2Pt-(3,5-dihexylPy):DMAP  




metastability of L2Pt-(3,5-Py) in the presence of the superior DMAP ligand was shown 
to be considerably better than it's Pd(II) analogue.  Additionally, the exchange process 
observed when heated was incredibly clean with no decomposition products observed 
at all providing precedent for the theory of dramatically increased overall stability. 
 
Scheme 3.1 - Substitution of 3,5-dihexylPy for DMAP ligands in N,N,N-pincer-platinum(II) complex 
L2Pt-(3,5-dihexylPy) in DMF-d7/MeCN-d3 (1:1).  Time required to reach equilibrium: 2 weeks at 
348 K.  No ligand exchange was observed at room temperature after 2 weeks. 
 
Figure 3.2 - 1H NMR spectra (500 MHz, DMF-d7/MeCN-d3 (1:1), 298 K) L2Pt-(3,5-dihexylPy) and 
DMAP (1:1, 1 mM): (a) t = 0 h; (b) t = 2 weeks at 348 K.  The lettering and colours in the figure refer 
to the assignments in Scheme 3.1. 
Similar exchange experiments were carried out with bis-anilide macrocycle L3 
(Scheme 3.2) to monitor how structural alterations to the N,N,N-pincer ligand affected 




ambient stability with all complexes shown to be stable in the reaction mixture at room 
temperature for 2 weeks.  At elevated temperature, however, there was a significant 
increase in the rate of ligand exchange compared to the bis-amide analogues.  The 
lutidine group of L3Pt-(3,5-lutidine) was exchanged for DMAP (Scheme 3.2a) reaching 
an equilibrium distribution of  25:75 (L3Pt-(3,5-lutidine):DMAP) within just 18 h.  This 
process could be reversed by adding an equivalent of p-toluenesulfonic acid (Scheme 
3.2b).  The results suggested that the platinum-complexed [2]rotaxane proposed in 
Figure 3.1, incorporating both DMAP and Py binding sites and a bis-anilide macrocycle, 
could operate as an acid-base switchable molecular shuttle with a thermal stimulus in a 
coordinating solvent. 
 
Scheme 3.2 - Reversible substitution of 3,5-dihexlypyridine and DMAP ligands in macrocycle-
platinum complex L3Pt-(3,5-lutidine)/DMAP in DMF-d7/MeCN-d3 (1:1): (a) neutral conditions; (b) 
in the presence of TsOH (1 equiv).  Time required to reach equilibrium: 18 h at 348 K.  No ligand 
exchange was observed in CDCl3, either under neutral conditions, nor in the presence of TsOH, even 
after heating at reflux for 5 days. 
The method proposed here to increase the metastability of far-from-equilibrium states 
depends very simply upon raising the kinetic barrier to equilibration from either of the 
fixed co-conformers of the [2]rotaxane.  Although this is beneficial because it results in 
longer-term information storage, it comes at the cost of a heavier energy penalty to 
intentional metal-ligand bond labilisation.  One way of offsetting this is with the use of a 
kinetic stimulus21 to lower the energy barrier during operation and it has indeed been 





3.5 Photophysics and Photochemistry of Platinum(II)-Py Bonds 
To date, the majority of work relating to the photophysical and photochemical 
properties of platinum(II) complexes has focused upon electronic and spectroscopic 
characteristics with a view of gaining control over their photoluminescence.23 Reported 
applications include use in light-emitting devices,24 chemical sensors,25 bioimaging and 
labelling,26 solar energy conversion,27 and photogeneration of hydrogen from water.28 
Although the elucidation of relevant excited states of these complexes is a sine qua non 
for obtaining a general understanding in any of the bespoken fields, the collective 
primary incentive for further research is provided by the allure of chemo-stable 
systems with high luminescent quantum yields and electronic properties that can be 
easily tuned by means of simple synthetic manipulation.  The main challenges facing 
these systems are competitive non-radiative decay pathways and photodecomposition 
of the platinum species.  An area that has received far less attention, however, is one in 
which these pathways, previously deemed deleterious, are actively encouraged within 
platinum(II) complexes specifically designed to undergo controlled photodissociation 
to yield pre-ordained, desirable photoisomerisation products.22 Regardless of the 
respective goals of these systems, a comprehensive understanding of the relevant 
photophysical and electronic processes involved is essential to enable their effective 
incorporation as functioning components into advanced molecular machines. 
As a coordination centre, platinum(II) has a strong thermodynamic preference for dsp2 
hybridisation and hence, has proved to be an interesting alternative to the more 
extensively studied metal ions within the world of inorganic photochemistry, such as 
ruthenium(II), chromium(III) and rhodium(III) that generally form 6-coordinate 
octahedral complexes.  It is the 4-coordinate square-planar geometry that 
predominantly dictates the character of the excited states.29 Platinum in the +2 
oxidation state has a d8 electron configuration defined by discrete energy levels 
according to the well-established ligand field theory.30 This equates to four filled 
bonding or non-bonding metal-based d-orbitals (dz2, dxy, dxz, and dyz) and a strongly 
antibonding dx2-y2 orbital.  For platinum(II) complexes solely comprised of simple 
inorganic ligands such as [PtCl2]2- or [Pt(NH3)4]2+, the dx2-y2 provides the only empty 
orbital accessible to the ground state upon irradiation.  However, such a transition is 
Laporte forbidden and would therefore be very weak.  Furthermore, due to 




significant D2d distortion away from the D4h square-planar configuration towards a 
tetrahedral conformation.31 Such rearrangements promote coupling to the ground state 
and thus facilitate rapid radiationless deactivation of the excited species.32 Hence, 
simple complexes generally have short-lived ligand field excited states and rarely show 
any significant luminescence.29 
It is possible to influence the relative positions of the energy levels involved via careful 
ligand selection according to steric and electronic properties.  However, the 
inauguration of more electronically complex ligands, such as conjugated aromatics, 
complicates the picture somewhat by introducing new accessible excited states and 
consequently, a new range of possible photo-induced transitions including ligand 
centred (π-π*) and metal to ligand charge transfer (d-π*, MLCT), among others.  
Consider the system described in the Figure 3.3a where an electron residing in a 
ground state d-orbital is promoted into a π*-orbital centred on the ligand via a Laporte 
allowed photoinduced MLCT.  The molecule then undergoes radiationless decay from 
the upper vibrational states, dissipating energy to the surroundings until it reaches the 
lowest vibrational level of the electronically excited molecular state (π1*, υ=0).  From 
here, it can either return to the ground state by spontaneously emitting the remaining 
excess energy in the form of fluorescence, or it can thermally populate the adjacent d* 
excited state centred on the metal, from whence it can undergo subsequent non-
radiative decay to the ground state.  It is clear from this generic example that the 
luminescence properties and, to some extent, the excited state lifetimes of such systems 
are dictated by the disparity between the two excited state energy levels.  In order to 
obtain highly emissive compounds this energy gap must be maximised either by raising 
the d*-state to inaccessible energies, or by lowering the potentially emissive π*-state. 
Figure 3.3a displays a simplified description of the potential energy landscape because 
it is only concerned with the ground and first two singlet excited states.  However, 
platinum’s high spin-orbit coupling constant (ε) brings states of higher multiplicity into 
play by promoting rapid inter-system crossing (ISC).  Figure 3.3b accounts for this by 
describing a similar system but with the 1d*-state raised to an inaccessible energy, and 
a readily accessible excited triplet state available to the first singlet excited state via 
ISC.  The triplet state lies below its singlet analogue in energy in accordance with 
Hund’s maximum multiplicity rule, which dictates that the state of the complex with 





Figure 3.3 - Potential energy profile showing the possible pathways of a platinum(II) complex 
promoted from the ground state (GS) via UV-irradiation (hν) into: (a) the first excited singlet 
ligand-based state (π1*).  The molecule descends to the lowest vibrational level from whence it can 
thermally access a metal-based state (d*) and thence non-radiatively return to the ground state; 
(b) the first singlet excited state (1MLCT*). Intersystem crossing (ISC) mediates transfer into a 
triplet state of ligand parentage (3MLCT*), where it rapidly descends to the lowest vibrational 
level.  The molecule can then radiatively dissipate energy via phosphorescence or undergo 
thermally activated internal conversion (IC) to a highly dissociative metal-based antibonding 
orbital state (3d-d*) leads to Pt-ligand bond breaking. 
Similar to the previous example, irradiation induces a metal to ligand charge transfer to 
the first singlet excited state, followed by rapid relaxation, non-radiatively transferring 
energy to the surroundings as the molecule descends through the vibrational levels. At 
the intersect of the potential energy surfaces, the ligand-based triplet and singlet states 
share a common geometry where spin-orbit coupling can mediate the unpairing of 
electron spins and thus facilitate a non-radiative transition between the two states via 
ISC.  From there the molecule continues to dissipate energy to the surroundings 
descending the triplet’s vibrational ladder until it reaches the lowest vibrational level 
where it is trapped because the solvent cannot absorb the final large quantum of 
energy and radiative return to the ground state is spin forbidden.  These conditions 
manifest themselves in the formation of a relatively long-lived, paramagnetic state and 
it is from this state that various possibilities to manipulate the system arise depending 
on the desired application of the molecule.  For the majority of systems mentioned 
previously in which high luminosity is the ultimate goal, the final step would involve 
radiative decay back to the ground state in the form of phosphorescence.  Although this 




breaks the selection rule and can render the triplet state a slowly radiating reservoir.33 
Alternatively, for systems with ambitions more akin to those of this project in which 
organised bond dissociation is the coveted concluding process, an additional element of 
control over decay from the ligand-based triplet excited state must be introduced. 
Because the photolability of transition metal compounds is generally associated with 
the enforced population of metal-centred (MC) antibonding orbitals,34 this can be 
realised by means of a low-lying metal-centred triplet state (such as 3d-d* in Figure 
3.3b) that is thermally accessible from the triplet MLCT state (3MLCT*).  Thermal 
energy can excite the molecule to a higher vibrational level causing its electrons to 
undergo a reorganisation that results in internal conversion (IC); a radiationless 
transition to another state of identical multiplicity that occurs most readily when the 
two states share a common nuclear geometry (i.e. at the intersect of their respective 
potential energy profiles).  If the metal-centred antibonding state into which the 
molecule converts is dissociative, there will be no ground state analogue and such a 
conversion will result in the breaking of a chemical bond where the photolability of the 
compound will be related to the energy difference between the emitting 3MLCT and the 
dissociative 3MC states. 
These mechanisms have been studied extensively for ruthenium(II) complexes35 and in 
2004, Sauvage et al. reported two such complexes in which the motility of one 
component of  a catenane molecule could be photochemically controlled by means of 
photoinduced ligand exchange as a result of orchestrated population of a dissociative 
excited state.36 Although ruthenium(II) systems stand as a useful paradigm for 
predicting the possible photophysical mechanisms, apart from a few reports of 
photoisomerisations,27a,f there has not been substantial literature precedent for 
successful photonically stimulated ligand dissociation in platinum(II) complexes until 
quite recently.  In 2007, Fujita et al. reported the potential to labilise an otherwise inert 





Scheme 3.3 - One-way catenane formation of a Pt(II)-linked coordination ring via the 
photolabilisation of a Pt(II)-pyridine bond.  Reagents and Conditions: DMSO/H2O (1:2), hv, 15 min, 
quant. yield.22b 
This property was exploited to accommodate efficient photoinduced catenane 
formation in the synthesis of a so-called "molecular lock" where a pyridyl ligand was 
reversibly coordinated to platinum dependent upon aqueous/non-aqueous solvent 
environment (Scheme 3.3).  Kinetic studies supported the theory of a photoinduced, 
dissociative mechanism, however, there is some debate as to the specific orbitals and 
excited states involved.  DFT calculations showed a "reasonable" agreement with the 
authors’ theory that photo-excitation induces a direct transition from the ground state 
highest occupied molecular orbital (HOMO) into an antibonding orbital dominated by 
metal dx2-y2 character and consequently inducing dissociation of the pyridine ligand.  
Although the HOMO was not officially assigned, calculated projections showed a large 
coefficient on the metal centre implying that this excitation equates to a Laporte 
forbidden d-d* transition corresponding to an indiscernible band in the UV-visible 
absorption spectrum.  Considering the unprecedented efficiency of the catenation, it 
seems more likely that the reaction proceeds via a mechanism more akin to that 
proposed earlier for ruthenium(II) complexes.  Regardless of this contention, the 
overall result of the study is indisputable: platinum(II)-pyridine bonds can be 
significantly labilised upon UV irradiation providing a clear mandate for further 
research in this area.  Indeed, Lusby and Pike later reported the use of light as a kinetic 
stimulus in N-heterocyclic ligand exchange between cyclometalated platinum(II) 
complexes.22e 
In order to transform these systems from simple ligand exchange processes into a fully 
functioning component of a synthetic molecular machine, the fundamental mechanism 
must be considered and each aspect tuned appropriately to meet the goals of the new 
design.  Taking each facet in turn; the basis of a selectively labilisable metal-ligand bond 




conformation.  Distortion of D2d symmetry in the complex can lead to reduction of the 
ligand field and lowering of the deleterious d-d* singlet excited states to a thermally 
accessible level, the end result being rapid non-radiative deactivation of the excited 
state.  One way in which the conformation can be locked is by using rigid chelate 
ligands.  Cyclometalating ligands can also serve as strong σ-donors that increase the 
splitting of the platinum d-orbitals and therefore help to raise the dx2-y2 to inaccessible 
energies.37  Additionally, multidentate ligands can help avoid unwanted decomposition 
products, as the idealised labilising stimulus should specifically target only the bond 
that coordinates the platinum to the exchanging ligand.  Selecting a tridentate N,N,N-
pincer ligand to occupy the other three coordination sites on the platinum reduces the 
chance of complete metal dissociation from the pincer motif and favours the permanent 
breaking of the metal-monodentate ligand coordinate bond, which will be the most 
photolabile in the complex as a result of the chelate effect.  MLCT transitions can be 
maximised by introducing low lying π*-orbitals facilitated through the introduction of 
good π-donor ligands.   Swift ISC crossing is accommodated by platinum’s high spin-
orbit coupling constant.  It has also been reported that the use of strongly ligating 
solvents can increase the quantum yield of ligand exchange.34 With these preconditions 
in mind, macrocycle L3 provides a reasonable starting point in the search for a rigid, π-
donor, tridentate ligand with the prediction that irradiation with an appropriate 
wavelength of light in the presence of a coordinating solvent will lower the activation 
energy to platinum(II)-pyridyl bond labilisation, thus acting as a kinetic stimulus for 
use in the pH-switchable molecular shuttle outlined in Figure 3.1. 
This chemistry could also find useful application in the designs of advanced bimetallic 
molecular walker systems similar to the one described in Chapter II.  Although both 
metals reside in the same group of the periodic table, irradiation of platinum(II) 
complexes is far more likely to promote population of dissociative triplet states than in 
their palladium(II) counterparts on account of the former's greater size and therefore 
spin orbit coupling constant.  If two opposing complexes could be effectively tuned to 
accommodate a labilising process in the platinum(II) moiety at sufficiently low 
temperatures to render a Pd-N bond inert, such a stimulus would be orthogonal to the 
heat/protonation switch proposed previously and could therefore function in tandem 




3.6 Synthesis and Characterisation of [2]Rotaxane L3Pt 
The synthetic strategy of [2]rotaxane Py-L3Pt is outlined in Schemes 3.4-3.6 and full 
details are given in the Experimental Section 3.10.   
Scheme 3.4 - Synthesis of molecular thread.  Reaction conditions: (a) 10-undecynoic acid, DCC, 
CHCl3, RT, 18 h, 99%; (b) LiAlH4, THF, 40 °C, 10 h, 98%; (c) methyl acrylate, 98 °C, 3 days, 90%; (d) 
LiAlH4, THF, RT, 18 h, 73%; (e) 6, PPh3, DIAD, THF, RT, 4 h, 61%; (f) propargyl alcohol, Pd(PPh3)4, 
CuI, Et3N, THF, RT, 15 h, 55%; (g) Pd(PPh3)4, CuI, Et3N, THF, 50 °C, 6 h, 64%; (h) Pd(OH)2/C, H2, 
K2CO3, CHCl3/THF (1:1), RT, 18 h, 95%; (i) 6, PPh3, DIAD, THF, RT, 12 h, 56%. 
DCC coupling of commercially available 4-amniopyridine (1) and 10-undecynoic acid 
afforded amide 2 and subsequent reduction (LiAlH4) gave rise to amine derivative 3 




in methyl acrylate (excess) to give 4, followed by reduction (LiALH4).  Subjection of 5 to 
Mitsunobu reaction conditions38 with bulky phenol 639 gave rise to compound 7.  The 
synthesis of the Py-station fragment was achieved by desymmertrisation of 
commercially available 3,5-dibromopyridine (8) through Sonagashira cross-coupling 
with 1 equivalent of propargyl alcohol to give 9, which was subsequently submitted to 
Pd-catalysed Sonagashira cross-coupling with 7 to yield 10, the hydrogenation of 
which (Pd(OH)2/C) afforded the saturated monostoppered thread 11.  The isolated full 
thread was synthesised for reference purposes to aid in the characterisation of the 
shuttle using a Mitsunobu reaction to couple 11 with phenol 6 to give 12 in 56% yield. 
Scheme 3.5 - Synthesis of Pt(II)-complexed macrocycle.  Reaction conditions: (a) aniline 
hydrochloride, 180 °C, 45 min, 31%; (b) pyridine-2,6-dicarboyl dichloride, Et3N, THF, RT, 18 h, 
87%; (c) 1,6-dibromohexane, K2CO3, DMF, RT, 3 days, 45%; (d) NaH, PtCl2(SMe2)2, THF, RT, 15 h, 
78%. 
The platinum(II)-coordinated macrocycle was synthesised by first heating 
commercially available aniline hydrochloride with 2,2-bis(p-hydroxyphenyl)propane) 
(13) to afford 2-aniline-(2-phenolpropane) (14) which was subsequently reacted with 
pyridine-2,6-dicarboyl dichloride (0.5 equiv) at 0 °C to yield diol 15 (Scheme 3.5a & 
3.5b).  The free macrocycle 16 was synthesised via Williamson reaction of 1,6-
dibromohexane with 15, which was then metallated by reaction with PtCl2(SMe2)2 and 
sodium hydride to give L3.  Combining monostoppered thread, 11, with 1 equivalent of 
trifluoroacetic acid led to selective protonation of the more basic DMAP station and 
subsequent addition of L3 resulted in complexation of the macrocycle-platinum moiety 
exclusively to the Py binding site to yield pseudo-rotaxane 17 (Scheme 3.6a).  Attempts 
to mimic the synthesis of isolated thread 12 using the stopper and pseudo-rotaxane 17 
under Mitsunobu conditions proved unsuccessful, possibly as a consequence of using a 
triphenylphosphine mediated reaction with a platinum-complexed species.  To 
circumnavigate this problem, the alcohol group of 13 was converted to the 
corresponding mesylate and Williamson coupled to 6 to give the target [2]rotaxane 




Scheme 3.6 - Synthesis of Pt(II)-complexed molecular shuttle. Reaction conditions: (a) L3, TsOH (1 
equiv), CHCl3, 50 °C, 18 h, 63%.  b) (i) MsCl, Et3N, CHCl3, RT, 1 h, (ii) 6, NaH, THF, RT, 4 h, (iii) 15-
crown-5, DMSO, 48 °C, 48 h, 56%. 
Electrospray mass spectrometry confirmed the product's constitution as L3Pt with a 
mass peak at 2276.29 m/z corresponding to [M+H]+ and an isotopic distribution 
concordant with theoretical predictions.  1H NMR spectroscopy (Figure 3.4) showed 
exclusive formation of the Py-L3Pt co-conformation; i.e. the platinum-macrocycle 
fragment, L3Pt, was solely coordinated to the Py-station.  A comparison of the spectra 
of free thread 12 (Figure 3.4a) and Py-L3Pt in CDCl3 (Figure 3.4b) shows significant 
upfield shifts of between 0.55-0.59 ppm for resonances associated with the Py-station 
(Hv-x) upon threading.  Similarly the signals of the protons adjacent to the Py-station 
(Hu+y) are shifted upfield by 0.55 and 0.67 ppm respectively as they are shielded by the 
presence of the macrocycle.  Meanwhile, the DMAP-station signals (Hi+j) of the rotaxane 






Figure 3.4 - 1H NMR spectra (500 MHz, CDCl3, 298 K) of [2]rotaxane L3Pt and free thread for 
comparison: (a) thread 12; (b) Py-L3Pt. The lettering in the figure refers to assignments in Figure 
3.1. 
3.7 Macrocycle to DMAP-Station Shuttling Experiments 
In an attempt to translocate the platinum(II)-coordinated macrocycle from the Py-
station to its thermodynamically favoured DMAP counterpart, Py-L3Pt was subjected to 
the neutral ligand exchange reaction conditions developed for the non-interlocked 
model experiments (DMF-d7/MeCN-d3 (1:1), 348 K, Scheme 3.2a), and the reaction 
followed by 1H NMR spectroscopy.  However, no changes were observed in the 
[2]rotaxane resonances during 6 weeks of heating after which solvent decomposition 
started to occur.  It was postulated that the lack of macrocycle translocation might be 
the result of remnant trace acid from the synthesis in the solution meaning the DMAP-
station would in fact be protonated.  In this event, the platinum-Py bond may be 
labilised under the reaction conditions but the protonated DMAP-station would be 
inaccessible meaning no shuttling would be observed as the system would 
thermodynamically favour the starting co-conformer under the conditions.  This 
hypothesis was tested by submitting a fresh sample of Py-L3Pt to the same conditions 




also no changes seen in the chemical shifts of the resonances relating to the DMAP-
station (Hj+i) upon the addition of base, implying that the reaction mixture was already 
neutralised in the previous experiment. 
Another explanation for the lack of shuttling could be that the interlocked nature of the 
[2]rotaxane affords the system a considerable increase in stability in comparison to the 
free macrocycle analogues.  Such a phenomenon could be explained from a steric 
perspective: if the alkyl chain between the two stations provides a sufficient steric 
barrier to translocation, the labilised macrocycle would remain in the vicinity of the Py-
station under the reaction conditions and, therefore, simply reform the starting co-
conformer upon suspension of the stimulus.  The simplest method of overcoming such 
a thermodynamic barrier is to increase the energy input into the system.  Fresh 
independent samples of Py-L3Pt were made up in the solvent mixture as well as in neat 
DMF and each refluxed for 7 days but to no avail.  Identical samples were heated to 
their respective boiling points whilst exposing them to microwave radiation for 48 h 
but showed no sign of isomerisation or decomposition. 
An alternative method of probing this theory is to increase the relative stability of the 
intermediate platinum(II)-solvent complex, facilitating incremental escapement of the 
macrocycle from the local thermodynamic minimum of the Py-station.  This was done 
by incorporating solvents with increased coordinating ability (neat MeCN, DMSO).  
Unsuccessful attempts were also made in neat pyridine and in the presence of excess 
un-tethered DMAP.  Heating the system at 348 K in C2H4Cl2/CH3CN (2:8) for 5 days 
resulted in alkylation of the nitrogen at the 1-position of the DMAP-station through 
decomposition of the dichloroethane.  This product was confirmed by mass 
spectrometry (m/z = 2341.48, [M+H]+). 
The labilisation of kinetically inert platinum(II)-pyridine coordination bonds by salt-
mediated nucleophilic activation has previously been reported40 and attempts were 
made to synthesise an intermediate platinum(II)-chloride complex by heating Py-L3Pt 
in DMF at 383 K in the presence of tetrabutyl ammonium chloride (5 equiv) for 4 
weeks.  Although this resulted in some unidentified variations in the 1H NMR spectrum 
over time, the product could not be isolated from the starting material in the crude 
mixture.  Attempts to remove the chloride ion to allow the macrocycle to equilibrate 
and coordinate to one of the two stations in the thread were made by the addition of 




decomposition products were observed and the expected favoured product of DMAP-
L3Pt could not be isolated by column chromatography. 
Considerable labilisation of platinum(II)-pyridine bonds has also been reported in the 
presence of strong hydrogen-bond donor solvents41 such as 2,2,2-trifluoroethanol 
(TFE) which exhibits a hydrogen bond donating ability equivalent to that of phenol42 
and weakly acidic character resulting in the formation of a 1:1 acid-base complex with 
pyridine.  Platinum(II)-pyridine bonds are said to be labilised in TFE due to the 
stabilisation afforded to the dissociated pyridine ligands through strong hydrogen 
bonding to the solvent.  Although such an approach would certainly make the DMAP-
station inaccessible as well, it was attempted to see if the platinum-complexed 
macrocycle could at least be moved away from the Py-station to form an intermediate 
metal-solvent complex.  A clean sample of Py-L3Pt was dissolved in DMSO/TFE (3:7) 
and heated at 358 K whilst being subjected to microwave radiation for 48 h.  No change 
was observed in the 1H NMR.  Following a similar theory of blocking the Py-station once 
the metal-ligand bond had been labilised, the [2]rotaxane was dissolved in DMSO in the 
presence of TsOH (2 equiv) and heated at 358 K with microwave irradiation for 48 h 
but, again, no changes were observed from the starting material. 
3.8 Kinetic Stimulus: Photoirradiation 
Although the conditions developed for the non-interlocked model experiments sufficed 
in overcoming the kinetic barrier to equilibration in intermolecular ligand exchange 
(Scheme 3.2a), it is possible that the slight differences between these systems and the  
[2]rotaxane have a profound effect on the kinetic stability of the Pt(II)-N bond, thus 
rendering the conditions inadequate for bond labilisation in the interlocked structure.  
The application of a kinetic stimulus to reduce the magnitude of the energy barrier 
could vastly increase the degree of bond dissociation under the conditions and 
accelerate the rate of shuttling.  Photoirradiation was proposed as one such stimulus in 
Section 3.5 and so the photochemistry of Py-L3Pt was investigated to assess the 
applicability of using light as an additional stimulus to instigate shuttling of the 






Figure 3.5 - UV-visible absorption spectrum for Py-L3Pt: molar extinction coefficient (ε) vs 
irradiation wavelength. 
The broad, bell-shape of the peak centred at 340 nm is indicative of a charge transfer 
transition and represents the population of the first MLCT singlet excited state.  It was 
predicted that from this state the system could undergo intersystem crossing to a 
dissociative triplet state and thus promote increased metal-ligand bond lability.  A 
solution of Py-L3Pt in DMF-d7/MeCN-d3 (1:1, 1 mM) was irradiated at 340 nm at 348 K 
and the reaction followed by 1H NMR (Figure 3.6) 
 
Figure 3.6 - 1H NMR spectra (500 MHz, DMF-d7/MeCN-d3 (1:1), 298 K) of Py-L3Pt upon 




No signs of shuttling were observed and, after 20 h of irradiation, considerable 
decomposition had taken place.  In an attempt to reduce this deterioration, the 
irradiation wavelength was varied within the proposed MLCT absorption bracket using 
a range of bandwidth filters, the solvents were degassed with argon using a freeze-
thaw technique to remove any air which could lead to the formation of reactive singlet 
oxygen species, and the temperature of the reaction varied.  Figure 3.6 demonstrates 
the best results obtained using this method.  It was clear from these experiments that 
the complex structure and electronics needed to be tuned in order to achieve the 
desired metal-ligand bond dissociation without significant decomposition of the 
complex.  More worrying, however, was that Figure 3.6c appears to show 
decomposition not only of the metal complex, but also of the thread which had been 
predicted to be stable under the conditions.  Before tinkering with the subtle 
photophysics of the Pt(II) complex to improve the efficiency of the system, experiments 
were carried out to test the photostability of the free ligand sites in the track. 
 
Figure 3.7 - 1H NMR spectra (500 MHz, MeCN-d3, 298 K) of DMAP upon irradiation with UV-light 
(340 nm ± 40 nm) at 298 K: (a) t = 0 h; (b) t = 4 h. 
A solution of DMAP in MeCN-d3 was irradiated with UV-light at 298 K and the reaction 
followed by 1H NMR (Figure 3.7).  Significant decomposition was observed after just 4 h 
and, although this process could be retarded by running the experiments at high 
concentrations and by removing oxygen from the system, it could never be completely 
prevented in any solvent tested.  This discovery marked the end of investigations into 
using UV-light as a kinetic stimulus as they clearly show that it is not compatible with 




overcome this problem whilst retaining a pyridyl thread, a platinum(II) complex would 
have to be devised with an MLCT absorption band at higher wavelengths where DMAP 
can be irradiated without initiating photodecomposition. 
3.9 Conclusion 
The development of switchable components with high degrees of metastability is 
important for the advancement of molecular machinery such as synthetic molecular 
walkers and stimuli-responsive shuttles for use in molecular electronics.  Manipulation 
of metal coordination motif energetics can help in this progression by providing 
operational control over submolecular components. 
The system described in this chapter looked to enhance the kinetic stability of previous 
pH-switchable molecular shuttles through the incorporation of platinum(II) ions.  
Considering the relative ease with which this goal was achieved in non-interlocked 
model experiments, the exceptional stability of the [2]rotaxane under a large range of 
conditions was certainly surprising and ultimately prevented operation of the final 
interlocked system.  This is thought to be due to steric restrictions causing a dearth of 
sufficient pathways for the coordinating solvent, scavenger ligand or anion to reach the 
platinum(II) centre meaning that, once the platinum-Py bond has been labilised under 
the applied stimulus, it simply reforms the original complex due to a lack of alternative 
ligand partners.  This steric restriction around the metal-centre may also explain the 
difficulties encountered when trying to form the rotaxane via a Mitsunobu reaction in 
the final step of the synthesis.  Further work on this system could involve extending the 
alkyl chain between the stations and their adjacent bulky stoppers to alleviate the 
steric restrictions and more closely mimic the model systems where the coordinating 
solvent species enjoy free passage to the metal ion.  Attempts to employ 
photoirradiation as a kinetic stimulus proved unsuccessful due in part to 
photodecomposition of the thread at the required wavelengths for metal-ligand 
labilisation meaning further in-depth investigation and tuning of the relevant energy 
levels of the excited states involved is required. 
One point is certain, however; the migration from palladium(II) to platinum(II) metal-
ligand complexes in these types of rotaxane allows for an exceptional increase in 
molecular stability and metastability of co-conformers and may well prove useful in the 




3.10 Experimental Section 
General Information 
4-[tris-(4-tert-butylphenyl)methyl]phenol (6)39 was prepared according to a modified 
literature procedure.  10-Undecynoic acid, propargyl alcohol, 1,6-dibromohexane, 
bis(p-hydroxyphenyl)propane), pyridine-2,6-dicarboyl dichloride, 3,5-lutidine,  
4-dimethylaminopyridine and compounds 1 and 8 were purchased from Sigma Aldrich.  
The syntheses of L2Pt-(3,5-dihexylPy), L2PtDMAP and 3,5-dihexylPy are described in 
Chapter II, Section 2.8. 
Synthesis of [2]Rotaxane L3Pt 
Synthesis of 2 
 
To a solution of 4-aminopyridine (5.16 g, 55.0 mmol, 2.00 equiv) and 10-undecynoic 
acid (5.00 g, 27.0 mmol, 1.00 equiv) in CHCl3 (250 mL) was added 
dicyclohexylcarbodiimide (7.36 g, 36.0 mmol, 1.30 equiv) and the solution allowed to 
stir at room temperature for 15 h.  A white precipitate was observed, filtered off and 
the solvent was removed under reduced pressure.  The resulting crude residue was 
purified by column chromatography (SiO2, MeOH/EtOAc 5:95) to give 2 (7.01 g, 99%) 
as a colourless oil.  1H NMR (400 MHz, CDCl3): δ = 8.47 (d, J = 6.3 Hz, 2H, Ha), 7.79 (s, 
1H, Hc), 7.59 (d, J = 6.3 Hz, 2H, Hb), 2.42 (t, J = 7.5 Hz, 2H, Hd), 2.18 (td, J = 7.0, 2.6 Hz, 
2H, Hk), 1.94 (t, J = 2.6 Hz, 1H, H l), 1.81 – 1.66 (m, J = 14.5, 7.2 Hz, 2H, He), 1.56 – 1.46 
(m, 2H, Hj), 1.44 – 1.23 (m, 8H, Hf+g+h+i).  13C NMR (101 MHz, CDCl3): δ = 172.60, 149.15, 
113.78, 84.85, 68.29, 37.94, 34.09, 29.33, 29.24, 29.03, 28.78, 28.54, 25.28, 18.51.  
HRMS (NSI+): m/z = 259.1806 [M+H]+ (calcd. 259.1810 for C16H23N2O+). 
Synthesis of 3 
 
A 500 mL, oven-dried round-bottom flask was charged with 2 (7.01 g, 27.0 mmol, 1.0 




tablets (10.0 g, 263 mmol, 9.8 equiv) were added and the solution stirred for 1 h.  
Effervescence and a grey precipitate were observed.  The ice bath was removed and the 
solution left to stir at 40 °C for 12 h.  The reaction was quenched with H2O, added 
dropwise.  The grey precipitate was filtered off and the solution dried over MgSO4.  The 
solvent was removed under reduced pressure to give 3 (6.47 g, 98%) as a pale yellow 
oil.  1H NMR (500 MHz, CDCl3): δ = 8.17 (dd, J = 4.9, 1.5 Hz, 2H, Ha), 6.42 (dd, J = 4.9, 1.5 
Hz, 2H, Hb), 4.20 (s, 1H, Hc), 3.13 (td, J = 7.1, 5.6 Hz, 2H, Hd), 2.18 (td, J = 7.1, 2.6 Hz, 2H, 
Hl), 1.94 (t, J = 2.6 Hz, 1H, Hm), 1.61 (m, 2H, He), 1.52 (m, 2H, Hk), 1.44 – 1.35 (m, 4H, 
Hf+k), 1.35 – 1.25 (m, 8H, Hg+h+i+j).  13C NMR (126 MHz, CDCl3): δ = 153.63, 149.91, 
107.58, 84.87, 68.25, 42.80, 29.51, 29.41, 29.26, 29.14, 28.82, 28.57, 27.11, 18.52.  
HRMS (NSI+): m/z = 245.2003 [M+H]+ (calcd. 245.2018 for C16H25N2+). 
Synthesis of 4 
 
3 (6.47 g, 26.4 mmol, 1 equiv) was dissolved in methyl acrylate (48 g, 555 mmol, 35 
equiv) and refluxed at 98 °C for 3 days.  Excess methyl acrylate was removed under 
reduced pressure yielding a brown, oily residue.  The crude product was purified by 
column chromatography (SiO2, acetone/MeOH 9:1) to give 4 (7.17 g, 90%) as a pale, 
yellow oil.  1H NMR (400 MHz, CDCl3): δ = 8.20 (dd, J = 5.2, 1.4 Hz, 2H, He), 6.48 (dd, J = 
5.2, 1.4 Hz, 2H, Hd), 3.70 (s, 3H, Ha), 3.66 (t, J = 7.1 Hz, 2H, Hc), 3.31 (t, J = 7.8 Hz, 2H, 
Hf), 2.61 (t, J = 7.1 Hz, 2H, Hb), 2.18 (td, J = 7.1, 2.6 Hz, 2H, Hn), 1.94 (t, J = 2.6 Hz, 1H, 
Ho), 1.63 – 1.54 (m, 2H, Hg), 1.54 – 1.47 (m, 2H, Hm), 1.45 – 1.36 (m, 2H, Hl), 1.37 – 1.16 
(m, 8H, Hh+i+j+k).  13C NMR (126 MHz, CDCl3): δ = 172.06, 152.75, 148.84, 106.68, 84.85, 
77.16, 68.27, 52.12, 50.50, 45.96, 31.95, 29.55, 29.49, 29.13, 28.81, 28.56, 27.06, 18.52.  
HRMS (NSI+): m/z = 331.2376 [M+H]+ (calcd. 331.2386 for C20H31N2O2+). 
Synthesis of 5 
 
A solution of 4 (7.17 g, 21.8 mmol, 1.0 equiv) in THF (240 mL) was cooled to 0 °C and 




added and the reaction mixture stirred for 1 h.  The ice bath was removed and the 
solution stirred at room temperature for 15 h.  The reaction was quenched with H2O, 
added dropwise.  Violent effervescence and a grey precipitate were observed.  The 
precipitate was filtered off and rinsed with THF.  The rinsings and remaining solvent 
were combined and dried over MgSO4.  The solvent was removed under reduced 
pressure to give 5 (4.77 g, 73%) as a yellow oil.  1H NMR (400 MHz, CDCl3): δ = 8.15 (d, 
J = 6.6 Hz, 2H, Hf), 6.51 (d, J = 6.6 Hz, 2H, He), 3.72 (t, J =5.7 Hz, 2H, Hb), 3.47 (t, J = 7.1 
Hz, 2H, Hd), 3.30 (t, J = 7.6 Hz, 2H, Hg), 2.18 (td, J = 7.0, 2.6 Hz, 2H, Ho), 1.94 (t, J = 2.6 Hz, 
1H, Hp), 1.89 – 1.80 (m, J = 6.6, 3.3 Hz, 2H, Hc), 1.64 – 1.55 (m, 2H, Hh), 1.55 – 1.47 (m, 
2H, Hn), 1.42 – 1.35 (m, 2H, Hm), 1.35 – 1.23 (m, 8H, Hi+j+k+l).  13C NMR (101 MHz, 
CDCl3): δ = 153.15, 148.40, 106.63, 84.87, 68.26, 59.90, 50.41, 47.00, 29.91, 29.56, 
29.50, 29.13, 28.81, 28.55, 27.09, 26.95, 18.51.  HRMS (NSI+): m/z = 303.2435 [M+H]+ 
(calcd. 303.2436 for C19H31N2O+). 
Synthesis of 7 
 
PPh3 (4.99 g, 19.0 mmol, 1.2 equiv) was dissolved in the minimum volume of THF (20 
mL) and the solution cooled to 0 °C.  DIAD (4.48 g, 22.2 mmol, 1.4 equiv) was added 
dropwise via syringe over 30 min.  The reaction mixture turned cloudy.  A solution of 5 
(4.77 g, 15.8 mmol, 1.0 equiv) in THF (15 mL) was added via syringe and the mixture 
stirred for 30 min.  A solution of 6 (8.79 g, 17.4 mmol, 1.1 equiv) in THF (30 mL) cooled 
to 0 °C was added dropwise, and the solution stirred for 30 min.  The reaction mixture 
was allowed to warm to room temperature and stirred for 12 h.  The solvent was 
removed under reduced pressure and the crude product chromatographed (SiO2, 
CH2Cl2/MeOH 99:1) to give 7 (7.59 g, 61%) as a brown solid. m.p. 107-110 °C.  1H NMR 
(400 MHz, CDCl3): δ = 8.19 (d, J = 6.4 Hz, 2H, H j), 7.26 (d, J = 8.6 Hz, 6H, Hc), 7.16 – 7.12 
(m, 2H, He), 7.11 (d, J = 8.6 Hz, 6H, Hb), 6.80 (d, J = 8.9 Hz, 2H, Hd), 6.54 (d, J = 6.4 Hz, 
2H, Hi), 4.00 (t, J = 5.6 Hz, 2H, Hf), 3.57 (t, J = 7.2 Hz, 2H, Hh), 3.33 (t, J = 7.3, 2H, Hk), 




1.58 (m, 2H, Hl), 1.57 – 1.48 (m, 2H, Hr), 1.46 – 1.37 (m, 2Hq), 1.33 (m, 35H, Hm+n+o+p+a).  
13C NMR (101 MHz, CDCl3) δ = 156.5, 152.9, 148.9, 148.5, 144.2, 140.1, 132.5, 130.8, 
124.2, 113.0, 106.6, 84.8, 68.3, 64.8, 63.2, 50.5, 47.1, 34.4, 31.5, 29.5, 29.4, 29.1, 28.8, 
28.5, 27.1, 27.0, 26.9, 18.5.   HRMS (NSI+): m/z = 789.5684 [M+H]+ (calcd. 789.5717 for 
C56H73N2O+). 
Synthesis of 9 
 
To a mixture of THF/Et3N (1:1, 200 mL) was added 3,5-dibromopyridine (9.01 g, 38.0 
mmol, 1.00 equiv) and the solution purged with nitrogen for 50 min.  Propargyl alcohol 
(2.13 g, 38.0 mmol, 1.00 equiv) was added and the mixture purged for a further 30 min.  
Pd(PPh3)4 (2.63 g, 2.28 mmol, 0.06 equiv) and CuI (0.87 g, 4.56 mmol, 0.12 equiv) were 
added and the reaction stirred under nitrogen at room temperature for 16 h.  The 
solvent was removed under reduced pressure and the crude product dissolved in 
CH2Cl2, and washed with sat. NH4Cl and H2O.  A deep blue aqueous layer was observed.  
The organic layers were combined and dried over MgSO4.  The solvent was removed 
under reduced pressure and the crude product purified by column chromatography 
(SiO2, CH2Cl2/MeOH 98:2) to give 9 (4.25 g, 53%) as a yellow/brown solid.  m.p. 99-
102 °C.  1H NMR (400 MHz, CDCl3): δ = 8.63 – 8.58 (m, 2H, Ha+c), 7.87 (t, J = 2.0 Hz, 1H, 
Hb), 4.51 (d, J = 6.2 Hz, 2H, Hd), 2.61 (t, J = 6.3 Hz, 1H, He).  13C NMR (126 MHz, CDCl3): δ 
= 150.23, 149.97, 141.12, 132.19, 128.73, 92.59, 80.96, 51.45. 
Synthesis of 10 
 
To a mixture of THF/Et3N (3:1, 80 mL) was added 7 (7.59 g, 9.63 mmol, 1.00 equiv) 
and the solution purged with nitrogen for 40 min.  To the mixture was added 9 (2.04 g, 
9.63 mmol, 1.00 equiv) and the solution purged for 30 min.  Pd(PPh3)4 (0.51 g, 0.41 




the reaction stirred at 50 °C for 5 h.  The solvent was removed under reduced pressure 
and the crude product dissolved in CH2Cl2 and washed with ammonia solution (1 M, 2 x 
20 mL).  The organic layer was dried over MgSO4 and the solvent removed under 
reduced pressure.  The resulting residue was purified by flash column chromatography 
(SiO2, CH2Cl2/MeOH 85:15) to give 10 (5.69 g, 64%) as a brown solid, m.p. 124-127 °C.  
1H NMR (400 MHz, CDCl3): δ = 8.51 (d, J = 2.0 Hz, 1H, Hv), 8.50 (d, J = 2.0 Hz, 1H, Ht), 
8.15 (d, J = 6.5 Hz, 2H, H j), 7.67 (t, J = 2.0 Hz, 1H, Hu), 7.23 (d, J = 8.6 Hz, 6H, Hb), 7.10 (d, 
J = 8.9 Hz, 2H, He), 7.08 (d, J = 8.6 Hz, 6H, Hc), 6.77 (d, J = 8.9 Hz, 2H, Hd), 6.50 (d, J = 6.5 
Hz, 2H, Hi), 4.48 (s, 2H, Hw), 3.97 (t, J = 5.6 Hz, 2H, Hf), 3.53 (t, J = 7.1 Hz, 2H, Hh), 3.30 
(t, J = 7.9 Hz, 2H, Hk), 2.42 (t, J = 6.7 Hz, 2H, Hs), 2.10 – 1.98 (m, 2H, Hg), 1.65 – 1.52 (m, 
4H, Hr+l), 1.51 – 1.40 (m, 2H, Hq), 1.36 – 1.31 (m, 8H, Hm+n+o+p), 1.30 (s, J = 4.3 Hz, 27H, 
Ha).  13C NMR (101 MHz, CDCl3): δ = 156.5, 153.1, 151.1, 150.4, 148.5, 148.4, 144.2, 
140.9, 140.1, 132.5, 130.8, 124.2, 120.9, 119.8, 113.0, 106.6, 94.9, 92.6, 80.9, 76.9, 64.8, 
63.2, 50.9, 50.5, 47.1, 34.4, 31.5, 29.4, 29.1, 29.0, 28.7, 28.3, 27.0, 26.9, 26.7, 19.5.  HRMS 
(NSI+): m/z = 920.6095 [M+H]+ (calcd. 920.6094 for C64H78N3O2+). 
Synthesis of 11 
 
To a mixture of THF/CHCl3 (1:1, 100 mL) was added 10 (4.32 g, 4.70 mmol, 1.00 equiv) 
and the solution purged with nitrogen for 20 min.  Pd(OH)2/C (large excess) and K2CO3 
(0.035 g, 0.24 mmol, 0.05 equiv) were added and the solution purged with hydrogen 
for 30 min.  The reaction was left to stir under hydrogen at room temperature for 12 h.  
The reaction mixture was filtered through Celite® and the solvent removed under 
reduced pressure.  The crude black residue was purified by column chromatography 
(SiO2, CH2Cl2/MeOH 95:5) to give 11 (4.16 g, 95%) as an off-white solid.  m.p. 157-160 
°C.  1H NMR (400 MHz, CDCl3): δ = 8.28 (d, J = 2.0 Hz, 1H, Hw), 8.26 (d, J = 2.0 Hz, 1H, 
Hx), 8.12 (d, J = 6.5 Hz, 2H, H j), 7.32 (t, J = 2.0 Hz, 1H, Hv), 7.23 (d, J = 8.6 Hz, 6H, Hc), 
7.11 (d, J = 8.9 Hz, 2H, He), 7.07 (d, J = 8.6 Hz, 6H, Hb), 6.77 (d, J = 8.9 Hz, 2H, Hd), 6.62 




7.0 Hz, 2H, Hh), 3.38 (t, J = 7.4 Hz, 2H, Hk), 2.69 (t, J = 7.6 Hz, 2H, Hy), 2.56 (t, J = 7.5 Hz, 
2H, Hu), 2.13 – 2.03 (m, 2H, Hg), 1.88 (m, 2H, Hz), 1.66 – 1.52 (m, 4H, Hl+t), 1.30 (s, 27H, 
Ha), 1.36 – 1.22 (m, 14H, Hm+n+o+p+q+r+s).  13C NMR (101 MHz, CDCl3): δ = 156.2, 155.3, 
148.6, 147.7, 147.5, 144.1, 140.5, 137.7, 136.8, 136.0, 132.6, 130.8, 124,2, 113.0, 106.6, 
77.4, 64.4, 61.9, 51.2, 47.9, 36.2, 34.5, 34.1, 33.0, 31.5, 31.3, 29.6, 29.5, 29.4, 29.3, 29.2, 
27.0, 26.9, 26.8, 26.7, 26.3.  HRMS (ESI+): m/z = 928.6689 [M+H]+ (calcd. 928.6720 for 
C64H86N3O2+). 
Synthesis of 12 
 
An oven-dried 5 mL round bottom flask was charged with PPh3 (0.035 g, 0.132 mmol, 
1.2 equiv) in THF (1 mL) and the solution cooled to 0 °C.  DIAD (0.031 g, 0.154 mmol, 
1.4 equiv) was added dropwise and the solution stirred under nitrogen for 40 min. 11 
(0.102 g, 0.110 mmol, 1.0 equiv) was added in THF (1 mL) and the solution stirred for 
40 min.  6 (0.083 g, 0.165 mmol, 1.5 equiv) dissolved in minimum THF (1 mL) was 
added and the reaction allowed to warm to room temperature over 12 h.  The solvent 
was removed under reduced pressure and the crude product purified by column 
chromatography (SiO2, CH2Cl2/MeOH 98:2) to give 12 (53 mg, 56%) as an off-white 
solid.  m.p. 240 °C (dec.).  1H NMR (500 MHz, CDCl3): δ = 8.30 (s, 1H, Hx), 8.27 (s, 1H, 
Hv), 8.09 (d, J = 6.9 Hz, 2H, H j), 7.33 (s, 1H, Hw), 7.23 (d, J = 8.6 Hz, 6H, Hc), 7.22 (d, J = 
8.6 Hz, 6H, Hdd), 7.12 (d, J = 8.9 Hz, 2H, He), 7.08 (d, J = 8.9 Hz, 10H, Hbb), 7.08 (d, J = 8.6 
Hz, 6H, Hb), 7.07 (d, J = 8.6 Hz, 6H, Hcc), 6.76 (d, J = 8.9 Hz, 2H, Hd), 6.75 (d, J = 8.9 Hz, 
2H, Hcc), 4.00 (t, J = 5.3 Hz, 2H, Hf), 3.94 (t, J = 6.1 Hz, 2H, Haa), 3.68 (t, J = 6.9 Hz, 2H, 
Hh), 3.44 (t, J = 7.4 Hz, 2H, Hk), 2.78 (t, J = 7.5 Hz, 2H, Hy), 2.56 (t, J = 7.5 Hz, 2H, Hu), 
2.15 – 2.03 (m, 4H, Hg+z), 1.68 – 1.61 (m, 2H, Hl), 1.61 – 1.53 (m, 2H, Ht), 1.36 – 1.31 (m, 
2H, Hm), 1.30 (s, 27H, Ha,ff), 1.29 – 1.20 (m, 12H, Hn+o+p+q+r+s).  13C NMR (126 MHz, 
CDCl3): δ = 156.8, 156.3, 156.1, 148.6, 148.5, 147.8, 147.1, 144.3, 144.1, 140.7, 140.2, 
139.5, 138.2, 136.7, 136.2, 132.6, 132.4, 130.9, 130.8, 124.3, 124.2, 113.1, 113.0, 106.7, 




29.5, 29.4, 27.0, 26.9, 26.8, 26.7.  HRMS (NSI+): m/z = 1415.9940 [M+H]+ (calcd. 
1416.0040 for C101H128N3O2+). 
Synthesis of 14 
 
2,2-Bis(p-hydroxyphenyl)propane) (22.8 g, 100 mmol, 1.0 equiv) and aniline 
hydrochloride (38.9g, 300 mmol, 3.0 equiv) were added to a 150 mL round bottom 
flask and heated to 180 °C to give a clear liquid.  The resulting liquid was stirred at 180 
°C for 45 min and cooled to room temperature to give a sticky solid.  Water (600 mL) 
was added to give a suspension. The pH adjusted to >13 by addition of 50% NaOH. The 
resulting mixture was extracted with toluene (3 x 100 mL) to remove aniline.  The pH 
was adjusted to 5.5 by addition of 0.5 M HCl to give a white precipitate of the crude 
product which was collected and washed with water (20 mL). The powder was 
recrystallised from EtOH to give the pure 14 (7.1 g, 31 mmol, 31%) as a white 
microcrystalline solid.  1H NMR (400 MHz, DMSO-d6): δ = 9.15 (s, 1H, HA), 6.96 (d, J = 
8.7, 2H, HE), 6.83 (d, J = 8.6, 2H, HC), 6.61 (d, J = 8.7, 2H, HF), 6.43 (d, J = 8.6, 2H, HB), 
4.83 (s, 2H, HG), 1.49 (s, 6H, HD).  13C NMR (101 MHz, DMSO-d6): δ = 154.8, 146.0, 141.5, 
138.1, 127.3, 126.8, 114.5, 113.6, 40.8, 31.0.  HRMS (NSI+): m/z = 228.1382 [M+H]+ 
(calcd. 228.1388 for C15H18NO+). 
Synthesis of 15 
 
To a solution of 14 (0.560 g, 2.50 mmol, 2.3 equiv) and Et3N  (0.30 g, 3.00 mmol, 2.7 
equiv) in dry THF (50 mL) was added pyridine-2,6-dicarboyl dichloride (0.227g, 1.10 
mmol, 1 equiv) in THF (10 mL) slowly at 0 °C.  A white precipitate formed immediately 




temperature for 20 h and the solution filtered to remove the white precipitate, which 
was washed with THF (100 mL).  The solvent was removed under reduced pressure to 
give a fluffy solid which was recrystallised from EtOH/H2O to give 15 (0.570 g, 87%) as 
a white powder.  m.p. 270 °C (dec.).  1H NMR (400 MHz, DMSO-d6): δ = 10.97 (s, 2H, 
HC), 9.23 (s, 2H, HI), 8.39 (dd, J = 7.7, 0.8, 2H, HB), 8.30 (dd, J = 8.6, 6.8, 1H, HA), 7.76 (d, 
J = 8.7, 4H, HH), 7.28 (d, J = 8.8, 4H, HG), 7.04 (d, J = 8.7, 4H, H), 6.68 (d, J = 8.7, 4H, HD), 
1.63 (s, 12H, HF).  13C NMR (101 MHz, DMSO-d6): δ = 161.6, 155.1, 148.9, 147.1, 140.6, 
135.4, 127.4, 126.8, 125.3, 121.1, 114.7, 41.5, 30.70.  HRMS (NSI+): m/z = 586.2696 
[M+H]+, 608.2512 [M+Na]+ (calcd. 586.2706 for C37H36N3O4+, 608.2525 for 
C37H35N3NaO4+). 
Synthesis of 16 
 
To a solution of 15 (1.77 g, 3.02 mmol, 1.0 equiv) in DMF (600 mL) was added K2CO3 
(10 g, 76 mmol, 25 equiv).  To the stirring suspension was added 1,6-dibromohexane 
(0.737 g, 3.02 mmol, 1.0 equiv) slowly via syringe over a period of 30 min and the 
mixture stirred at room temperature for 3 days.  The solvent was removed under 
reduced pressure and the crude product dissolved in CH2Cl2, washed with H2O and 
dried over MgSO4.  The crude residue was purified by column chromatography (SiO2 
CH2Cl2/cyclohexane/Et2O 5:4:1) to give 16 (0.887 g, 45%) as a white crystalline solid.  
m.p. 330 °C (dec.).  1H NMR (400 MHz, CDCl3): δ = 9.47 (s, 2H, Hc), 8.47 (d, J = 7.8 Hz, 
2H, HB), 8.16 (t, J = 7.8 Hz, 1H, HA), 7.56 (d, J = 8.6 Hz, 4H, HD), 7.16 (d, J = 8.8 Hz, 4H, 
HG), 7.14 (d, J = 8.6 Hz, 4H, HE), 6.80 (d, J = 8.8 Hz, 4H, HH), 3.96 (t, J = 6.2 Hz, 4H, HI), 
1.82 (t, J = 6.1 Hz, 4H, HJ), 1.68 (s, 12H, HF), 1.53 (s, 4H, HK).  13C NMR (101 MHz, 
CDCl3): δ = 160.7, 157.3, 148.9, 148.8, 142.5, 140.1, 134.5, 128.1, 127.8, 125.4, 119.4, 





Synthesis of L3 
 
A 15 mL oven-dried round bottom flask was charged with 16 (0.167 g, 0.250 mmol, 1.0 
equiv).  THF (9 mL) was added and the solution purged with nitrogen for 20 min.  NaH 
(0.017 g, 0.450 mmol, 1.7 equiv) was added and the reaction mixture stirred for 5 h.  
After a cloudy solution was observed the vessel was wrapped in tin foil and cooled to 0 
°C.  PtCl2(SMe2)2 (0.176 g, 0.450 mmol, 1.8 equiv) was added and the reaction stirred 
under nitrogen for 12 h.  A yellow solution was observed with some white precipitate.  
The solution was filtered through cotton wool and the solvent removed under vacuum.  
The crude residue was purified by column chromatography (SiO2, CH2Cl2/MeOH 
95.5:0.5) to give L3 (0.070g, 78%) as an orange crystalline solid.  m.p. 345 °C (dec.).  1H 
NMR (400 MHz, CDCl3): δ = 8.17 (t, J = 7.8, 1H, HA), 7.96 (d, J = 7.8 Hz, 2H, HB), 7.22 (d, J 
= 8.4 Hz, 4H, HD), 7.13 (d, J = 8.4 Hz, 4H, HE), 6.98 (d, J = 8.8 Hz, 4H, HG), 6.67 (d, J = 8.8 
Hz, 4H, HH), 3.88 (t, J = 6.4 Hz, 4H, HI), 1.85 – 1.76 (m, 4H, HJ), 1.67 (s, 12HF), 1.55 – 
1.49 (m, 4HK), 1.38 (s, 6HC).  13C NMR (101 MHz, CDCl3): δ = 170.4, 157.0, 150.5, 148.6, 
145.1, 143.7, 141.0, 127.7, 127.5, 126.3, 126.1, 113.5, 67.7, 42.0, 30.23, 29.8, 29.1, 25.8, 
21.1.  HRMS (NSI+) : m/z = 923.3159 [M+H]+ (calcd. 923.3170 for C45H50N3O4PtS+). 
Synthesis of 17 
 
To a stirring solution of 11 (145 mg, 0.155 mmol, 1.0 equiv) in CHCl3 (1.5 mL) under 
nitrogen was added trifluoroacetic acid (21 mg, 0.186mmol, 1.2 equiv) dropwise.  The 




added via syringe.  The solution was heated to 55 °C and stirred under nitrogen for 3 
days.  The solution was washed with NaHCO3 solution and dried over NaSO4.  The 
solvent was removed under reduced pressure and the crude residue purified by 
column chromatography (SiO2, CH2Cl2/MeOH 96:4) to give 17 (176 mg, 63%) as an 
orange crystalline solid.  m.p. 230 °C (dec.).  1H NMR (500 MHz, CDCl3): δ = 8.10 (t, J = 
7.9 Hz, 2H, HA), 8.09 – 8.04 (m, 2H, Hj), 7.83 (d, J = 7.9 Hz, 2H, HB), 7.78 (d, J = 1.1 Hz, 
1H, Hv), 7.68 (d, J = 1.1 Hz, 1H, Hx), 7.23 (d, J = 8.6 Hz, 6H, Hc), 7.12 (d, J = 8.9 Hz, 2H, 
He), 7.07 (d, J = 8.6 Hz, 6H, Hb), 6.87 (d, J = 8.5 Hz, 4H, HG), 6.80 (d, J = 8.5 Hz, 4H, HH), 
6.79 (d, J = 8.8 Hz, 4H, HC), 6.75 (d, J = 8.9 Hz, 2H, Hd), 6.74 (s, 1H, Hw), 6.68 (d, J = 4.6 
Hz, 2H, Hi), 6.63 (d, J = 8.8 Hz, 4H, HD), 3.98 (t, J = 5.3 Hz, 2H, Hf), 3.94 (t, J = 6.5 Hz, 4H, 
HI), 3.63 (t, J = 7.2 Hz, 2H, Hh), 3.39 (t, J = 7.6 Hz, 2H, Hk), 3.13 (t, J = 6.0 Hz, 2H, Haa), 
2.12 – 1.99 (m, 6H, Hg+u+y), 1.90 – 1.80  (s, 4H, HJ), 1.65 – 1.56 (m, 6H, HK+l), 1.53 (s, 6H, 
HE,F), 1.34 – 1.31 (m, J = 12.0 Hz, 4H, Hm+z), 1.30 (s, 27H, Ha), 1.27 – 1.09 (m, 12H, 
Hn+o+p+q+r+t), 1.04 – 0.96 (m, H, Hs).  13C NMR (126 MHz, CDCl3): δ = 169.86, 156.72, 
156.17, 152.13, 149.58, 149.05, 148.56, 146.95, 144.11, 143.49, 143.16, 141.15, 140.55, 
140.34, 139.52, 139.28, 137.74, 132.58, 130.81, 127.33, 126.42, 125.80, 125.29, 124.22, 
113.53, 113.00, 106.71, 67.86, 64.37, 63.18, 59.97, 51.25, 48.06, 41.54, 34.44, 32.75, 
32.39, 32.06, 31.51, 30.36, 30.17, 30.14, 29.75, 29.71, 29.65, 29.50, 29.18, 28.72, 28.10, 
27.04, 26.88, 25.91, 22.82, 14.26.  HRMS (ESI+): m/z = 1789.9585 [M+H]+ (calcd. 
1789.9655 for C107H129N6O6Pt+). 
Synthesis of Py-L3Pt 
 
To a solution of 17 (0.060 g, 0.033 mmol, 1.0 equiv) in CHCl3 (10 mL) as added MsCl 
(0.008 g, 0.067 mmol, 2.0 equiv) and Et3N (0.014 g, 0.134 mmol, 4.0 equiv) and the 
reaction stirred at room temperature for 1 h.  The reaction was quenched with H2O and 
the crude product extracted with CH2Cl2, washed with brine and dried over MgSO4.  




to a solution of NaH (0.024 g, 0.602 mmol, 4.9 equiv) and 6 (0.310 g, 0.614 mmol, 5.0 
equiv) in THF (30 mL) that had been stirring at room temperature for 4 h. 
15-crown-5 (0.135 g, 0.614 mmol, 5.0 equiv) and DMSO (1.5 mL) were added and the 
reaction stirred at 48 °C for 48 h.  The solvents were removed under reduced pressure, 
the crude product dissolved in CH2Cl2 and washed with H2O and brine.  The organic 
fractions were dried over MgSO4 and the solvent removed under reduced pressure.  
The crude residue was purified by column chromatography (SiO2, CH2Cl2/MeOH 9:1) 
to give Py-L3Pt (0.158 g, 56%) as an orange solid m.p. 181-184 °C.  1H NMR (500 MHz, 
CDCl3): δ = 8.12 (s, 1H, H j), 8.12 – 8.08 (m, 1H, HA), 7.88 (d, J = 7.9 Hz, 2H, HB), 7.73 – 
7.69 (m, 2H, Hv+x), 7.25 – 7.22 (m, 4H, Hc), 7.22 – 7.15 (m, 12H, Hc+dd), 7.09 –7.04 (m, 
16H, Hb,e,bb,ee), 6.83 (s, 8H, HG+H), 6.79 (d, J = 8.8 Hz, 4H, HD), 6.78 (s, 1H, Hw), 6.77 – 6.74 
(m, 2H, Hd), 6.66 (d, J = 9.0 Hz, 2H, Hcc), 6.61 (d, J = 8.8 Hz, 4H, HC), 6.57 (d, J = 5.6 Hz, 
2Hi), 3.97 (t, J = 5.5 Hz, 2H, Hf), 3.92 – 3.85 (m, 4H, HI), 3.57 (d, J = 7.1 Hz, 2H, Hh), 3.56 
– 3.51 (m, 2H, Haa), 3.36 – 3.28 (m, 2H, Hk), 2.11 (t, J = 7.6 Hz, 2H, Hy), 2.08 – 2.04 (m, 
2H, Hg), 2.01 (t, J = 7.6 Hz, 2H, Ht), 1.81 (d, J = 6.1 Hz, 4H, HJ), 1.63 – 1.53 (m, 8H, HK,l,z), 
1.48 (s, 6HE/F), 1.49 (s, 6HE/F), 1.30 (s, 27H, Ha/ff), 1.28 (s, 27H, Ha/ff), 1.27 – 1.21 (m, 
12H, Hm,n,o,p,q,r), 1.23 – 1.15 (m, 2H, Ht), 1.06 - 1.00 (m, 2H, Hs).  13C NMR (126 MHz, 
CDCl3): δ =169.89, 156.73, 156.45, 156.39, 154.07, 152.31, 149.40, 149.12, 148.52, 
148.47, 146.88, 145.72, 144.16, 144.15, 143.44, 143.26, 140.29, 140.18, 140.15, 139.66, 
138.69, 137.39, 132.52, 132.45, 130.83, 130.82, 127.30, 126.46, 125.76, 125.28, 124.20, 
113.42, 113.04, 112.91, 106.64, 67.66, 65.65, 64.68, 63.18, 63.16, 50.75, 47.49, 41.48, 
34.43, 34.42, 32.39, 30.39, 30.22, 30.01, 29.83, 29.81, 29.76, 29.70, 29.61, 29.52, 29.35, 
29.14, 28.78, 28.55, 27.13, 26.98, 25.91, 22.83, 14.27.  HRMS (NSI+): m/z = 2276.2843 
[M+H]+ (calcd. 2276.2941 C144H171N6O6Pt+). 
Synthesis Model Compounds 





To a solution of L3 (50 mg, 0.054 mmol, 1.0 equiv) in CHCl3 (2 mL) was added DMAP 
(6.6 mg, 0.054 mmol, 1.0 equiv) and the mixture stirred at 50 °C under nitrogen for 15 
h.  The solvent was removed under reduced pressure and the crude residue purified by 
column chromatography (SiO2, CH2Cl2/MeOH 98:2) to give L3PtDMAP (45 mg, 83%) as 
an orange crystalline solid.  m.p. 300 °C  (dec.).  1H NMR (400 MHz, CDCl3): δ = 8.11 (t, J 
= 7.9 Hz, 1H, HA), 7.90 (d, J = 7.8 Hz, 2H, HB), 7.13 (d, J = 7.2 Hz, 2H, H l), 6.97 – 6.84 (m, 
12H, HC+D+G), 6.60 (d, J = 8.7 Hz, 4H, Hh), 5.64 (d, J = 7.2 Hz, 2H, Hm), 3.88 (t, J = 5.8 Hz, 
4H, HI), 2.70 (s, 6H, Hn), 1.85 – 1.78 (m, 4H, HJ), 1.58 (s, 12H, HE+F), 1.56 - 1.52 (m, 4H, 
HK).  13C NMR (126 MHz, CDCl3): δ = 170.30, 156.88, 153.41, 152.49, 150.60, 146.39, 
144.01, 143.35, 139.55, 127.68, 126.85, 125.87, 125.69, 113.29, 107.29, 67.46, 41.84, 
39.48, 30.50, 29.59, 26.36.  HRMS (NSI+): m/z = 1005.3637 [M+Na]+ (calcd. 1005.3643 
for C50H53N5NaO4Pt+). 
Synthesis of L3Pt-(3,5-lutidine) 
 
 
To a solution of L3 (50 mg, 0.054 mmol, 1.0 equiv) in CHCl3 (2 mL) was added 3,5-
lutidine (5.8 mg, 0.054 mmol, 1.0 equiv) and the mixture stirred at 50 °C under 
nitrogen for 15 h.  The solvent was removed under reduced pressure and the crude 
residue purified by column chromatography (SiO2, CH2Cl2/MeOH 97:3) to give L3Pt-
(3,5-lutidine) (44 mg, 85%) as an orange crystalline solid.  m.p. 290 °C (dec.).  1H NMR 
(400 MHz, CDCl3): δ = 8.12 (t, J = 7.8 Hz, 1H, HA), 7.90 (d, J = 7.8 Hz, 2H, HB), 7.58 (s, 2H, 
Hm), 6.94 – 6.82 (m, 12H, HC+D+G), 6.77 (s, 1H, Hl), 6.65 (d, J = 8.8 Hz, 4H, HH), 3.94 (t, J = 
6.3 Hz, 4H, HI), 1.88 – 1.80 (m, 4H, HJ), 1.67 (s, 6H, Hn), 1.60 – 1.56 (m, 4H, HK), 1.55 (s, 
12H, HE+F).  13C NMR (126 MHz, CDCl3): δ =170.06, 156.79, 149.47, 146.92, 143.41, 
143.03, 140.05, 138.60, 134.77, 127.30, 126.39, 125.51, 113.57,67.80, 41.51, 30.05, 






General Procedures for Model Exchange Experiments 
Exchange of 3,5-dihexylPy for DMAP in L2Pt-(3,5-dihexylPy) (Scheme 3.1) 
To two vacuum dried NMR tubes was added L2Pt-(3,5-dihexylPy) (0.25 mL, 2.0 mM, 1 
equiv) and DMAP (0.25 mL, 2.0 mM, 1 equiv) each from stock solutions in DMF-
d7/CD3CN (1:1).  The tubes were sealed.  One was left at room temperature and the 
other heated at 348 K for two weeks during which time each was monitored by 1H NMR 
spectroscopy.  The room temperature sample shoed no changes throughout the 
duration of the experiment.  The heated sample reached an equilibrium distribution of 
25:75 L2Pt-(3,5-dihexylPy):DMAP within 2 weeks. 
Exchange of 3,5-lutidine for DMAP in L3Pt-(3,5-lutidine) (Figure 3.2a) 
To two vacuum dried NMR tubes was added L3Pt-(3,5-lutidine) (0.25 mL, 2.0 mM, 1 
equiv) and DMAP (0.25 mL, 2.0 mM, 1 equiv) each from stock solutions in DMF-
d7/CD3CN (1:1).  The tubes were sealed.  One was left at room temperature and the 
other heated at 348 K and each monitored by 1H NMR spectroscopy.  The room 
temperature sample shoed no changes throughout the duration of the experiment (2 
weeks).  The heated sample reached an equilibrium distribution of 25:75 L3Pt-(3,5-
lutidine):DMAP within 18 h. 
Exchange of DMAP for 3,5-lutidine in L3PtDMAP (Figure 3.2b) 
To two vacuum dried NMR tubes was added L3Pt-(3,5-lutidine) (0.16 mL, 3.0 mM, 1 
equiv), DMAP (0.16 mL, 3,0 mM, 1 equiv), and TsOH (0.16 mL, 3,0 mM, 1 equiv) each 
from stock solutions in DMF-d7/CD3CN (1:1).  The tubes were sealed.  One was left at 
room temperature and the other heated at 348 K and each monitored by 1H NMR 
spectroscopy.  The room temperature sample showed no changes throughout the 
duration of the experiment (2 weeks).  The heated sample reached an equilibrium 
distribution of 25:75 L3Pt-(3,5-lutidine):DMAP within 18 h. 
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The synthesis and characterisation of an unprecedented macrocycle (M11) containing a 
palladium(II)-pyridine motif and a hydrazone linkage is described.  In the context of this 
thesis, M11 represents a model for a molecular walker unit featuring one palladium(II) 
and one hydrazone foot attached to a two-foothold section of a molecular track.  The 
dynamic chemistry of M11 is investigated through various ring-opening experiments 
carried out under thermodynamic control.  The results of these experiments indicated that 
the hydrazone bond exchanges only under acidic conditions, whereas the palladium(II)-
ligand bond is only labile at elevated temperatures in the presence of a coordinating 
solvent. 
These findings led to the design and synthesis of a first generation small-molecule walker-
track system incorporating the core components of macrocycle M11 with an extended 
four-foothold track.  This chapter addresses the teething problems associated with the 
initial design and lays out a proposal for improvements in a second generation model 






Having discounted platinum(II) complexes as potential opposing feet to the 
palladium(II) chemistry developed in Chapter II, an alternative orthogonally operable 
switch was sought in the continued quest to integrate the palladium-foot into a fully 
functioning molecular walker system.  Previous pursuits of this target have 
independently incorporated Cu(I)/Cu(II), and Co(II)/Co(III) redox ligand-exchange 
chemistry, however, the operation of both systems ultimately proved incompatible 
with that of the palladium(II) ligand exchange.1  In broadening the search beyond the 
confines of bimetallic systems, other kinetically switchable linkages were considered 
along with their chemical compatibility with transition metal complexes of the kind 
used in this study. 
Dynamic Covalent Chemistry 
Synthetic organic chemistry to date has revolved around the design, synthesis and 
isolation of specific compounds that possess attractive properties and applications.  
The synthetic strategies employed to reach these target molecules are predominantly 
based on either individual, or ensembles of isolable kinetically controlled chemical 
reactions that irreversibly form stable covalently bonded products.  Nature, on the 
other hand, more often makes use of dynamic chemical systems under thermodynamic 
control in which multiple components are interconnected through a range of reversible 
exchange reactions and where the final product distribution is defined by the relative 
free energies of all the possible products.  This method provides the potential for real-
time checks and control mechanisms and enables biological systems to respond rapidly 
to changes in their environments.  The allure of attaining such reversible control over 
covalent bond formation inspired the dawn of dynamic covalent chemistry (DCC), an 
area that has given rise to a wealth of literature over the last decade2 by bridging the 
fields of dynamic supramolecular chemistry3 and traditional covalent synthesis.  
Although it has been heralded as a potential game-changer in the field of drug 
discovery where binding affinity towards target receptors can beneficially distinguish 
between members of dynamic combinatorial libraries,4 dynamic covalent chemistry 
has also found applications in a wide range of other areas including dynamic polymers 
(dynamers),5 sensors,6 the synthesis and manipulation of mechanically interlocked 




The complex behaviour of dynamic covalent systems can often be far more powerful 
than that attainable through the sum of their individually operated components and it 
is possible to use the chemistry to mimic the environment-responsive nature of 
biological systems.  By integrating molecular networks of synthetic chemical species 
that interact with one another in a predesigned manner, the final thermodynamically 
favoured product can be selected and controlled using suitable external stimuli.  
However, predicting the resultant phenomena of an applied stimulus to these systems 
is not trivial, especially when the exchange reactions involved are said to be 
communicating,9 i.e. when the reaction products of one component have an affect upon 
the procedure of another.  Additional control can be attained by incorporating 
orthogonal10 and non-concurrent exchange processes where reactions do not take 
place simultaneously and give products that have no influence over the operation of 
other components.  Such control mechanisms have been incorporated into some of the 
molecular motor systems mentioned previously11 to ratchet positional isomer 
distributions of molecular bipeds away form their thermodynamic minima,12 thus 
facilitating the walking of small molecules down a track.   These examples represent 
double-level13 systems with two orthogonal, non-concurrent exchange reactions, each 
responsible for the stepping of an individual foot of the walker unit.  There is a 
requirement that under the first set of conditions, only one of the two bond types is 
dynamic whilst the other remains kinetically locked.  Similarly, under the second, 
mutually exclusive set of conditions, the relative rates of bond forming and bond 
breaking are reversed. 
The implications and potential benefits of utilising multiple reactions instigated by 
orthogonal external stimuli have been impressively demonstrated11 but by no means 
comprehensively explored or exploited.  Reversible reactions form the toolbox of 
dynamic covalent chemistry2d and knowledge of the dynamism of different reaction 
types under mutually exclusive conditions empowers the designers of complex 
molecular machinery with the ability to integrate independent, yet ultimately 
cooperative reaction mechanisms into systems with a much greater consideration for 
the requirements of the surrounding environment (e.g. solubility, pH, temperature). 
The palladium(II) motif described in Chapter II exhibited promise as a potential foot in 
a molecular walker system in which the inert Pt(II) anchor moiety could be replaced 




choose from, the concept of a double-level, constitutionally dynamic14 system 
combining DCC with transition metal coordination chemistry in the design of a 
molecular walker system was considered as an exciting advancement in the field. 
Hydrazone Exchange 
The reversible hydrolysis of hydrazone containing moieties has been studied and the 
general mechanism is shown in Scheme 4.1 where acid-catalysed hydrolysis of the 
initial hydrazone is the rate-limiting step followed by the condensation of the 
hemiaminal to the new mixture of products. 
 
Scheme 4.1 - Mechanism of reversible hydrolysis of a hydrazone: E = electron-withdrawing group 
(typically acyl); rds = rate determining step. 
The equilibrium distribution lies heavily in favour of the hydrazone product whilst 
allowing exchange to take place through a low but sufficient concentration of 
hydrolysed monomers.  This provides an important and exploitable difference from the 
better-documented dynamic covalent chemistry of imines.8d,15 Hydrazones are more 
stable than imines because the nitrogen substituent can participate in delocalisation of 
the imine double bond decreasing the partial charge on the carbon atom and raising the 
energy of the LUMO, thus making it less susceptible to nucleophilic attack.  This 
increased stability means that, unlike imine exchange, hydrazones require acid16 or 
nucleophilic base17 to be hydrolysed and can therefore be kinetically locked under 
neutral conditions.  Hydrazone exchange has proven to be a tremendously versatile 
tool effective in both organic10b,11,18 and aqueous media.19  
This chapter reports the synthesis and dynamic chemistry of macrocycle M11,  which 
incorporates both the palladium(II) moiety described in Chapter II, and a separate 
hydrazone unit within the bonds that make up the ring.  Selective ring-opening of M11 
at either the hydrazone or palladium linkages was achieved by reversible covalent or 
metal-ligand bond formation respectively using one of two sets of mutually exclusive 
reaction conditions; namely, acid, or heat in the presence of a coordinating solvent.  The 
dynamic chemistry was investigated in terms of competition between fully reversible 




control.  The results from this study, along with the developed synthetic strategy, were 
then incorporated into the synthesis of a small molecule designed to walk repetitively 
up and down a four-foothold molecular track in response to an oscillating chemical 
environment. 
4.3 System Design and Independent Addressability 
The successful operation of each of the proposed foot motifs in the design have been 
independently demonstrated with great success in previous systems, however, the 
potential to operate them in tandem within a single molecule requires that each foot is 
kinetically stable under the operating conditions of its partner.  The hydrazone linkage 
is by no means an innocent functional group when working with transition metals18c 
and carrying out palladium(II)-ligand exchange processes in close proximity is without 
precedent.  Experiments were therefore developed to test whether the palladium(II) 
complexes were stable under the conditions previously established for hydrazone 
exchange11a (Scheme 4.2). 
After 22 h at room temperature under acidic conditions in CDCl3, L2Pd-(2,6-dihexylPy) 
remained unchanged while 30% of hydrazone 1 had been converted to 4 as shown in 
Figure 4.1.  In a similar experiment in the absence of 2-picoline and L2Pd-(2,6-
dihexylPy), but with a greater excess of trifluoroacetic acid (TFA), the hydrazone 
exchange was shown to be much faster reaching an equilibrium state with 65% 
exchange from 1 to 4 within 20 h implying that the reaction rate can be controlled as a 
function of acid concentration. 
To test a potential hydrazone foot's stability to the palladium(II)-stepping conditions, 
an equimolar solution of compound 1 and benzaldehyde (2) in CDCl3/CD3CN (7:3, 0.1 
mM) was heated to 228 K for 16 h, during which time no change was observed in the 1H 
NMR spectrum. 
These results provided precedent for a potential small molecule walker-track system 
with two different foot-foothold linkages based around the independently operable 





Scheme 4.2 - Acid mediated hydrazone exchange in the presence of spectator compounds  
2-picoline and L2Pd-(2,6-dihexylPy) with 1 drop of 20% CF3COOH in CDCl3. 
 
Figure 4.1 - Partial 1H NMR spectra (400 MHz, CDCl3, 298 K) of a 0.1 mM mixture of L2Pd-(2,6-
dihexylPy), 1, 2, and 2-picoline in CDCl3 with one drop of acid solution (20% TFA in CDCl3) at: (a) t 
= 0 h; (b) solution (a) after 22 h at room temperature.  The lettering and colours in the figure refer 
to assignments in Scheme 4.2. 
4.4 Synthesis of Macrocycle M11 
So far, experiments have dealt with intermolecular exchanges.  To ensure that the 
results could be extended into intramolecular systems, macrocycle M11 was devised to 
further probe the dynamic chemistries involved.  The target macrocycle can be viewed 
as a biped with an Pd(II)-N,N,N-pincer motif and a hydrazone moiety which act as 
opposing feet respectively attached to 2,6-substituted pyridine and benzaldehyde 




M11 is outlined in Scheme 4.3-4.5 and full details are given in the Experimental Section 
4.11. 
 
Scheme 4.3 - Synthesis of 2-foothold track.  Reagents and conditions: (a) SOCl2, MeOH, RT, 15 h, 
quant.; (b) 1-bromopropane, K2CO3, DMF, RT, 3 days, 32%; (c) TBDPSCl, DIPEA, DMF, 328 K, 3 h, 
94%; (d) LiAlD4, THF, RT, 13 h, 94%; (e) Dess-Martin periodinane, CH2Cl2, RT, 16 h, 51%; (f) TBAF, 
THF, 273 K, 2 h, 90%; (g) 6-methyl-2-pyridine methanol, PPh3, DIAD, THF, 8 h, 42%. 
Esterification of 3,5-dihydroxybenzoic acid (5) was achieved by stirring with thionyl 
chloride in MeOH for 12 h to give ester 6 in quantitative yield.  Williamson coupling 
with 1-bromopropane (1 equiv) in DMF afforded monosubstituted substrate 7 within  
3 days.  The phenol group was protected by reaction with tert-butyldiphenylsilyl 
chloride (TBDPSCl) using N,N-diisopropylethylamine (DIPEA) in DMF to give 8.  The 
ester was reduced to deuterated alcohol 9 using LiAlD4 (4 equiv) in THF before 
subsequent Dess-Martin oxidation to deuterated aldehyde 10.  The silyl ether was 
deprotected with tetrabutylammonium fluoride (TBAF) to give 11, which was 
subsequently coupled to  6-methyl-2-pyridine methanol using Mitsunobu conditions to 
give two-foothold track 12. 
 
Scheme 4.4 - Synthesis of Pd(II)- and hydrazone foot motifs.  Reagents and conditions: (a) 4-
bromobut-1-ene, K2CO3, butanone, 368 K, quant.; (b) Pd(OAc)2, CH3CN, RT, 16 h, 78% ; (c) SOCl2, 





Palladium(II) complex 14 was prepared from the same pyridine-2,6-dicarboxamide 
unit described in Chapter II in two steps through Williamson alkylation with  
4-bromobut-1-ene in butanone to give 13, followed by reaction with palladium(II) 
acetate in CH3CN to give the product as a yellow/green precipitate.  The hydrazide 
moiety 17 was sourced from 6-heptanoic acid (15), which was esterified by reaction 
with thionyl chloride in methanol to give 16, and subsequently converted to the 
product through reaction with hydrazine monohydrate in MeOH with a yield of 63% 
over the two steps. 
 
Scheme 4.5- Synthesis of macrocycle M11 . Reagents and conditions: (a) 17, acetic acid, MeOH, RT, 
12 h, 90%; (b) (i) Grubbs II, CH2Cl2, RT, 18 h, 58%, (ii) H2, Pd(OH)2/C , K2CO3, THF, RT, 4 h, 90%. 
Palladium(II) precursor 14 was coordinated to the pyridine binding site of track 12 by 
stirring the two in an equimolar solution with CHCl3 for 5 h to give complex 18.  The 
opposing hydrazone foot (17) was attached by stirring with 18 and glacial acetic acid 
at room temperature to give 19.  Ring closing metathesis using Grubbs II catalyst in 
CH2Cl2 followed by hydrogenation of the resultant double bond (Pd(OH)2/C, K2CO3, 
THF) afforded macrocycle M11 in 52% yield over two steps. 
Upon forming M11, the 1H NMR spectrum became convoluted at room temperature on 
account of encapsulating the hydrazone linkage within the 25-membered ring resulting 
in the formation of different isomers of the amide bond that were not interchangeable 
at room temperature.  The spectrum could be simplified using variable temperature  






Figure 4.2 - 1H NMR spectra (400 MHz, C2D2Cl4) of M11: (a) 378 K; (b) 348 K ;(c) 318 K; (d) 298 
K.  The lettering and colours in (a) refer to the assignments in Scheme 4.5. 
4.5 Cyclooligomerisation of Macrocycle M11 
Macrocycle M11 was independently subjected to the two different sets of chemical 
conditions optimised in the intermolecular model studies to establish their 
effectiveness in instigating cyclooligmerisation via hydrazone and palladium(II)-ligand 
exchange under thermodynamic control (Scheme 4.6). 
 
Scheme 4.6 - Two sets of reaction conditions for the efficient conversion of macrocycle M11 into a 
distribution of cyclic oligomers M1n by dynamic bond formation: Conditions 1: M11 (6 µmol,  
1 equiv), 0.5 mL CDCl3, TFA (30 µmol, 5 equiv), RT, 24 h; Conditions 2: M11 (6 µmol, 1 equiv), 0.5 




Under both sets of conditions (heating in CDCl3/CD3CN (7:3) and TFA in CDCl3) 
detectable amounts of dimeric (M12) and trimeric (M13) macrocyclic analogues of M11 
were observed in the equilibrium mixtures after typical equilibration times of 12-24 h 
(after which time the composition of reaction mixtures no longer changed).  Although 
the progression of the reactions was hard to follow by 1H NMR on account of the 
different isomers of the hydrazone linkages, the results were confirmed by electrospray 
ionisation-mass spectrometry (ESI-MS) (Figure 4.3). 
 
Figure 4.3 -Mass spectrum (ESI+) of an equilibrium mixture containing M11 and higher oligomers 
M1n after treatment of M11 under acidic conditions outlined in Scheme 4.6. 
4.6 Ring-Opening of Macrocycle M11 in the Presence of Scavengers 
To confirm which linkage was dynamic under the different oligomerisation conditions, 
macrocycle M11 was opened at each end in the presence of a suitable, acyclic 
"scavenger" molecule.  M11 was first subjected to conditions to labilise the Pd(II)-foot 
(CDCl3/CD3CN (7:3), 1 mM, 338 K,) in the presence of 5 equivalents of 2,6-lutidine 
(Scheme 4.7a) which gave ring-opened compound 20 in a 75% isolated yield.  A 
separate sample of M11 was subjected to conditions to labilise the hydrazone foot 
(CDCl3, 1 mM, TFA (5 equiv), RT) in the presence of 5 equivalents of p-anisaldehyde 





Scheme 4.7 - Dynamic covalent ring-opening of macrocycle M11 in the presence of an acyclic 
aldehyde or pyridyl scavenger: (a) Pd(II)-ligand exchange of M11 (1 equiv) with metal scavenger 
2,6-lutidine (5 equiv) in CDCl3/CD3CN (7:3) (initial concentration of M11 12 mM), 338 K, 15 h ; (b) 
acid-mediated (TFA, 5 equiv) hydrazone exchange of macrocycle M11 (1 equiv) with aldehyde 
scavenger p-anisladehyde (5 equiv) in CDCl3 (initial concentration of M11 12 mM), RT, 15 h. 
 
Figure 4.4 - 1H NMR spectra (400 MHz, CDCl3, 298 K) of the isolated ring-opened products and the 
starting material for comparison: (a) 20; (b) 21; (c) M11 .  The lettering and colour refer to the 




The 1H NMR spectra of both isolated open products are shown in Figure 4.4 along with 
that of M11.  It can be clearly seen that the resonances of the two products are easily 
resolvable at room temperature compared to those of the starting material indicating 
that the hydrazone linkage is no longer constrained within the macrocycle and thus 
confirming the opening of the rings.  Both products were isolated from a range of by-
products by preparative thin layer chromatography on silica.  These by-products were 
assumed to be oligomeric species formed as a result of running the experiments at 
higher concentrations than in previous intermolecular exchanges in order to favour the 
ring-opened products.  This prediction was supported by mass spectrometry. 
4.7 Design of a Dynamic Synthetic Small Molecule Walker-Track System 
The dynamic behaviour of macrocycle M11 meets the criteria required for the key 
operational components of a non-directional molecular walker laid out in Chapter I; in 
essence, it comprises two independently operable chemical switches.  The goal of 
converting the simple macrocycle into a functioning walker system can be realised by 
extending the track to enable walking in the form of intramolecular dynamic exchange 
between footholds as opposed to the intermolecular stepping demonstrated in the 
presence of a high concentration of scavenger moieties.  In this way, the biped unit of 
M11 could be made to randomly walk up and down a 4-foothold track with a high 
degree of processivity by means of alternating the orthogonal stimuli developed in the 
macrocycle ring-opening (Figure 4.5). 
 
Figure 4.5 - Proposed operation of walker track conjugate 1,2-T1 (chemical structure shown in 
Scheme 4.9) when exposed to different sets of stimuli: Stimulus 1: heat in the presence of a 
coordinating solvent labilises Pd(II)-foot (A) from pyridyl footholds (1 & 3); Stimulus II: acid, 





4.8 Synthesis, Characterisation and Operation of 1,2-T1 
The synthetic strategy for the target walker-track conjugate 1,2-T1 used macrocycle 
M21 (a direct analogue of M11) as a core scaffold providing the potential for future 
compartmental extension of the track allowing for variations to be incorporated, such 
as branches or polymeric extensions.  The synthetic route for the track is illustrated in 
Scheme 4.8, whilst the design of macrocycle M21 is very similar to that described 
previously for M11 and is outlined in Scheme 4.9.  Full details are given in Experimental 
Section 4.11. 
 
Scheme 4.8 - Synthesis of free track. Reagents and conditions: (a) TBDMSCl, DIPEA, DMF, 328 K,  
3 h, 51%; (b) 6-methyl-2-pyridine methanol, PPh3, DIAD, THF, RT, 15 h, 74%; (c) TBAF, DIPEA, 
THF, 273 K, 2 h, 77%; (d) TsCl, THF/H2O/ (3:1), RT, 16 h, 95%; (e) 11, Cs2CO3, THF, RT, 89%;  
(f) Cs2CO3, THF, RT, 68%.  
3,5-dihydroxybenzaldehdyde (22) was mono-protected through reaction with one 
equivalent of tert-butyldimethylsilyl chloride and DIPEA in DMF to yield 23  
(Scheme 4.8a), which was coupled to 6-methyl-2-pyridine methanol under Mitsunobu 
reaction conditions to afford track fragment 24.  Ditosylate 27 was synthesised 
according to a modified literature procedure20 by reacting 2,6-pyridinemethanol (26) 
with tosyl chloride, in THF/H2O (3:1).  The second half of the four-foothold track was 
achieved by Williamson coupling of 11 and 27 to give the product in 89% yield 
(Scheme 4.8e).  Free track T1 was synthesised in a similar manner attaching 25 to 28 





Scheme 4.9 - Synthesis of walker-track conjugate. Reagents and conditions: (a) CHCl3, RT, 16 h, 
91%; (b) 17, acetic acid, MeOH, RT, 12 h, 93%; (c) (i) Grubbs II, CH2Cl2, RT, 18 h, 58%, (ii) TBAF, 
DIPEA, THF, 273 K, 2 h, 78%, (iii) Pd(OH)2, H2, K2CO3, THF, RT, 4 h, 96%; (d) Conditions 1: 28, 
Cs2CO3, THF, RT, 16%; Conditions 2: 28, K2CO3, 18-crown-6, acetone, RT, 16 h, max 60%, min 42%; 
Conditions 3: 28, K2CO3, 18-crown-6, acetone, RT, 6 days, 50%. 
The palladium(II) foot was attached by reacting an equimolar solution of 24 and 14 to 
give complex 29 (Scheme 4.9a), which was subjected to hydrazone forming conditions 
(acetic acid, MeOH) in the presence of 17 to give precursor 30.  Ring closing metathesis 
followed by silyl deprotection using TBAF in THF and subsequent hydrogenation gave 
the product M21 (Scheme 4.9c).  The 1H NMR spectrum of this new macrocycle 
unsurprisingly showed the same hydrazone isomers as M11 at room temperature but 
could be resolved at elevated temperature.  Williamson reaction conditions were used 
in an attempt to couple M21 and 28 in the synthesis of the target walker-track 
conjugate 1,2-T1, however, the product was only ever observed in poor yield.  
Conditions were screened varying the reaction times, the solvent and the base.  The 
best results came from using K2CO3 in combination with 18-crown-6 in acetone for 16 
h giving the product in a remarkable 60% yield.  However, this result was not precisely 
reproducible.  An alternative attempt was made with the same reagents in CH2Cl2 for  
6 days, which afforded 1,2-T1 in a more modest but reproducible 50% yield. 
4.9 Heat-Driven Stepping of Palladium(II)-Foot 
Walker-track conjugate 1,2-T1 was submitted to the reaction conditions optimised in 
the intermolecular model studies and the ring-opening of macrocycle M11 




spectroscopy but, unfortunately, very little change was observed in the spectra.  Due to 
the chemical similarity of the two pyridyl footholds within the track, only small 
variations were expected anyway, and they were predicted to be difficult to interpret in 
low concentration NMR experiments run at high temperature, however, when carried 
out on a larger scale full high temperature NMR analysis (13C, HSQC, HMBC, COSY, 
ROESY, DOSY) showed the product to be identical to the starting material.  Although 
the previous models implied that the palladium(II)-foot should indeed function under 
these conditions, the results from the attempted stepping either mean that the walker's 
first step actually worked and the product is simply indistinguishable from the starting 
material by NMR and HPLC analysis, or else the starting material is considerably more 
favoured and the equilibrium distribution lies completely in its favour.  This first of 
these scenarios seems unlikely whilst the second could be explained by additional 
steric hindrance around foothold three.  To test this theory and prove that the Pd-
pyridyl bond was indeed being labilised under the chosen conditions, the stepping 
reaction was repeated with the addition of 5 equivalents of scavenger 2,6-lutidine 
(Scheme 4.10).  The reaction showed formation (2,6-lutidine),2-T1 in 70% yield. 
 
Scheme 4.10 - Ring-opening of 1,2-T1 in the presence of 2,6-lutidine.  Reagents and conditions:  
(a) 2,6-lutidine (5 equiv), CDCl3/CD3CN (7:3), 338 K, 23 h, 70%. 
These results give further evidence that the reaction conditions for palladium(II)-foot 
stepping are effective and suggest that foothold-1 is, in effect, unanimously favoured 
over its counterpart pyridyl foothold-3.  This realisation means that the biped unit 
cannot be made to walk along the track of this system.  Considering the degree of 
electronic similarity between the two stations in question, it can be inferred that this 
bias emanates from their disparate steric environments.  Although CPK modelling had 
previously indicated that a single methylene spacer would be enough to comfortably 
accommodate the palladium(II) complex when coordinated to the central foothold, 




4.10 Conclusions and Future Work 
Whilst the first generation walker-track conjugate 1,2-T1 has been found wanting in 
terms of the ultimate goal of this project, the information acquired through the 
synthesis, operation and model studies described in this chapter will be invaluable in 
the design of subsequent superior systems (Figure 4.6).  The effective ring-opening of 
macrocycle M11 gives precedent for the use of palladium(II) ligand chemistry and 
hydrazone exchange as effective components for use in conjunction with orthogonal 
chemical stimuli as independently addressable feet in a molecular biped. 
 
Figure 4.6 - Potential adjustments to improve the functionality of 1,2-T1: (i) an increase in steric 
bulk at position X would help give a more even distribution between footholds 1 and 3 when 
operating the Pd(II)foot; (ii) increasing y would aid characterisation of the system by NMR 
spectroscopy by eliminating the hydrazone isomer issues that convolute the spectra at RT; (iii) 
increasing z would also help give a more even distribution between footholds 1 and 3 when 
operating the Pd(II) foot if X were left as a hydrogen atom; (iv) by incorporating a DMAP 
derivative in the foothold-3 position the Pd(II) step could be made directional conforming to an 
energy ratchet mechanism. 
It has been shown that encapsulating the hydrazone linkage within strained 
macrocycles can convolute the NMR spectra of these species.  A second-generation 
design should try and avoid this by increasing the degree of flexibility afforded to the 
macrocycle formed by the two fixed feet and the track.  Track T1 was designed as an 
ABAB system with the potential for incremental extension.  Although this is useful 
when trying to mimic the polymeric nature of biological molecular tracks, it makes 1H 
NMR analysis of operation difficult.  The introduction of deuterium labelling of the 
benzaldehyde footholds in T1 proved effective in differentiating between them, 
however, the pyridine footholds (1 & 3) were almost indistinguishable by NMR.  One 
method of labelling them would be to replace pyridine foothold-3 with a 2,6-
substituted DMAP derivative.  This would not only enable the operator to differentiate 
between ligand sites, but also allow for directionality to be introduced into the system 
by upgrading the palladium(II) component from a simple dynamic switch to an energy 




acid in order to operate the hydrazone foot means that processivity could still be 
maintained with the addition of a single equivalent of acid used to apply a bias between 
footholds during the palladium(II) stepping.  Finally, the steric issue of the two pyridyl 
footholds would need to be addressed either by increasing the steric bulk of foothold-1 
to match that of 3, or else, by increasing the alkyl chain lengths between footholds to 
ensure an even steric hindrance of both pyridyl moieties. 
4.11 Experimental Section 
General Information 
Compounds 1,20 2321 and 2722 were prepared according to modified literature 
procedures.  Benzaldehyde (2), 3,5-dihydroxybenzoic acid (5), 6-heptenoic acid (15), 
3,5-dihydroxybenzaldehyde (22), 1-bromopropane, 2,6-pyridinemethanol (26), 4-
bromobutene and 6-methyl-2-pyridine methanol were purchased from Sigma Aldrich. 
Synthesis of Macrocycle M11 
Synthesis of 6 
 
To a solution of 3,5-dihydroxybenzoic acid (5) (5.00 g, 32.0 mmol, 1.0 equiv) in dry 
MeOH (100 mL) was added SOCl2 (5 mL) and the mixture stirred at room temperature 
under nitrogen for 12 h.  The solvent was removed under reduced pressure to give 6 
(5.35 g, quant.) as a pale yellow powder.  m.p. 158-163 °C.  1H NMR (400 MHz, MeOD): δ 
= 6.93 (d, J = 2.3 Hz, 2H, Hb), 6.48 (t, J = 2.3 Hz, 1H, Hc), 3.86 (s, 3H, Ha).  13C NMR (101 
MHz, MeOD): δ = 168.68, 159.74, 133.01, 108.79, 108.24, 52.52. HRMS (NSI+): m/z = 
191.0317 [M+Na]+ (calcd. 191.0320 for C8H8NaO4+). 
Synthesis of 7 
 
Under nitrogen, 6 (2.50 g, 15.0 mmol, 1.0 equiv) and K2CO3 (6.20 g, 45.0 mmol, 3.0 




g, 15.0 mmol, 1.0 equiv) was added via syringe over a period of 1 h.  The reaction 
mixture was stirred at room temperature for 16 h.  The solvent was removed under 
reduced pressure, the crude product dissolved in EtOAc and washed with H2O, aqueous 
LiCl, and brine.  The organic fractions were dried over MgSO4 and the solvent removed 
under reduced pressure.  The crude product was purified by column chromatography 
(SiO2, EtOAc/petrol ether 1:4) to give 7 (1.00 g, 32%) as a white solid.  m.p. 76-78 °C.  
1H NMR (400 MHz, MeOD): δ = 7.05 – 7.00 (m, 2H, Hb+d), 6.58 (t, J = 2.3 Hz, 1H, Hc), 3.94 
(t, J = 6.5 Hz, 2H, He), 3.88 (s, 3H, Ha), 1.87 – 1.74 (m, 2H, Hf), 1.06 (t, J = 7.4 Hz, 3H, Hg).  
13C NMR (101 MHz, MeOD): δ = 168.6, 161.8, 159.9, 133.1, 109.9, 107.7, 107.5, 70.8, 
52.6, 23.6, 10.8. 
Synthesis of 8 
 
To a solution of 7 (0.620 g, 2.96 mmol, 1.0 equiv) in dry DMF (40 mL) at 0 °C was added 
DIPEA (1.22 g, 9.47 mmol, 3.2 equiv) and the solution stirred for 20 min.  TBDPSCl 
(1.63 g, 5.91 mmol, 2.0 equiv) was added in dry DMF (10 mL) and the solution stirred 
at 55 °C for 3 h. Brine was added, the crude product extracted with CH2Cl2 and washed 
with HCl (1 M), H2O, and brine.  The organic phase was dried over MgSO4.  The solvent 
was removed under reduced pressure and the crude residues combined and purified 
by column chromatography (SiO2, petrol ether/CH2Cl2 3:1) to give 8 (1.25 g, 94%) as a 
white solid.  m.p. 121-123 °C.  1H NMR (400 MHz, CDCl3): δ = 7.82 – 7.74 (m, 4H, HAr), 
7.52 – 7.37 (m, 6H, HAr), 7.21 – 7.15 (m, 2H, Hb+d), 6.48 (t, J = 2.3 Hz, 1H, Hc), 3.85 (s, 3H, 
Ha), 3.71 (t, J = 6.6 Hz, 2H, He), 1.73 – 1.63 (m, 2H, Hf), 1.18 (s, 9H, Hh), 0.95 (t, J = 7.4 
Hz, 3H, Hg).  13C NMR (101 MHz, CDCl3): δ = 166.9, 159.8, 156.6, 135.6, 132.6, 131.8, 
130.1, 127.9, 113.6, 111.2, 108.6, 69.7, 52.1, 26.6, 22.4, 19.6, 10.4.  HRMS (ESI+): m/z = 




Synthesis of 9 
 
To a solution of 8 (0.380 g, 0.846 mmol, 1.0 equiv) in dry THF (35 mL) at 0 °C was 
added LiAlD4 (0.140 g, 3.40 mmol, 4.0 equiv) and the reaction stirred at room 
temperature for 13 h.  The reaction was quenched with H2O followed by NaOH (0.1 M) 
and dried over MgSO4.  The solvent was removed under reduced pressure and the 
crude product purified by column chromatography (SiO2, CH2Cl2/MeOH 98:2) to give 9 
(0.340 g, 94%).  m.p. 136-139 °C.  1H NMR (400 MHz, CDCl3): δ = 7.73 (d, J = 7.3 Hz, 4H, 
HAr), 7.46 – 7.34 (m, 6H, HAr), 6.46 (s, 1H, Ha/b), 6.37 (s, 1H, Ha/b), 6.22 (s, 1H, Hc), 3.65 
(t, J = 6.6 Hz, 2H, Hd), 1.72 – 1.60 (m, 2H, He), 1.12 (s, 9H, Hg), 0.93 (t, J = 7.4 Hz, 3H, Hf).  
13C NMR (101 MHz, CDCl3): δ = 160.2, 156.7, 142.9, 135.7, 133.0, 130.0, 127.9, 110.6, 
106.3, 105.4, 69.5, 26.75, 22.5, 19.6, 10.5.  HRMS (ESI+): m/z = 423.2323 [M+H]+ (calcd. 
423.2324 for C26H31D2O3Si+). 
Synthesis of 10 
 
An equimolar solution of 9 (0.111 g, 0.260 mmol, 1.0 equiv) and Dess-Martin 
periodinane (0.110 g, 0.259 mmol, 1.0 equiv) was made up in CH2Cl2 and stirred at 
room temperature for 3 h.  The reaction mixture was washed with H2O and the organic 
fraction dried over MgSO4.  The solvent was removed under reduced pressure and the 
crude residue purified by column chromatography (SiO2, petrol ether/CH2Cl2 3:2) to 
give 10 (76 mg, 51%) as a colourless oil.  1H NMR (400 MHz, CDCl3): δ = 7.74 – 7.68 (m, 
4H, HAr), 7.48 – 7.34 (m, 6H, HAr), 6.94 (dd, J = 2.3, 1.3 Hz, 1H, Ha/b), 6.84 (dd, J = 2.3, 1.3 
Hz, 1H, Ha/b), 6.53 (t, J = 2.3 Hz, 1H, Hc), 3.72 (t, J = 6.6 Hz, 2H, Hd), 1.73 – 1.62 (m, 2H, 
He), 1.12 (s, 9H, Hg), 0.94 (t, J = 7.4 Hz, 3H, Hf).  13C NMR (126 MHz, CDCl3): δ =191.8, 
160.6, 157.3, 138.1, 135.6, 132.5, 130.3, 128.1, 114.5, 113.0, 107.5, 69.9, 26.6, 22.4, 




Synthesis of 11 
 
To a solution of 10 (76 mg, 0.17 mmol, 1.0 equiv) in dry THF (10 mL) was added TBAF 
(1 M in THF, 0.17 mL, 0.17 mmol, 1.0 equiv) at 0 °C forming a yellow solution which 
was stirred for 2 h.  The reaction was quenched with H2O (4 mL) at 0 °C and the crude 
product extracted with CH2Cl2, washed with H2O and brine, and dried over MgSO4.  
The crude product was purified by column chromatography (SiO2, MeOH/CH2Cl2 1:99) 
to give 11 (28 mg, 90%) as a brown oil.  1H NMR (400 MHz, CDCl3): δ = 7.00 (dd, J = 2.3, 
1.2 Hz, 1H, Hd/f), 6.94 (dd, J = 2.3, 1.2 Hz, 1H, Hd/f), 6.67 (t, J = 2.3 Hz, 1H, He), 3.95 (t, J = 
6.6 Hz, 2H, Hc), 1.90 – 1.76 (m, 2H, Hb), 1.04 (t, J = 7.4 Hz, 3H, Ha).  13C NMR (101 MHz, 
CDCl3): δ = 192.92, 161.04, 157.82, 138.14, 109.14, 109.10, 108.05, 70.07, 22.51, 10.55. 
HRMS (NSI+): m/z = 182.0923 [M+H]+ (calcd. 082.0927 for C10H12DO3+). 
Synthesis of 12 
 
To a solution of PPh3 (0.26 g, 0.99 mmol, 1.2 equiv) in dry THF (2 mL) was added DIAD 
(0.24 g, 1.2 mmol, 1.4 equiv) at 0 °C under nitrogen, forming a yellow cloudy solution 
which was stirred for 20 min.  6-methyl-2-pyridinemethanol (0.11 g, 0.91 mmol, 1.1 
equiv) was added in THF (1 mL) and the solution stirred for 20 min.  11 (0.15 g, 0.83 
mmol, 1.0 equiv) was added in THF (1.5 mL) and the solution turned clear yellow.  The 
reaction mixture was allowed to warm to room temperature and stirred for 12 h.  The 
solvent was removed under reduced pressure and the residue purified by column 
chromatography (SiO2, MeOH/CH2Cl2 0.5:99.5) to give 12 (0.22 g, 93%) as a colourless 
oil.  1H NMR (500 MHz, CDCl3): δ = 7.60 (t, J = 7.7 Hz, 1H, Hc), 7.29 (d, J = 7.7 Hz, 1H, 
Hb/d), 7.09 (d, J = 7.7 Hz, 1H, Hb/d), 7.08 – 7.07 (m, 1H, Hf/h), 7.04 – 7.00 (m, 1H, Hf/h), 
6.81 (t, J = 2.3 Hz, 1H, Hg), 5.19 (s, 2H, He), 3.94 (t, J = 6.6 Hz, 2H, Hi), 2.57 (s, 3H, Ha), 
1.86 – 1.75 (m, 2H, Hj), 1.03 (t, J = 7.4 Hz, 3H, Hk).  13C NMR (126 MHz, CDCl3): δ = 192.0 




71.2, 70.1, 22.6, 22.1, 10.6.  HRMS (NSI+): m/z = 287.1501 [M+H]+ (calcd. 287.1506 for 
C17H19DNO3+). 
Synthesis of 13 
 
To a solution of compound 10 (Chapter II) (0.70 g, 1.8 mmol, 1.0 equiv) and K2CO3 (1.2 
g, 9.0 mmol, 5.0 equiv) in butanone (60 mL) was added 4-bromobutene (1.2 g, 9.0 
mmol, 5.0 equiv) and the solution stirred at 70 °C under nitrogen for 2 days.  H2O (50 
mL) was added and the crude product extracted with butanone, dried over MgSO4 and 
purified by column chromatography (SiO2, MeOH/CH2Cl2 0.05:95.5) to give 13 (0.78 g, 
99%) as a colourless oil.  1H NMR (400 MHz, CDCl3): δ = 8.51 (t, J = 6.1 Hz, 2H, Hj), 7.78 
(s, 2H, He), 7.09 (d, J = 8.0 Hz, 4H, Hb), 6.99 (d, J = 8.0 Hz, 4H, Hc), 5.83 (ddt, J = 17.0, 
10.2, 6.7 Hz, 1H, Hh), 5.22 – 5.09 (m, 2H, Hi), 4.48 (d, J = 6.2 Hz, 4H, Hd), 4.05 (t, J = 6.6 
Hz, 2H, Hf), 2.54 (q, J = 6.6 Hz, 2H, Hg), 2.26 (s, 6H, Ha).  13C NMR (101 MHz, CDCl3): δ = 
167.78, 163.58, 150.84, 137.39, 135.14, 133.50, 129.50, 127.87, 117.97, 111.61, 68.16, 
43.37, 33.20, 21.24.  HRMS (NSI+): m/z = 444.2277 [M+H]+ (calcd. 444.2287 for 
C27H30N3O3+). 
Synthesis of 14 
 
To a solution of 13 (0.80 g, 1.8 mmol, 1.0 equiv) in MeCN (55 mL) was added Pd(OAc)2 
(0.42 g, 1.8 mmol, 1.0 equiv) and the solution stirred at room temperature for 12 h.  A 
bright yellow precipitate was filtered off and washed with cold MeCN.  The product was 




amorphous solid.  1H NMR (400 MHz, CDCl3): δ = 7.17 (s, 2H, He), 7.15 (d, J = 7.8 Hz, 4H, 
Hb), 7.04 (d, J = 7.8 Hz, 4H, Hc), 5.88 – 5.72 (m, 1H, Hh), 5.18 – 5.04 (m, 2H, Hi), 4.44 (s, 
4H, Hd), 4.15 (t, J = 6.5 Hz, 2H, Hf), 2.59 – 2.48 (m, 2H, Hg), 2.26 (s, J = 13.1 Hz, 6H, Ha), 
1.96 (s, J = 2.8 Hz, 3H, Hj).  13C NMR (126 MHz, CDCl3): δ = 170.7, 154.6, 138.7, 135.9, 
133.1, 129.0, 128.6, 127.3, 118.3, 116.5, 111.2, 69.1, 50.1, 33.0, 21.2, 2.7, 2.0.  HRMS 
(NSI+): m/z = 589.1422 [M+H]+ (calcd. 589.1431 for C29H31N4O3Pd+). 
Synthesis of 16 
 
6-heptenoic acid (1.0 g, 7.8 mmol, 1.0 equiv) was added to MeOH (25 mL) at 0 °C.  
Thionyl chloride (2.0 g, 17 mmol, 2.2 equiv) was added via syringe and the solution 
stirred at room temperature for 16 h.  The solvent was removed under reduced 
pressure to give 16 (1.1 g, quant.) as a colourless oil.  1H NMR (400 MHz, CDCl3): δ = 
5.79 (ddt, J = 16.9, 10.2, 6.7 Hz, 1H, Hc), 5.05 – 4.91 (m, 2H, Ha) 3.66 (s, 3H, Hh), 2.31 (t, J 
= 7.5 Hz, 2H, Hg), 2.06 (q, J = 7.1 Hz, 2H, Hd), 1.65 - 1.61 (m, 2H, Hf), 1.47 – 1.36 (m, 2H, 
He).  13C NMR (101 MHz, CDCl3): δ = 174.3, 138.5, 114.8, 51.6, 48.5, 34.1, 33.5, 28.5, 
24.5. 
Synthesis of 17 
 
To a stirring solution of 16 (1.10 g, 7.80 mmol, 1.0 equiv) in MeOH (25 mL) was added 
hydrazine monohydrate (1.95 g, 39 .0mmol, 5.0 equiv) and the reaction mixture 
refluxed for 12 h.  The solvent was removed under reduced pressure and the crude 
product purified by column chromatography (SiO2, CH2Cl2/MeOH 95:5) to give 17 
(0.70 g, 63%) as a white solid, m.p. 63 – 65 °C. 1H NMR (400 MHz, CDCl3): δ = 6.71 (s, 
1H, Hh), 5.78 (ddt, J = 16.9, 10.2, 6.7 Hz, 1H, Hc), 5.03 – 4.93 (m, 2H, Ha), 3.89 (s, 2H, Hi), 
2.20 – 2.11 (m, 2H, Hg), 2.11 – 2.01 (m, 2H, Hd), 1.73 – 1.57 (m, 2H, Hf), 1.48 – 1.35 (m, 




Synthesis of 18 
 
To a solution of 14 (0.25 g, 0.42 mmol, 1.0 equiv) in CHCl3 (50 mL) was added 12 (0.12 
g, 0.42 mmol, 1.0 equiv) and the solution stirred at room temperature for 5 h.  The 
solvent was removed under reduced pressure and the crude residue purified by 
column chromatography (SiO2, CH2Cl2/MeOH, 97:3) to yield 18 (0.32 g, 93%) as a 
yellow oil.  1H NMR (500 MHz, CDCl3): δ = 7.82 (t, J = 7.8 Hz, 1H, Hl), 7.45 (d, J = 7.8 Hz, 
1H, Hk/m), 7.36 (s, 2H, He), 7.11 (d, J = 7.6 Hz, 1H, Hk/m), 7.05 (dd, J = 2.1, 1.1 Hz, 1H, 
Hq/o), 6.87 (dd, J = 2.2, 1.1 Hz, 1H, Hq/o), 6.74 (d, J = 7.8 Hz, 4H, Hb), 6.57 (t, J = 2.3 Hz, 
1H, Hp), 6.45 (d, J = 7.9 Hz, 4H, Hc), 5.87 (ddt, J = 17.0, 10.3, 6.7 Hz, 1H, Hh), 5.22 – 5.12 
(m, 2H, Hi), 4.59 (s, 2H, Hn), 4.28 – 4.18 (m, 4H, Hd+f), 3.98 (t, J = 6.6 Hz, 2H, Hr), 3.81 (d, 
J = 14.2 Hz, 2H, Hd’), 2.66 – 2.56 (m, 5H, Hj+g), 2.00 (s, 6H, Ha), 1.89 – 1.76 (m, 2H, Hs), 
1.05 (t, J = 7.4 Hz, 3H, Ht).  13C NMR (126 MHz, CDCl3): δ = 191.44, 171.23, 169.37, 
160.84, 160.47, 158.93, 154.33, 139.12, 138.09, 136.25, 133.18, 128.85, 127.30, 124.57, 
120.67, 118.13, 111.25, 108.66, 108.40, 107.61, 77.41, 77.16, 76.91, 70.19, 68.94, 68.83, 
53.54, 49.22, 33.02, 26.03, 22.54, 22.04, 20.86, 10.60.  HRMS (NSI+): m/z = 834.2608 
[M+H]+ (calcd. 834.2593 for C44H46DN4O6Pd+). 
Synthesis of 19 
 
To a solution of 18 (0.25 g, 0.31 mmol, 1.0 equiv) and 17 (0.044 g, 0.31 mmol, 1.0 
equiv) in dry MeOH (40 mL) was added glacial acetic acid (5 drops) and the solution 
stirred at room temperature for 16 h.  The solvent was removed under reduced 




CH2Cl2/MeOH 95:5) to yield 19 (0.27 g, 90%) as a yellow oily solid.  1H NMR (500 MHz, 
CDCl3): δ = 9.35 (s, 1H, Hs), 7.82 (t, J = 7.8 Hz, 1H, Hk), 7.48 (d, J = 7.9 Hz, 1H, Hj/l), 7.37 
(s, 2H, He), 7.07 (d, J = 7.9 Hz, 1H, Hj/l), 6.88 (s, 1H, Hn/p), 6.76 (d, J = 7.8 Hz, 4H, Hb), 
6.65 (s, 1H, Hn/p), 6.45 (d, J = 7.8 Hz, 4H, Hc), 6.36 (t, J = 2.2 Hz, 1H, Ho), 5.94 – 5.76 (m, 
2H, Hh+w), 5.21 – 5.15 (m, 2H, Hq), 5.06 – 4.91 (m, 2H, Hx), 4.69 (s, 2H, Hm), 4.25 (t, J = 
6.6 Hz, 2H, Hr), 4.14 (d, J = 14.2 Hz, 2H, Hd), 3.95 (t, J = 6.6 Hz, 2H, Hf), 3.92 (d, J = 14.3 
Hz, 2H, Hd’), 2.75 (t, J = 7.5 Hz, 2H, Ht), 2.64 – 2.59 (m, 2H, Hg), 2.56 (s, 2H, Hi), 2.15 – 
2.09 (m, 2H, Haa), 1.88 – 1.79 (m, 2H, Hy), 1.77 – 1.70 (m, 2H, Hu), 1.52 – 1.44 (m, 2H, 
Hv), 1.06 (t, J = 7.4 Hz, 3H, Hz) .  13C NMR (126 MHz, CDCl3): δ = 207.13, 175.92, 171.24, 
169.41, 160.63, 160.58, 159.19, 158.78, 154.38, 139.10, 138.76, 138.08, 136.33, 135.82, 
133.20, 128.90, 127.33, 124.51, 120.72, 118.20, 114.73, 111.25, 107.23, 104.94, 103.76, 
77.41, 77.16, 76.91, 70.18, 69.96, 69.02, 68.84, 53.56, 49.29, 33.67, 33.07, 32.63, 31.07, 
28.74, 26.02, 24.34, 22.65, 22.09, 20.97, 10.70.  HRMS (NSI+): m/z = 958.3611 [M+H]+ 
(calcd. 958.3594 for C51H58DN6O6Pd+). 
Synthesis of M11 
 
To an oven-dried round-bottom flask was added 19 (96.0 mg, 0.100 mmol, 1.0 equiv) 
and the flask purged with nitrogen.  CH2Cl2 (110 mL, pre-purged with N2) was added 
via syringe.  Grubbs II (8.5 mg, 0.01 mmol, 0.1 equiv) was added and a light vacuum 
applied to the flask for 5 min.  The flask was purged with nitrogen for 15 min and 
stirred at room temperature for 24 h. Additional Grubbs II (8.5 mg, 0.01 mmol, 0.1 
equiv) was added and a light vacuum applied to the flask for 5 min.  The flask was 
purged with nitrogen for 15 min and stirred at room temperature for 24 h.  Ethyl vinyl 
ether (2 mL) was added and the solution stirred for 2 h.  The solvent was removed 
under reduced pressure and the crude residue was purified by column 
chromatography (SiO2, EtOAc) to give a yellow solid (54 mg, 58%), which was 
dissolved in dry THF (10 mL).  K2CO3 (37.0 mg, 0.270 mmol, 5.0 equiv) was added with 




hydrogen gas for 4 h.  The reaction mixture was filtered through Celite® and the solvent 
removed under reduced pressure.  The crude residue was purified by column 
chromatography (SiO2, CH2Cl2/MeOH 96:4) to yield M11 (45 mg, 52% from 19) as a 
yellow solid.  1H NMR (400 MHz, C2Cl4D2): δ = 8.78 (s, 1H, Hn), 7.88 (t, J = 7.8 Hz, 1H, 
Hr), 7.56 (d, J = 7.7 Hz, 1H, Hq/s), 7.37 (s, 2H, He), 7.14 (d, J = 7.7 Hz, 1H, Hq/s), 6.88 (t, J = 
7.7 Hz, 4H, Hb), 6.83 (s, 3H, Hu-w), 6.63 (d, J = 7.7 Hz, 4H, Hc), 5.16 (s, 2H, Ht), 4.41 (t, J = 
5.7 Hz, 2H, Hf), 4.17 (d, J = 14.4 Hz, 2H, Hd), 4.03 (t, J = 6.4 Hz, 2H, Hx), 4.01 (d, J = 14.4 
Hz, 2H, Hd’), 2.62 (s, 3H, Hp), 2.23 (s, 6H, Ha), 2.00 – 1.93 (m, 2H, Hg), 1.94 – 1.85 (m, 2H, 
Hy), 1.81 – 1.65 (m, 4H, Hh+m), 1.65 – 1.55 (m, 4H, Hk+j), 1.53 – 1.46 (m, 2H, Hi), 1.15 (t, J 
= 7.4 Hz, 3H, Hz).  HRMS (NSI+): m/z = 932.3466 [M+H]+ (calcd. 932.3437 for 
C49H56DN6O6Pd+). 
Ring-Opening Experiments 
Synthesis of 20 
 
To a solution of M11 (5.6 mg, 6.0 µmol, 1.0 equiv.) in CD3CN (0.1 mL) and CDCl3 (0.4 
mL) was added 2,6-lutidine (3.2 mg, 30 µmol, 5.0 equiv.) and the solution heated at 65 
°C for 15 hrs.  Toluene (1 mL) was added and the solvent removed gradually under 
reduced pressure.  The crude residue was purified by preparative thin layer 
chromatography (SiO2, MeOH/CH2Cl2 5:95) to give 20 as a yellow solid (4.7 mg, 75%).  
m.p. 180 °C (dec.).  1H NMR (500 MHz, CDCl3): δ = 9.26 (s, 1H, Hn), 7.61 (t, J = 7.7 Hz, 1H, 
Hu), 7.61 (t, J = 7.7 Hz, 1H, Hx), 7.35 (s, 2H, He), 7.33 (d, J = 7.4 Hz, 1H, Ht/v), 7.09 (d, J = 
7.6 Hz, 1H, Ht/v), 6.94 (d, J = 7.7 Hz, 2H, Hy), 6.87 (s, 1H, Hp/q), 6.81 (d, J = 7.8 Hz, 4H, 
Hb), 6.77 (s, 1H, Hp/q), 6.58 (t, J = 2.2 Hz, 1H, Hr), 6.47 (d, J = 7.8 Hz, 4H, Hc), 5.17 (s, 2H, 
Hs), 4.16 (t, J = 6.4 Hz, 2H, Haa), 4.02 (s, 4H, Hd), 3.90 (t, J = 6.6 Hz, 2H, H2), 2.76 (t, J = 
7.3 Hz, 2H, H2), 2.57 (s, 2H, Hw), 2.42 (s, 6H, Hz), 2.24 (s, 6H, Ha), 1.81 – 1.71 (m, 6H, 
Hg,l,bb), 1.50 – 1.37 (m, 6H, Hk,j,h), 1.03 (t, J = 7.4, Hz, 3H, Hcc).  13C NMR (126 MHz, 
CDCl3): δ = 175.78, 171.30, 169.52, 160.64, 160.57, 159.97, 158.13, 156.35, 154.37, 




105.47, 103.48, 70.98, 69.94, 69.85, 49.34, 32.64, 29.84, 29.13, 29.09, 28.87, 28.54, 
25.61, 25.56, 24.57, 24.54, 22.64, 21.16, 10.66.  HRMS (NSI+): m/z = 1039.4241 [M+H]+ 
(calcd. 1039.4172 for C56H65DN7O6Pd+). 
Synthesis of 21 
 
To a solution of M11 (5.6 mg, 6.0 µmol, 1.0 equiv) in CDCl3 (0.5 mL) was added p-
anisaldehyde (4.1 mg, 0.03 mmol, 5.0 equiv) and TFA (2.2 µL, 0.03 mmol, 5.0 equiv) and 
the reaction left at room temperature for 15 h.  The crude mixture was purified by 
preparative TLC (SiO2, CH2Cl2/MeOH 95:5) to give 21 as a yellow solid.  m.p. 175 °C 
(dec.)  1H NMR (500 MHz, CDCl3): δ = 8.79 (s, 1H, Hn), 7.86 (t, J = 7.7 Hz, 1H, Hu), 7.69 (s, 
1H, Ho), 7.58 (d, J = 8.7 Hz, 1H, Hx/y), 7.47 (d, J = 7.7 Hz, 1H, Ht/v), 7.38 (s, 2H, He), 7.12 
(d, J = 7.7, 1H, Ht/v), 7.06 (s, 1H, Hp/q), 6.91 (d, J = 8.7 Hz, 1H, Hx/y), 6.89 (s, 1H, Hp/q), 
6.76 (d, J = 7.8 Hz, 4H, Hb), 6.59 (t, J = 2.0 Hz, 1H, Hr), 6.47 (d, J = 7.8 Hz, 4H, Hc), 4.61 (s, 
2H, Hs), 4.23 (d, J = 14.1 Hz, 2H, Hd), 4.19 (t, J = 6.4 Hz, 2Hf), 3.99 (t, J = 6.6 Hz, 2H, Haa), 
3.84 (s, 3H, Hz), 3.83 (d, J = 14.1 Hz, 2H, Hd’), 2.76 (t, J = 7.4 Hz, 2H, Hm), 2.64 (s, 3H, Hw), 
2.02 (s, 6H, Ha), 1.87 - 1.73 (m, 6H, Hbb,g,l), 1.50 – 1.39 (m, 8H, Hh,i,j,l) 1.07 (t, J = 7.4 Hz, 
3H, Hcc).  HRMS (NSI+): m/z = 1068.4001 [M+H]+ (calcd. 1068.3961 for 
C57H64DN6O8Pd+). 
Synthesis of Molecular Walker-Track Conjugate 1,2-T1 
Synthesis of 24 
 
PPh3 (0.24 g, 0.82 mmol, 1.2 equiv) was dissolved in dry THF (2 mL) and cooled to 0 °C 




solution stirred for 20 min.  6-methyl-2-pyridine methanol (0.10 g, 0.82 mmol, 1.2 
equiv) was added in THF (1 mL) and the solution stirred for 20 min.  23 (0.19 g, 0.75 
mmol, 1 equiv) was added in THF (1.5 mL) and stirred for 4.5 h.  The solvent was 
removed under reduced pressure and the crude product purified by column 
chromatography (SiO2, CH2Cl2) to give 24 (0.20 g, 74%) as a colourless oil.  1H NMR 
(400 MHz, CDCl3): δ = 9.87 (s, 1H, Hi), 7.61 (t, J = 7.7 Hz, 2H, Hc), 7.30 (d, J = 7.5 Hz, 1H, 
Hd), 7.12 (dd, J = 2.4, 1.3 Hz, 1H, Hf), 7.10 (d, J = 7.8 Hz, 1H, Hb), 6.95 (dd, J = 2.2, 1.3 Hz, 
1H, Hh), 6.73 (t, J = 2.3 Hz, 1H, Hg), 5.18 (s, 2H, He), 2.58 (s, 3H, Ha), 0.97 (s, 9H, Hk), 
0.22 (s, 6H, Hj).  13C NMR (126 MHz, CDCl3): δ = 191.90, 160.14, 158.30, 157.57, 155.94, 
138.57, 137.31, 122.60, 118.49, 114.31, 113.54, 108.94, 71.21, 25.74, 24.50, 18.33, -
4.33.  HRMS (NSI+): m/z = 358.1834 [M+H]+ (calcd. 358.1838 for C20H28NO3Si+). 
Synthesis of 25 
 
To a solution of 24 (76 mg, 0.21 mmol, 1.0 equiv) in dry THF (10 mL) was added TBAF 
(1 M in THF, 0.21 mL, 0.21 mmol, 1.0 equiv) at 0 °C forming a yellow solution which 
was stirred for 2 h.  The reaction was quenched with H2O (4 mL) at 0 °C and the crude 
product extracted with CH2Cl2, washed with H2O and brine, and dried over MgSO4.  
The crude product was purified by column chromatography (SiO2, MeOH/CH2Cl2 1:99) 
to give 29 (46 mg, 90%) as a brown oil.  1H NMR (400 MHz, MeOD): δ = 9.83 (s, 1H, Hi), 
7.74 (t, J = 7.7 Hz, 1H, Hc), 7.39 (d, J = 7.6 Hz, 1H, Hd), 7.24 (d, J = 7.8 Hz, 1H, Hb), 7.03 
(dd, J = 2.0, 1.1 Hz, 1H, Hf), 6.94 (dd, J = 2.0, 1.1 Hz, 1H, Hh), 6.74 (t, J = 2.0 Hz, 1H, Hg), 
5.15 (s, 2H, He), 2.56 (s, 3H, Ha).  13C NMR (126 MHz, MeOD): δ = 193.77, 161.57, 
160.68, 159.31, 157.13, 140.15, 139.19, 124.07, 120.28, 110.53, 109.51, 107.66, 71.40, 
23.79.  HRES (ESI+): m/z = 244.1001 [M+H]+ (calcd. 244.0974 for C14H14NO3+). 





To a solution of 25 (29.5 mg, 0.122 mmol, 1.0 equiv) and 28 (61.0 mg, 0.134 mmol, 1.1 
equiv) in dry THF (4 mL) was added CsCO3 (119 mg, 0.365 mmol, 3.0 equiv) and the 
mixture stirred at room temperature for 15 h.  The solvent was removed under 
reduced pressure and the crude residue purified by column chromatography (SiO2, 
petroleum ether/EtOAc 6:4) to give T1 (44 mg, 68%) as a colourless oil.  1H NMR (500 
MHz, CDCl3): δ = 9.89 (s, 1H, Hhz), 7.77 (t, J = 7.8 Hz, 1H, HAr), 7.61 (t, J = 7.7 Hz, 1H, 
HAr), 7.45 (t, J = 7.6 Hz, 2H, HAr), 7.28 (d, J = 7.7 Hz, 1H, HAr), 7.13 (d, J = 2.3 Hz, 2H, HAr), 
7.11 – 7.09 (m, 2H, HAr), 7.04 (dd, J = 2.2, 1.1 Hz, 1H, HAr), 6.93 (t, J = 2.3 Hz, 1H, HAr), 
6.82 (t, J = 2.3 Hz, 1H, HAr), 5.24 (s, 4H, Hj+n), 5.20 (s, 2H, He), 3.96 (t, J = 6.6 Hz, 2H, Hr), 
2.58 (s, 3H, Ha), 1.86 – 1.78 (m, 2H, Hs), 1.04 (t, J = 7.4 Hz, 3H, Ht).  13C NMR (126 MHz, 
CDCl3) δ 191.73, 161.02, 160.36, 160.19, 160.12, 158.38, 156.44, 156.30, 155.75, 
138.68, 138.51, 137.93, 137.27, 122.64, 120.63, 118.47, 108.97, 108.66, 108.42, 108.26, 
108.17, 71.32, 71.05, 70.98, 70.15, 24.55, 22.58, 10.61.  HRMS (NSI+): m/z = 528.228 
[M+H]+ (calcd. 528.2245 for C31H30DN2O6+). 
Synthesis of 28 
 
To a solution of 11 (0.310 g, 1.67 mmol, 1.0 equiv) and 27 (3.80 g, 8.50 mmol, 5.0 
equiv) in dry THF (40 mL) was added CsCO3 (2.77 g, 8.50 mmol, 5.0 equiv) and the 
solution stirred at room temperature under nitrogen for 16 h.  CH2Cl2 (50 mL) and H2O 
(50 mL) were added and the two phases separated.  The organic layer was dried over 
MgSO4, the solvent removed under reduced pressure and the crude product purified by 
column chromatography (SiO2, petrol ether/EtOAc 2:1) to give 28 (0.58 g, 74%) as a 
colourless oil.  1H NMR (500 MHz, CDCl3): δ = 7.84 (d, J = 8.1 Hz, 2H, Hl/m), 7.73 (t, J = 
7.8 Hz, 1H, Hi), 7.43 (d, J = 7.8 Hz, 1H, Hh/j), 7.37 (d, J = 7.8 Hz, 1H, Hh/j), 7.34 (d, J = 8.1 
Hz, 1H, Hl/m), 7.06 – 7.04 (m, 1H, Hd/f), 7.04 – 7.02 (m, 1H, Hd/f), 6.78 (t, J = 2.2 Hz, 1H, 
He), 5.16 (s, 2H, Hg/k), 5.14 (s, 2H, Hg/k), 3.95 (t, J = 6.6 Hz, 2H, Hc), 2.44 (s, 3H, Hn), 1.87 
– 1.74 (m, 2H, Hb), 1.03 (t, J = 7.4 Hz, 3H, Ha).  13C NMR (126 MHz, CDCl3): δ = 191.59, 
161.03, 160.02, 156.43, 153.65, 145.24, 138.52, 138.02, 132.97, 130.07, 128.25, 121.09, 
121.08, 108.38, 108.32, 108.07, 71.67, 70.74, 70.17, 22.57, 21.80, 10.60.  HRES (ESI+): 






Synthesis of 29 
 
To a solution of 24 (0.22 g, 0.60 mmol, 1.0 equiv) in CHCl3 (150 mL) was added 14 
(0.36 g, 0.60 mmol, 1.0 equiv.) and the reaction mixture stirred at room temperature 
for 16 h.  The solvent was removed under reduced pressure and the crude product 
purified by column chromatography (SiO2, CH2Cl2/MeOH 97:3) to give 29 (0.42 g, 
77%) as a yellow oily solid.  1H NMR (400 MHz, CDCl3): δ = 9.91 (s, 1H, Hr), 7.84 (t, J = 
7.8 Hz, 1H, Hl), 7.46 (d, J = 7.7 Hz, 1H, Hk/m), 7.37 (s, 2H, He), 7.12 (d, J = 7.7 Hz, 1H, 
Hk/m), 6.99 (dd, J = 2.3, 1.2 Hz, 1H, Hq/o), 6.87 (dd, J = 2.3, 1.2 Hz, 1H, Hq/o), 6.74 (d, J = 
7.7 Hz, 4H, Hb), 6.57 (t, J = 2.3 Hz, 1H, Hp), 6.45 (d, J = 7.9 Hz, 4H, Hc), 5.88 (ddt, J = 17.0, 
10.2, 6.7 Hz, 1H, Hh), 5.26 – 5.13 (m, 2H, Hi), 4.60 (s, 2H, Hn), 4.28 = 4.20 (m, 4H, Hd+f), 
3.82 (d, J = 14.2 Hz, 2H, Hd’), 2.65 – 2.60 (m, 5H, Hg+j), 2.02 (s, 6H, Ha), 0.99 (s, 9H, Hs), 
0.22 (s, 6H, Ht).  13C NMR (126 MHz, CDCl3): δ = 191.66, 171.24, 169.42, 160.50, 158.98, 
157.54, 154.41, 139.14, 138.52, 138.19, 136.30, 133.21, 128.90, 127.35, 124.54, 120.60, 
118.20, 115.07, 113.27, 111.26, 107.96, 69.02, 68.89, 49.28, 33.08, 29.84, 26.07, 25.75, 
20.93, 18.35, -4.24.  HRMS (NSI+): m/z = 905.2932 [M+H]+ (calcd. 905.2926 for 
C47H55N4O6PdSi+). 





To a solution of 29 (0.077 g, 0.085 mmol, 1.0 equiv) in dry MeOH (20 mL) was added 
17 (0.013 g, 0.085 mmol, 1.0 equiv).  Glacial acetic acid (3 drops) was added and the 
solution stirred at room temperature under nitrogen for 12 h.  The solvent was 
removed under reduced pressure and the crude product purified by column 
chromatography (SiO2, CH2Cl2/MeOH 98:2) to yield 30 (0.083 g, 94%) as a yellow, oily 
solid.  1H NMR (400 MHz, CDCl3): δ = 8.98 (s, 1H, Hq), 7.83 (t, J = 7.8 Hz, 1H, Hk), 7.63 (s, 
1H, Haa), 7.47 (d, J = 7.7 Hz, 1H, Hj/l), 7.36 (s, 2H, He), 7.09 (d, J = 7.7 Hz, 1H, Hj/l), 6.84 
(s, 1H, Hn/p), 6.74 (d, J = 7.8 Hz, 4H, Hb), 6.65 (s, 1H, Hn/p), 6.44 (d, J = 7.8 Hz, 4H, Hc), 
6.34 (t, J = 2.2 Hz, 1H, Ho), 5.96 - 5.73 (m, 2H, Hx+h), 5.25 – 5.13 (m, 2H, Hs), 5.06 – 4.91 
(m, 2H, Hy), 4.71 (s, 2H, Hm), 4.25 (t, J = 6.6 Hz, 2H, Hf), 4.15 (d, J = 14.2 Hz, 2H, Hd/d’), 
3.90 (d, J = 14.2 Hz, 2H, Hd/d’), 2.74 (t, J = 7.5 Hz, 2H, Ht), 2.63 (q, J = 6.6 Hz, 2H, Hg), 2.55 
(s, 3H, Hi), 2.16 – 2.08 (m, 2H, Hw), 2.07 (s, 6H, Ha), 1.79 – 1.68 (m, 2H, Hu), 1.56 – 1.42 
(m, 2H, Hv), 0.96 (s, 9Hz), 0.20 (s, 6H, Hr).  13C NMR (126 MHz, CDCl3) δ 175.88, 174.09, 
171.20, 169.41, 163.59, 160.55, 159.14, 158.77, 157.24, 154.42, 150.97, 142.56, 142.46, 
139.12, 138.74, 138.11, 136.34, 135.82, 133.18, 129.52, 128.91, 127.90, 127.33, 124.46, 
120.61, 118.24, 114.75, 111.64, 111.51, 111.43, 111.20, 108.52, 107.41, 107.35, 69.06, 
68.88, 49.33, 33.67, 33.07, 32.74, 28.75, 25.83, 24.36, 21.01, 18.41, -4.18. HRMS (NSI+): 
m/z = 1029.3939 [M+H]+ (calcd. 1029.3926 for C54H67N6O6PdSi+). 
Synthesis of M21 
 
To an oven-dried round-bottom flask was added 30 (103 mg, 0.10 mmol, 1.0 equiv) and 
the flask purged with nitrogen.  CH2Cl2 (110 mL, purged with N2) was added via 
syringe.  Grubbs II (8.5 mg, 0.01 mmol, 0.1 equiv) was added and a light vacuum 
applied to the flask for 5 min.  The flask was purged with nitrogen for 15 min and 
stirred at room temperature for 24 h. Additional Grubbs II (8.5 mg, 0.01 mmol, 0.1 
equiv) was added and a light vacuum applied to the flask for 5 min.  The flask was 
purged with nitrogen for 15 min and stirred at room temperature for 24 h.  Ethyl vinyl 




under reduced pressure and the crude residue was purified by column 
chromatography (SiO2, EtOAc) to give a yellow solid HRMS (NSI+): m/z = 1001.3618 
[M+H]+ (calcd. 1001.3613 for C52H63N6O6PdSi+)(58 mg, 58%), which was dissolved in 
dry THF (10 mL).  TBAF (1 M in THF, 0.17 mL, 0.17 mmol, 1 equiv) at 0 °C forming a 
yellow solution which was stirred for 2 h.  The reaction was quenched with H2O (4 mL) 
at 0 °C and the crude product extracted with CH2Cl2, washed with H2O and brine, and 
dried over MgSO4.  The crude product was purified by column chromatography (SiO2, 
MeOH/CH2Cl2 1:99) to give a brown oil, which was dissolved in dry THF (10 mL).  
K2CO3 (37 mg, 0.27 mmol, 5 equiv) was added with Pd(OH)2/C (5 mg) and the solution 
stirred at room temperature in the presence of hydrogen gas for 4 h.  The reaction 
mixture was filtered through celite and the solvent removed under reduced pressure.  
The crude residue was purified by column chromatography (SiO2, CH2Cl2/MeOH 96:4) 
to yield M21 (27 mg, 52% from 30) as a yellow solid.  1H NMR (400 MHz, C2D2Cl4, 378 
K): δ = 8.51 (s, 1H, Ho), 7.84 (t, J = 7.8 Hz, 1H, Hr), 7.49, (d, J = 7.8 Hz, 1H, Hq/s), 7.31 (s, 
2H, He), 7.10 (d, J = 7.8 Hz, 1H, Hq/s), 6.88 (d, J = 7.6 Hz, 4H, Hb), 6.76 (s, 1H, Hu/w), 6.73 
(s, 1H, Hv), 6.62 (d, J = 7.7 Hz, 4H, Hc), 6.53 (s, 1H, Hu/w), 5.18 (s, 2H, Ht), 4.36 (t, J = 5.7 
Hz, 2H, Hf), 4.26 (d, J = 14.4 Hz, 2H, Hd), 3.91 (d, J = 14.4 Hz, 2H, Hd’), 2.62 – 2.59 (m, 2H, 
Hm), 2.55 (s, 3H, Hp), 2.23 (s, 6H, Ha), 2.00 – 1.89 (m, 2H, Hg), 1.78 – 1.69 (m, 2H, Hn), 
1.63 – 1.54 (m, 2H, Hl), 1.50 – 1.45 (m, 8H, Hh,i,j,k).  HRMS (NSI+): m/z = 889.2914 [M+H]+ 





Figure 4.7 - 1H NMR spectra (400 MHz, C2D2Cl4) of M21: (a) 378 K; (b) 348 K ;(c) 318 K; (d) 298 
K. 
Synthesis of 1,2-T1 
 
To a mixture of M21 (30 mg, 0.034 mmol, 1.0 equiv) and CsCO3 (55.4 mg, 0.17 mmol, 
5.0 equiv) in dry THF (10 mL) was added 28 (31 mg, 0.067 mmol, 2.0 equiv) and the 
mixture stirred at room temperature for 15 h.  The solvent was removed under 
reduced pressure and the crude residue purified by column chromatography (SiO2, 
CH2Cl2/MeOH 95:5) to give 1,2-T1 (24 mg, 61%) as a brown solid.  1H NMR (400 MHz, 
C2D2Cl4, 378 K): δ = 8.60 – 8.51 (m, 1H, Ho), 7.87 – 7.77 (m, 2H, Hr+z), 7.53 – 7.45 (m, 
2H, Hq/s+y/aa), 7.31 (s, 2H, He), 7.17 – 7.13 (m, 1H, Hcc), 7.11 – 7.06 (m, 3H, Hq/s+y/aa+bb), 
6.90 (t, J = 2.3 Hz, 1H, Hdd), 6.83 (d, J = 7.7 Hz, 4H, Hb), 6.82 – 6.78 (m, 1H, Hu/w), 6.71 (t, 




5.29 (s, 2H, Hbb), 5.26 (s, 2H, Ht), 4.35 (t, J = 5.9 Hz, 2H, Hf), 4.12 (d, J = 14.5 Hz, 2H, Hd), 
4.03 (t, J = 6.5 Hz, 2H, Hff), 3.96 (d, J = 14.5 Hz, 2H, Hd’), 2.63 – 2.58 (m, 2H, Hm), 2.58 (s, 
3H, Hp), 2.17 (s, 6H, Ha), 1.94 – 1.78 (m, 4H, Hl+gg), 1.73 – 1.35 (m, 10H, Hg,h,i,j,k), 1.08 (t, J 
= 7.4 Hz, 3H, Hhh). 
 
Figure 4.8 - 1H NMR spectra (400 MHz, C2D2Cl4, 378 K) of 1,2-T1 . 
 
Synthesis of (2,6-lutidine),2-T1 
 
A solution of 1,2-T1 ( 5.0 mg, 4.26 µmol, 1.0 equiv) and 2,6-lutidine (2.3 mg, 21.0 µmol, 
5.0 equiv) in CDCl3/CD3CN (7:3, 0.50 mL) was heated at 65 °C for 23 h.  The crude 
mixture was purified by preparative thin layer chromatography (SiO2, CH2Cl2/MeOH 
95:5) to give (2,6-lutidine),2-T1 (3.50 mg, 70%) as a viscous yellow oil.  1H NMR (500 
MHz, CDCl3): δ = 9.21 (s, 1H, Hn), 7.76 (t, J = 7.8 Hz, 1H, Hdd), 7.69 (s, 1H, Haa), 7.61 (t, J = 
7.7 Hz, 1H, Hx), 7.61 (t, J = 7.7 Hz, 1H, Hu), 7.47 – 7.43 (m, 2H, Hcc+ee), 7.34 (s, 2H, He), 
7.33 (d, J = 6.3 Hz, 1H, Ht/v), 7.12 (d, J = 6.3 Hz, 1H, Ht/v), 7.08 (dd, J = 2.3, 1.2 Hz, 1H, 
Hgg), 7.04 (dd, J = 2.3, 1.2 Hz, 1H, Hii), 6.95 (s, 1H, Hp/q), 6.94 (d, J = 7.7 Hz, 2H, Hy), 6.87 




Hr), 6.47 (d, J = 7.9 Hz, 4H, Hc), 5.24 (s, 4H, Hbb+ff), 5.21 (s, 2H, Hs), 4.15 (t, J = 6.5 Hz, 2H, 
Hjj), 4.02 (s, 4H, Hd), 3.96 (t, J = 6.6 Hz, 2H, Hf), 2.75 (t, J = 7.2 Hz, 2H, Hm), 2.43 (s, 6H, 
Hz), 2.24 (s, 6H, Ha), 1.84 – 1.79 (m, 2Hkk), 1.77 – 1.70 (m, 4Hg+l), 1.51 – 1.45 (m, 4H), 
1.04 (t, J = 7.4 Hz, 3H, Hll).  13C NMR (126 MHz, CDCl3): δ = 175.69, 171.31, 169.52, 
161.03, 160.58, 160.15, 160.07, 159.88, 158.20, 156.77, 156.33, 156.20, 154.38, 142.54, 
138.61, 138.51, 138.25, 137.91, 137.26, 136.29, 135.96, 129.50, 128.74, 127.88, 127.47, 
122.73, 122.51, 120.58, 120.49, 118.41, 111.65, 111.17, 108.49, 108.43, 108.02, 106.80, 
106.27, 103.96, 71.08, 71.02, 70.86, 70.17, 69.95, 49.35, 43.38, 32.60, 32.07, 29.85, 
29.75, 29.61, 29.51, 29.40, 29.28, 29.22, 29.08, 28.83, 28.53, 25.63, 25.54, 24.55, 24.50, 
22.84, 22.59, 21.23, 21.16, 14.26, 10.62.  HRMS (NSI+): m/z = 1280.4898 [M+H]+ (calcd. 
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